
<html lang="en"     class="pb-page"  data-request-id="ccb412c8-7768-4248-bda9-5b0863f0281b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.6b00085;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold" /></meta><meta name="dc.Creator" content="Vincent M.  Crowley" /></meta><meta name="dc.Creator" content="Anuj  Khandelwal" /></meta><meta name="dc.Creator" content="Sanket  Mishra" /></meta><meta name="dc.Creator" content="Andrew R.  Stothert" /></meta><meta name="dc.Creator" content="Dustin J. E.  Huard" /></meta><meta name="dc.Creator" content="Jinbo  Zhao" /></meta><meta name="dc.Creator" content="Aaron  Muth" /></meta><meta name="dc.Creator" content="Adam S.  Duerfeldt" /></meta><meta name="dc.Creator" content="James L.  Kizziah" /></meta><meta name="dc.Creator" content="Raquel L.  Lieberman" /></meta><meta name="dc.Creator" content="Chad A.  Dickey" /></meta><meta name="dc.Creator" content="Brian S. J.  Blagg" /></meta><meta name="dc.Description" content="Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum resident of the heat shock protein 90 kDa (Hsp90) family of molecular chaperones. Grp94 associates with many proteins involved in c..." /></meta><meta name="Description" content="Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum resident of the heat shock protein 90 kDa (Hsp90) family of molecular chaperones. Grp94 associates with many proteins involved in c..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 4, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00085" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00085" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00085" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00085" /></link>
        
    
    

<title>Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00085" /></meta><meta property="og:title" content="Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0019.jpeg" /></meta><meta property="og:description" content="Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum resident of the heat shock protein 90 kDa (Hsp90) family of molecular chaperones. Grp94 associates with many proteins involved in cell adhesion and signaling, including integrins, Toll-like receptors, immunoglobulins, and mutant myocilin. Grp94 has been implicated as a target for several therapeutic areas including glaucoma, cancer metastasis, and multiple myeloma. While 85% identical to other Hsp90 isoforms, the N-terminal ATP-binding site of Grp94 possesses a unique hydrophobic pocket that was used to design isoform-selective inhibitors. Incorporation of a cis-amide bioisostere into the radamide scaffold led to development of the original Grp94-selective inhibitor, BnIm. Structure–activity relationship studies have now been performed on the aryl side chain of BnIm, which resulted in improved analogues that exhibit better potency and selectivity for Grp94. These analogues also manifest superior antimigratory activity in a metastasis model as well as enhanced mutant myocilin degradation in a glaucoma model compared to BnIm." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00085"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00085">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00085&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00085&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00085&amp;href=/doi/10.1021/acs.jmedchem.6b00085" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3471-3488</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00120" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00176" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincent+M.++Crowley">Vincent M. Crowley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anuj++Khandelwal">Anuj Khandelwal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sanket++Mishra">Sanket Mishra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+R.++Stothert">Andrew R. Stothert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dustin+J.+E.++Huard">Dustin J. E. Huard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinbo++Zhao">Jinbo Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aaron++Muth">Aaron Muth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam+S.++Duerfeldt">Adam S. Duerfeldt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+L.++Kizziah">James L. Kizziah</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raquel+L.++Lieberman">Raquel L. Lieberman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chad+A.++Dickey">Chad A. Dickey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+S.+J.++Blagg">Brian S. J. Blagg</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry, The University of Kansas, 1251 Wescoe Hall Drive, Malott Hall 4070, Lawrence, Kansas 66045-7563, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Molecular Medicine and Byrd Alzheimer’s Research Institute, University of South Florida, Tampa, Florida 33613, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332 United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 785-864-2288. Fax: 785-864-5326. E-mail: <a href="/cdn-cgi/l/email-protection#9efcfcf2fff9f9def5ebb0fbfaeb"><span class="__cf_email__" data-cfemail="d5b7b7b9b4b2b295bea0fbb0b1a0">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00085&amp;href=/doi/10.1021%2Facs.jmedchem.6b00085" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3471–3488</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 22, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 January 2016</li><li><span class="item_label"><b>Published</b> online</span>4 April 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00085" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00085</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3471%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVincent%2BM.%2BCrowley%252C%2BAnuj%2BKhandelwal%252C%2BSanket%2BMishra%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D7%26contentID%3Dacs.jmedchem.6b00085%26title%3DDevelopment%2Bof%2BGlucose%2BRegulated%2BProtein%2B94-Selective%2BInhibitors%2BBased%2Bon%2Bthe%2BBnIm%2Band%2BRadamide%2BScaffold%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3488%26publicationDate%3DApril%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00085"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2323</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00085" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;M. Crowley&quot;},{&quot;first_name&quot;:&quot;Anuj&quot;,&quot;last_name&quot;:&quot;Khandelwal&quot;},{&quot;first_name&quot;:&quot;Sanket&quot;,&quot;last_name&quot;:&quot;Mishra&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;R. Stothert&quot;},{&quot;first_name&quot;:&quot;Dustin&quot;,&quot;last_name&quot;:&quot;J. E. Huard&quot;},{&quot;first_name&quot;:&quot;Jinbo&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Aaron&quot;,&quot;last_name&quot;:&quot;Muth&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;S. Duerfeldt&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;L. Kizziah&quot;},{&quot;first_name&quot;:&quot;Raquel&quot;,&quot;last_name&quot;:&quot;L. Lieberman&quot;},{&quot;first_name&quot;:&quot;Chad&quot;,&quot;last_name&quot;:&quot;A. Dickey&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;S. J. Blagg&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;3471-3488&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00085&quot;},&quot;abstract&quot;:&quot;Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum resident of the heat shock protein 90 kDa (Hsp90) family of molecular chaperones. Grp94 associates with many proteins involved in cell adhesion and signaling, including integrins, Toll-like receptors, immunoglobulins, and mutant myocilin. Grp94 has been implicated as a target for several therapeutic areas including glaucoma, cancer metastasis, and multiple myeloma. While 85% identical to other Hsp90 isoforms, the N-terminal ATP-binding site of Grp94 possesses a unique hydrophobic pocket that was used to design isoform-selective inhibitors. Incorporation of a cis-amide bioisostere into the radamide scaffold led to development of the original Grp94-selective inhibitor, BnIm. Structure–activity relationship studies have now been performed on the aryl side chain of BnIm, which resulted in improved analogues that exhibit better potency and selectivity for Grp94. These analogues also manifest superior antimigratory activity in a metastasis model as w&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00085&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00085" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00085&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00085" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00085&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00085" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00085&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00085&amp;href=/doi/10.1021/acs.jmedchem.6b00085" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00085" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00085" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00085%26sid%3Dliteratum%253Aachs%26pmid%3D27003516%26genre%3Darticle%26aulast%3DCrowley%26date%3D2016%26atitle%3DDevelopment%2Bof%2BGlucose%2BRegulated%2BProtein%2B94-Selective%2BInhibitors%2BBased%2Bon%2Bthe%2BBnIm%2Band%2BRadamide%2BScaffold%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D7%26spage%3D3471%26epage%3D3488%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/jmcmar.2016.59.issue-7/20160414-01/jmcmar.2016.59.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Glucose regulated protein 94 (Grp94) is the endoplasmic reticulum resident of the heat shock protein 90 kDa (Hsp90) family of molecular chaperones. Grp94 associates with many proteins involved in cell adhesion and signaling, including integrins, Toll-like receptors, immunoglobulins, and mutant myocilin. Grp94 has been implicated as a target for several therapeutic areas including glaucoma, cancer metastasis, and multiple myeloma. While 85% identical to other Hsp90 isoforms, the N-terminal ATP-binding site of Grp94 possesses a unique hydrophobic pocket that was used to design isoform-selective inhibitors. Incorporation of a <i>cis</i>-amide bioisostere into the radamide scaffold led to development of the original Grp94-selective inhibitor, BnIm. Structure–activity relationship studies have now been performed on the aryl side chain of BnIm, which resulted in improved analogues that exhibit better potency and selectivity for Grp94. These analogues also manifest superior antimigratory activity in a metastasis model as well as enhanced mutant myocilin degradation in a glaucoma model compared to BnIm.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Molecular chaperones are responsible for the conformational maturation of nascent polypeptides into their bioactive conformations.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> One family of chaperones is the 90 kDa heat shock proteins (Hsp90), which has emerged as a promising therapeutic target for the treatment of many diseases.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7">(2-7)</a> The Hsp90 family is responsible for the maturation of more than 200 client proteins, many of which belong to signaling pathways that are commonly hijacked in cancer. In fact, Hsp90 clients are directly associated with all ten hallmarks of cancer and thus represents a unique opportunity to simultaneously target multiple oncogenic pathways.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Hsp90 exists as a homodimer within cells and consists of three domains: an N-terminal domain, a middle domain, and a C-terminal dimerization domain. The N-terminal domain contains an ATP-binding pocket in which ATP hydrolysis provides the necessary energy for client protein maturation. The middle domain is responsible for client protein binding and interactions with cochaperones and partner proteins. The C-terminal domain contains a dimerization motif and is responsible for modulating client protein release.</div><div class="NLM_p">The majority of Hsp90 research has focused on the development of N-terminal inhibitors, which compete with ATP within the binding site.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> N-terminal inhibitors have entered clinical studies for the treatment of various cancers.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> However, some concerns have been raised that must be addressed before new Hsp90 inhibitors are developed. A common factor among all clinical candidates is that they exhibit <i>pan</i>-Hsp90 inhibition, meaning they manifest similar affinities against all four Hsp90 isoforms: Hsp90α and Hsp90β are found in the cytosol, tumor necrosis factor receptor-associated protein 1 (Trap1) is localized to the mitochondria, and glucose regulated protein 94 (Grp94) resides in the endoplasmic reticulum (ER).</div><div class="NLM_p">Many clients of the Hsp90-dependent protein folding process have been identified, however, clients with specific dependency on each isoform remain underinvestigated although some isoform-dependent substrates have been determined. For instance, maturation of the hERG channel and its trafficking to the cell surface was found to be solely dependent upon the Hsp90α isoform and suggests that inhibition of Hsp90α may contribute to some of the cardiotoxicity observed in clinical trials.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> It is also likely that other isoform-dependent client proteins contribute to other toxicities, which highlights the need to develop new strategies for Hsp90 inhibition. An alternative to <i>pan</i>-inhibition is the development of isoform-selective inhibitors. Such molecules would provide an opportunity to elucidate isoform-dependent client proteins associated with each isoform while simultaneously reducing/derisking potential liabilities associated with <i>pan</i>-inhibition. Unfortunately, the development of isoform-selective inhibitors is challenging due to the fact that 85% identity is shared within the N-terminal ATP-binding site of all four Hsp90 isoforms. In fact, Hsp90α and Hsp90β are 95% identical within their N-terminal ATP-binding pocket, while Grp94 is least similar to only 85% identity.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a></div><div class="NLM_p">Grp94 is responsible for the maturation of proteins associated with cell-to-cell signaling and cell adhesion. Client proteins dependent upon Grp94 include many integrins (α-2, α-4, α-L, and β-4), Toll-like receptors (TLR1, TLR2, TLR4, and TLR9), insulin-like growth factor-I and -II, immunoglobulins, and mutant myocilin.<a onclick="showRef(event, 'ref5 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref5 ref20 ref21 ref22">(5, 20-22)</a> Grp94 is essential only during embryonic development and therefore appears to represent a nontoxic drug target. However, overexpression of Grp94 is associated with tumor aggressiveness and poor clinical prognosis for cancer patients.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In fact, Grp94 is responsible for the maturation and trafficking of proteins required for metastasis and cell migration and thus represents a nontoxic target for the development of antimetastatic agents. More recently, mutant myocilin has also been identified as a Grp94-dependent substrate and studies have shown that inhibition of Grp94 leads to the disaggregation of mutant myocilin and consequently represents a novel target for the treatment of primary open-angle glaucoma (POAG).<a onclick="showRef(event, 'ref4 ref21 ref24'); return false;" href="javascript:void(0);" class="ref ref4 ref21 ref24">(4, 21, 24)</a> While Grp94 may represent an ideal target for cell migration and glaucoma, Grp94 has also been shown to be essential in multiple myeloma, which appears to possess increased ER stress. Inhibition of Grp94 has been shown to induce cell death in multiple myeloma, as disruption of interactions between Grp94 and LRP6 results in reduced cell-trafficking of LRP6 to the cell surface.<a onclick="showRef(event, 'ref3 ref5 ref25'); return false;" href="javascript:void(0);" class="ref ref3 ref5 ref25">(3, 5, 25)</a> LRP6 is a coreceptor of Frizzled in the Wnt pathway and reduction of these interactions leads to caspase 9 activation and apoptosis. Grp94 has also been shown to interact with Her2 and, consequently, disruption of these interactions leads to Her2 degradation via the lysosome and may represent an alternative mechanism to treat Her2 overexpressing breast cancers.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a></div><div class="NLM_p">Grp94 is least similar, in its N-terminal ATP-binding pocket, to other Hsp90 isoforms due to a five amino acid insertion (QEDGQ) into the primary sequence.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This insertion results in the creation of a hydrophobic, secondary binding region within the N-terminal ATP-binding site of Grp94. As such, this unique pocket provides an opportunity to develop Grp94-selective inhibitors.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> Prior studies via a high throughput screening method identified NECA (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) as a Grp94-selective inhibitor that bound to this secondary pocket.<a onclick="showRef(event, 'ref22 ref30'); return false;" href="javascript:void(0);" class="ref ref22 ref30">(22, 30)</a> Recently, a high throughput screen identified a series of Grp94-selective inhibitors based on the purine scaffold and subsequent optimization led to the development of <b>2</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Co-crystallization of <b>3</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) with Grp94 showed this inhibitor to induce a conformational change within Grp94 that revealed an extended binding pocket distinct from the secondary pocket observed with NECA and RDA (<b>4</b>).<a onclick="showRef(event, 'ref26 ref27 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref30 ref31 ref32">(26, 27, 30-32)</a> Co-crystallization of the resorcinol containing <i>pan</i>-Hsp90 inhibitor, radamide (RDA, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) with canine Grp94 (cGrp94), revealed that the amide bond existed in both the <i>cis</i>- and <i>trans</i>-amide conformations.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The <i>cis</i>-amide conformation projected the quinone moiety into the secondary binding pocket, while the <i>trans</i>-amide did not. On the basis of the RDA co-crystal structure, it was clear that a <i>cis</i>-amide conformation was required for selective Grp94 inhibition. The incorporation of a <i>cis</i>-amide bioisostere (e.g., imidazole) into the RDA scaffold predisposes the aryl ring into the unique binding pocket found in Grp94 and ultimately led to the discovery of BnIm (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> BnIm demonstrates Grp94 selectivity in vitro as determined by inhibition of IGF-II secretion and the trafficking of Toll-like receptors at concentrations that did not result in cytosolic Hsp90-dependent client protein degradation. BnIm provided a lead compound for Grp94-selective inhibition, however, analysis of the unique binding pocket of Grp94 revealed further interactions could be realized improving the selectivity and affinity of this scaffold for Grp94, reported herein.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Purine-based Grp94-selective inhibitors (<b>1</b>, <b>2</b>, and <b>3</b>). Resorcinol-based <i>pan</i>-Hsp90 (<b>4</b>) and Grp94-selective (<b>5</b>) inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Grp94-Selective Inhibitor Design, Synthesis, and Biochemical Screening</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63507" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63507" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The co-crystal structure of RDA with cGrp94 revealed the <i>cis</i>-amide to project the aryl side chain into the secondary binding pocket, which is surrounded by hydrophobic amino acids (Val82, Ile166, Ala167, Phe195, Val197, Phe199, Tyr200, and Trp223), suggesting that affinity may be increased through additional hydrophobic interactions (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>a).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In contrast, Hsp90β contains the backbone carbonyl of Asn92 and the ε-NH<sub>2</sub> of Lys98, which blocks access to these hydrophobic residues and can be used as a paradigm to predict Grp94-selective inhibition (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>b). Docking of BnIm into the RDA co-crystal structure with Grp94 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD">2GFD</a>) suggested that substitutions on the aryl side chain would provide additional interactions with the secondary pocket of Grp94, allowing for optimization of the aryl side chain for Grp94-selective inhibition. Nonpolar substitutions at the 4-position were proposed to extend further into the hydrophobic pocket and to produce increased affinity and selectivity. However, larger substitutions at this position would likely result in steric clash with Val82 and exhibit decreased affinity. Because of the close proximity of Tyr200 to the 3-position of the aryl side chain, substitutions at this position appeared detrimental to Grp94 affinity. Substitutions at the 2-position were likely to increase affinity through hydrophobic interactions with the secondary pocket. Furthermore, these substitutions have the potential to produce the conformational shift observed with the purine-based Grp94-selective inhibitor, <b>3</b> (see <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), and project into the extended binding pocket.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> On the basis of these observations, the aryl side chain of BnIm was investigated to probe the unique pocket present in Grp94 and to elucidate structure–activity relationships for optimal affinity and selectivity</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structures of RDA with Hsp90 isoforms. cGrp94 (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD">2GFD</a>) highlights the hydrophobic and π-rich nature of the unique secondary binding pocket of Grp94. Only <i>cis</i>-RDA shown for clarity. yHsp82 (B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS">2FXS</a>) highlights the hydrogen bonding network present and restricted access to the aromatic residues. Residues are numbered as in their respective proteins. BnIm docked in to Gpr94 (C) highlighting substitution positions on the aryl side chain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because the <i>cis</i>-amide bioisostere, imidazole, could be prepared via a multicomponent cyclization reaction with an aromatic aldehyde, access to the desired analogues was achieved by varying the substitutions on the aryl amine component, which were either commercially available or readily accessible (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). 4-Ethynylbenzylamine (<b>6a</b>) was synthesized from 4-iodobenzylamine following literature precedent.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Aromatic nitriles were reduced using lithium aluminum hydride to produce the requisite amines (<b>6b</b>–<b>e</b>). The substituted benzoic acid was reduced to the corresponding benzyl alcohol, <b>8</b>, using lithium aluminum hydride, and then converted to the corresponding azide, which was subsequently reduced to the desired amine, <b>6f</b>, via Staudinger reduction. The basic amines were then cyclized with aldehyde <b>9</b> in the presence of ammonium bicarbonate and glyoxal, followed by desilylation with tetrabutylammonium fluoride to provide the desired analogues, <b>10</b>–<b>64</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).<a onclick="showRef(event, 'ref28 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref28 ref35 ref36">(28, 35, 36)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) LiAlH<sub>4</sub>, THF, 0–25 °C, 12 h; (b) DBU, DPPA, toluene, 0–25 °C, 12 h; (c) PPh<sub>3</sub>, THF:H<sub>2</sub>O (10:1), 25 °C, 12 h.</p></p></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Once in hand, the analogues were screened via a competitive binding fluorescence polarization assay using Grp94 or Hsp90α and FITC-labeled geldanamycin (FITC-GDA). Geldanamcyin is a potent, natural product N-terminal <i>pan</i>-Hsp90 inhibitor that competes with Grp94 inhibitors for the N-terminal ATP-binding site.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Analogues were originally screened at 25 μM to determine the percent of FITC-GDA (tracer) bound compared to vehicle control (0% tracer displaced, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Apparent <i>K</i><sub>d</sub> Values with Grp94 and Hsp90α</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0016.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">% Tracer bound determined when incubated with 25 μM of inhibitors. Data are the average of at least two experiments ± SEM. n.d. = not determined.</p></div></div><div></div></div><div class="NLM_p">The 25 μM screen provided insight into the structural requirements for binding of the aryl side chain to the Grp94 secondary pocket. Substitutions at the 4-position typically maintained similar affinity as BnIm, but provided increased selectivity in several cases. As hypothesized, polar substitutions (<b>17</b> and <b>21</b>) manifested lower affinity due to the hydrophobic nature of the secondary binding pocket (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Incorporation of a bicyclic system was not tolerated as the naphthyl (<b>23</b> and <b>24</b>) and quinoline (<b>25</b>) derivatives manifested decreased affinity for both Grp94 and Hsp90α. Substitutions at the 3-position were not beneficial, as all of the analogues resulted in decreased affinity for both isoforms compared to BnIm. Alternatively, substitutions at the 2-position typically increased Grp94 affinity and improved selectivity versus Hsp90α.</div><div class="NLM_p">Analogues that displaced ≥70% of the tracer when incubated with Grp94 at 25 μM were subsequently evaluated to determine their apparent <i>K</i><sub>d</sub> against Grp94 and Hsp90α. BnIm manifests an apparent <i>K</i><sub>d</sub> of 1.1 μM for Grp94 and 13.1 μM for Hsp90α. Substitutions at the 4-position were designed to extend further into the hydrophobic pocket present in Grp94 and to increase selectivity over other isoforms. Modest increases in selectivity were observed with these compounds (<b>11</b>, <b>12</b>, and <b>18</b>), while increases in affinity were observed with analogues containing halogen substitutions. Incorporation of a larger methyl group (<b>14</b>) resulted in a substantial increase in selectivity for Grp94, as well as increased affinity. Extended alkyl chains (<b>15</b> and <b>16</b>) were too large for accommodation into the secondary pocket of Grp94 and resulted in decreased affinity.</div><div class="NLM_p">As observed in the 25 μM screen, substitutions at the 3-position did not manifest improved affinity nor selectivity for Grp94 compared to BnIm (<b>26</b>–<b>32</b>). Alternatively, substitutions at the 2-position provided additional insights into the modes of binding for these analogues. Small substitutions at the 2-position were tolerated, however, such substitutions did not increase selectivity or affinity. Larger substitutions produced increased selectivity for Grp94 versus other Hsp90 isoforms, as <b>38</b>, <b>39</b>, and <b>40</b> manifested >40-fold selectivity for Grp94 over Hsp90α, which is likely due to induction of a conformational shift in the tertiary structure of Grp94. Patel and colleagues previously reported the co-crystallization of <b>3</b> with Grp94 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>), in which a conformational shift was observed that resulted in an extended binding region within the Grp94 ATP-binding site.<a onclick="showRef(event, 'ref26 ref31'); return false;" href="javascript:void(0);" class="ref ref26 ref31">(26, 31)</a> This pocket is distinct from the secondary pocket observed with NECA and RDA (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), as this region opens due to the migration of Phe199, which allows additional access to the binding pocket as observed with <b>3</b>. Substitutions at the 2-position may also induce a similar conformational change in Grp94, which allows access to this region and increases selectivity for Grp94. In the case of <b>40</b> (Grp94 apparent <i>K</i><sub>d</sub> = 0.2 μM; 41-fold selective), the increased selectivity was accompanied by a ∼6-fold increase in affinity for Grp94 compared to BnIm. Extension or branching of the alkyl ether (<b>41</b> and <b>42</b>) improved affinity for Grp94, although a loss in selectivity was observed. Larger alkyl ethers were not accommodated within the secondary binding pocket of Grp94 and likely push the benzyl side chain toward the solvent exposed region to form hydrogen bonds with polar amino acids. Such polar residues are present in both Grp94 and Hsp90 and provides an explanation for the loss of selectivity and an increase in affinity. <b>44</b> was synthesized in an attempt to combine beneficial substitutions observed with the 2- and 4-positions, however, affinity was compromised as compared to the parent compounds (<b>14</b> and <b>38</b>), suggesting the effects of these substitutions are not additive (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Tertiary structure of RDA bound to Grp94 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD">2GFD</a>) showing the open conformation of the N-terminal domain of Grp94. (B) Tertiary structure of <b>3</b> bound to Grp94 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>) showing the conformational shift (blue, green, and orange helices) of the N-terminal domain induced by the inhibitor binding to Grp94 revealing the extended binding pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because of the high density of aromatic amino acids within the unique secondary binding pocket of Grp94, the incorporation of heterocycles was proposed to improve both π–π interactions and affinity for Grp94.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The requisite heterocyclic amines (<b>6g</b>–<b>l</b>) were synthesized from the corresponding aldehydes through conversion to the oximes (<b>66a</b>–<b>e</b>) followed by reduction via lithium aluminum hydride (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Chlorination of thiophen-2-ylmethanamine via sulfuryl chloride provided <b>6m</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Radical bromination of 5-methylisoxazole followed by conversion to the azide and subsequent reduction resulted in <b>6n</b>. The aromatic carboxylic acid <b>68</b> was reduced to the corresponding alcohol using lithium aluminum hydride followed by conversion to the azide and then Staudinger reduction to yield <b>6o</b>. Deprotonation of 3-chlorothiophene with <i>n</i>-butyllithium followed by the addition of CO<sub>2</sub>(<i>g</i>) provided a mixture of carboxylate regioisomers which were separable via flash chromatography after reduction to the corresponding alcohols (<b>69b</b> and <b>69c</b>) with lithium aluminum hydride. These isomers were then converted to the corresponding azides, followed by Staudinger reduction to provide the requisite basic amines, <b>6p</b> and <b>6q</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The desired analogues were obtained through the multicomponent reaction detailed in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> to produce analogues <b>45</b>–<b>64</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Amines from Aromatic Aldehydes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, Ac<sub>2</sub>O, 0 °C, 1 h; (b) 50% H<sub>2</sub>SO<sub>4</sub> (aq), 110 °C, 5 min; (c) conc HCl, 40 °C, 12 h; (d) NH<sub>2</sub>OH·HCl, NaOAc, MeOH, 25 °C, 8 h; (e) LiAlH<sub>4</sub>, THF, 0–25 °C, 12 h; (f) potassium vinyltrifluoroborate, Pd(dppf)Cl<sub>2</sub>, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, toluene, 110 °C, 14 h; (g) H<sub>2</sub>, 10% Pd/C, EtOH, 25 °C, 6 h.</p></p></figure><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) SO<sub>2</sub>Cl<sub>2</sub>, 15 °C, AcOH:Et<sub>2</sub>O (9:1), 1 h; (b) NBS, AIBN, CCl<sub>4</sub>, 80 °C, 4 h; (c) NaN<sub>3</sub>, MeOH:H<sub>2</sub>O (10:1), 25 °C, 12 h; (d) PPh<sub>3</sub>, THF:H<sub>2</sub>O (10:1), 25 °C, 12 h; (e) LiOH, THF:MeOH:H<sub>2</sub>O (9:1:1), 25 °C, 10 h; (f) LDA, MeI, THF, −40 °C, 3 h; (g) LiAlH<sub>4</sub>, THF, 0–25 °C, 12 h; (h) DBU, DPPA, toluene, 25 °C, 12 h; (i) <i>n</i>-BuLi, CO<sub>2</sub>(g), THF, −78 °C, 2 h.</p></p></figure><div class="NLM_p">As can be seen in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, the incorporation of an electron poor (compared to benzene) pyridine ring (<b>61</b>–<b>64</b>) resulted in decreased selectivity and affinity for Grp94. In contrast, the incorporation of electron rich five-membered heterocycles proved beneficial for Grp94 affinity. Converting the phenyl ring of BnIm to the bioisosteric replacement, thiophene (<b>50</b>), resulted in a significant increase in Grp94 affinity compared to BnIm. The furan and thiophene (<b>46</b> and <b>50</b>, respectively) analogues exhibited both increased affinity and selectivity and consequently, substitutions about these rings were explored. The energy minimized structures of BnIm and <b>46</b> were overlaid and revealed the 5-position of the heterocycle to align similar to the 4-position of the BnIm benzyl side chain (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Therefore, substitutions at the 5-position of both the furan and thiophene rings were sought to achieve increased selectivity and affinity.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of the minimized structures of BnIm (cyan) and <b>46</b> (green) highlighting the overlapping 4- and 5-positions, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Apparent <i>K</i><sub>d</sub> of Heterocyclic Analogues with Grp94 and Hsp90α</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0017.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0018.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">% Tracer bound determined when incubated with 25 μM of inhibitors. Data are the average of at least two experiments ± SEM. n.d. = not determined.</p></div></div><div></div></div><div class="NLM_p last"><b>53</b> was shown to manifest improved selectivity for Grp94 compared to the 3- and 4-chloro substituted thiophene analogues (<b>55</b> and <b>55</b>), supporting the hypothesis that 5-substituents bind similar to the 4-substituted phenyl ring. Incorporation of a 5-chloro substitution on the smaller furan ring (<b>48</b>) resulted in increased affinity for Grp94 while maintaining selectivity. However, incorporation of an ethyl substitution at the 3-position of the thiophene to mimic the 2-position of the benzene ring resulted in both reduced affinity and selectivity.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Co-Crystallization of Grp94 with a Grp94-Selective Inhibitor</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45023" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45023" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The co-crystal structure of the N-terminal domain of Grp94 lacking the acidic linker (NΔ41, see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a>) in complex with <b>48</b> (referred to as VC3 in the PBD file) was solved to 2.6 Å resolution to support the proposed docking interactions (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a, Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.6b00085/suppl_file/jm6b00085_si_001.pdf" class="ext-link">Table 1</a>). The structure reveals <b>48</b> in the ATP-binding site is stabilized by hydrogen bonding interactions with Asp149 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b,c), similar to other resorcinol-based <i>pan</i>-Hsp90 inhibitors. There are few other direct interactions between <b>48</b> and the NΔ41 ATP-binding site, which are mediated through conserved water molecules (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>c). In contrast to RDA, <b>48</b> is bound to Grp94 in a single orientation, illustrating the effectiveness of the <i>cis</i>-amide bioisostere in reducing binding heterogeneity.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of <b>48</b> bound to Grp94. (a) Surface representation of ATP-binding pocket with <b>48</b> as ball and stick. Arrow points to a well-ordered loop at the mouth of the active site. (b) Cartoon representation of the structure as in (a) highlighting H-bonding interactions (≤3.5 Å) and loop configuration. (c) Zoomed view of <b>48</b> in active site with H-bonding interactions as in (b). (d) Final 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density contoured at 1 σ (gray mesh) superimposed with initial <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> density contoured at 3 σ (green) after molecular replacement (see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The electron density for <b>48</b> was largely continuous for the length of the molecule, with the notable exception of the chlorinated furan moiety (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>d), which apparently samples multiple conformations within the ATP-binding site. It is possible that the chlorinated furan dwells in the extended hydrophobic region to increase selectivity (as predicted through modeling studies); however, the final binding mode modeled, based on optimal fit to 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>d) and <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> difference density (not shown), is one in which the chloride substituent is nestled in an ordered loop (residues 165–170) at the entry to the ATP-binding site (arrow, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a,b). Notably, this loop is disordered in the structure complexed with RDA. The furan moiety also appears to be involved in a cation−π interaction with Lys168 to stabilize this loop. In general, phenyl rings form stronger cation−π interactions due to a larger quadrapole moment compared to furan rings. However, modeling studies suggest that the phenyl ring of BnIm cannot orient in a manner that allows this interaction (data not shown) and therefore accounts for the increased affinity manifested by the smaller heterocycles (<b>45</b>–<b>60</b>). Taken together, <b>48</b>, and by analogy other analogues described within this series, bind to the ATP-binding site of Grp94 in a mode that manifests increased selectivity over the other Hsp90 isoforms.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Grp94-Selective Inhibition in Cancer</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63043" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63043" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Grp94 is responsible for the maturation and trafficking of several proteins associated with cell signaling and adhesion. One such client of Grp94 are the integrins, which are essential for cell adhesion and migration through promoting interactions between the intracellular actin cytoskeleton and the extracellular matrix.<a onclick="showRef(event, 'ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39">(37-39)</a> Integrins are dependent upon Grp94 for not only their maturation but also their transport to the cell surface. Therefore, inhibition of Grp94 leads to decreased trafficking of integrins to the cell surface and results in decreased integrin expression at the cell surface. As a result, decreased cell migration is observed and provides a new opportunity for the development of antimetastatic agents.<a onclick="showRef(event, 'ref29 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref29 ref40 ref41">(29, 40, 41)</a> For example, selective inhibition of Grp94 results in decreased migration of MDA-MB-231 cells, an aggressive form of metastatic breast cancer. In a wound-healing scratch assay, Grp94-selective inhibitors, <b>40</b> and <b>48</b>, produced decreased wound closing at 24 h compared to BnIm and vehicle control (70% and 73% closed at 500 nM, respectively, <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). In fact, these analogues manifested superior antimigratory activity compared to BnIm at 10-fold lower concentrations. Furthermore, these analogues were evaluated for antiproliferative activity against the same cell line and were found to manifest no antiproliferative activity up to 100 μM (78% and 107% viable at 100 μM, respectively, <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), confirming that the antimigratory activity is not linked to cell viability. These data are in agreement with the nonessential nature of Grp94 and provides a large therapeutic window for the development of Grp94-selective inhibitors as a new class of antimetastatic agents.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Wound-healing scratch assay results after 24 h treatment with BnIm, <b>40</b>, <b>48</b>, or vehicle. Antiproliferative activity given is relative to vehicle control (<i>n</i> = 4). ND = not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, integrin α2 was determined to be dependent upon Grp94 for its maturation and trafficking to the cell surface through proteomic and Western blot analyses of Grp94 knockdown cells.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Similarly, selective inhibition of Grp94 resulted in the degradation of integrin α2 (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A,B). Integrin α2 forms a heterodimer with integrin β1 on the cell surface,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> which is responsible for binding to collagen in the extracellular matrix to promote metastasis and invasion. <b>40</b> and <b>48</b> both induced the degradation of integrin α2, providing evidence that the decrease in cell migration results from Grp94-selective inhibition. Furthermore, <b>40</b> and <b>48</b> do not result in the degradation of Akt (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>C), a well-known client protein that is dependent upon the cytosolic isoforms of Hsp90. It should be noted that a slight induction of the pro-survival heat shock response was observed with <b>40</b> and <b>48</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>D). However, this occurred at concentrations 10–50-fold higher than antimigratory activity was demonstrated.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Western blot analysis of MDA-MB-231 cells treated with Grp94-selective inhibitors, geldanamycin (GDA, a <i>pan</i>-Hsp90 inhibitor), or vehicle control (DMSO, 0.25% final concentration). Ratio of Integrin α2 (B), Akt (C), and Hsp70 (D) normalized to actin for each compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Primary Open Angle Glaucoma and Grp94-Selective Inhibition</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64341" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64341" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although POAG is characterized clinically by irreversible optic nerve damage and retinal ganglion cell death that leads to vision loss, the risk factor of elevated intraocular pressure typically results from decreased outflow of the aqueous humor through Schlemm’s canal of the trabecular meshwork (TM) extracellular matrix in the anterior segment of the eye. A contributor to TM dysfunction is TM cell death,<a onclick="showRef(event, 'ref24 ref43'); return false;" href="javascript:void(0);" class="ref ref24 ref43">(24, 43)</a> which can be brought about by the aggregation of mutant myocilin.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Nonsynonymous mutations in myocilin, localized to its olfactomedin domain, result in non-native tertiary structures, which promote facile aggregation and leads to TM cell death.<a onclick="showRef(event, 'ref43 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref45">(43, 45)</a> Recently, it was demonstrated that Grp94 associates with amyloid-like aggregates of mutant myocilin but cannot triage these aggregates for degradation through the ER-associated degradation (ERAD) pathway.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Our prior studies showed that inhibition of Grp94 allows mutant myocilin degradation through autophagy, which decreases intracellular levels of myocilin and, ultimately, reduces toxicity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Therefore, these newly designed Gpr94-selective inhibitors were evaluated for their ability to promote mutant myocilin clearance in an inducible HEK model. Treatment with <b>48</b> resulted in a substantial decrease of mutant myocilin levels at 1 μM (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A,C), however, treatment with <b>40</b> only resulted in a slight decrease in myocilin levels. The difference in activity between <b>40</b> and <b>48</b> is not readily clear and is currently being investigated in our laboratory. As expected, <b>40</b> and <b>48</b> did not induce the degradation of the cytosolic Hsp90 isoform-dependent client, Akt (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B,D), nor was there any measurable induction of the pro-survival heat shock response, as monitored by Hsp70 induction (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>E). This is in contrast to Western blot analysis of the MDA-MB-231 cell line above (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) and is due to the Hsp90 isoforms in cancer cells having a higher affinity for inhibitors (and ATP) compared to the Hsp90 isoforms in nontransformed cells.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Western blot analysis of HEK cells overexpressing the I477N myocilin mutant and treated with 1 μM of indicated Grp94-selective inhibitors illustrating (A) myocilin degradation and (B) lack of AKT degradation and Hsp70 induction. Ratio of myocilin (C), AKT (D), and Hsp70 (E) normalized to actin for each compound. Vehicle = DMSO and 17-AAG = 17-(allylamino)-17-demethoxygeldanamycin (<i>pan</i>-Hsp90 N-terminal inhibitor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43442" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43442" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Structure–activity relationship studies were performed on the aryl side chain of BnIm, which interacts with the unique secondary pocket of Grp94 (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). Substitutions at the 2- and 4-positions were tolerated within this binding region. Incorporation of an ethoxy group at the 2-position manifested a significant increase in affinity, as well as selectivity. <b>40</b> manifests nearly a 10-fold increase in affinity for Grp94 compared to BnIm and 40-fold selectivity for Grp94 over the cytosolic Hsp90 isoforms. Replacing the phenyl ring of the side chain with five-membered heterocycles also resulted in increased affinity for Grp94 as observed with <b>48</b>. A crystal structure of the N-terminal domain of Grp94 was solved revealing a cation−π interaction between the furan ring and Lys168, which accounts for the increased affinity observed with the five-membered heterocycles. Grp94-selective inhibition reduced cell migration of aggressive breast cancer cells without manifesting toxicity and thus provided a large therapeutic index. Additionally, Grp94 inhibition resulted in the degradation of myocilin aggregates and provides a nontoxic approach to the treatment of POAG. These data presented herein provide a strong foundation for the further development of rationally designed Grp94-selective inhibitors for the treatment of metastasis and POAG.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0010.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Summary of structure–activity relationships for the BnIm series of Grp94-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry General</h3><div class="NLM_p last"><sup>1</sup>H NMR were recorded at 400 (Bruker AVIIIHD 400 MHz NMR with a broadband X-channel detect gradient probe) or 500 MHz (Avance AVIII 500 MHz spectrometer with a dual carbon/proton cryoprobe), and <sup>13</sup>C were recorded at 125 MHz (Bruker AVIII spectrometer equipped with a cryogenically cooled carbon observe probe); chemical shifts are reported in δ (ppm) relative to the internal standard (CDCl<sub>3,</sub> 7.26 ppm or MeOD, 3.31 ppm). HRMS spectra were recorded with a LCT Premier (Waters Cor., Milford, MA). The purity of compounds was determined by HPLC (Agilent 1100 series quaternary pump; 60% MeCN/40% water; Agilent C-18 column, 4.6 mm × 150 mm, 5 μM) with UV detection. All biologically tested compounds were determined to be >95% pure. TLC analysis was performed on glass backed silica gel plates and visualized by UV light. All solvents were reagent grade and used without further purification.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> General Procedure for Multicomponent Cyclization Reaction</h3><div class="NLM_p">Basic amines (e.g., <b>6a</b>–<b>6q</b>, 0.26 mmol) were added to a stirred solution of <b>9</b> (125 mg, 0.26 mmol) in wet MeOH (2 mL) and stirring continued for 30 min at rt before the addition of NH<sub>4</sub>HCO<sub>3</sub> (0.26 mmol) and glyoxal (0.26 mmol). After stirring for 12 h, tetrabutylammonium fluoride (0.52 mL of 1 M solution in THF, 0.52 mmol) was added and then stirred for 30 min before the reaction was quenched with saturated aqueous NH<sub>4</sub>Cl (10 mL) and extracted with EtOAc (3 × 10 mL). The organic layers were combined, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 1:49 MeOH:DCM) to afford the desired product as amorphous solids.</div><div id="sec7_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Methyl 2-(2-(1-Benzyl-1<i>H</i>-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate (<b>5</b>)</h4><div class="NLM_p last">Yield 54 mg (54%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.28–7.23 (m, 3H), 7.01–6.97 (m, 2H), 6.95 (d, <i>J</i> = 1.5 Hz, 1H), 6.81 (d, <i>J</i> = 1.5 Hz, 1H), 6.40 (s, 1H), 5.02 (s, 2H), 3.79 (s, 3H), 3.48–3.41 (m, 2H), 2.89–2.83 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.81, 162.06, 158.06, 147.65, 141.73, 136.17, 128.93, 127.99, 126.91, 126.53, 120.10, 114.76, 105.88, 102.46, 52.45, 49.38, 30.77, 26.08. HRMS (ESI) <i>m</i>/<i>z</i> [M – H]<sup>−</sup> C<sub>20</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>4</sub> 385.0955, found 385.0953. <i>t</i><sub>R</sub> = 5.062 min, 99.0%.</div></div><div id="sec7_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (4-Ethynylphenyl)methanamine (<b>6a</b>)</h4><div class="NLM_p last"><b>6a</b> was synthesized from 4-iodobenzylamine hydrochloride following procedures detailed in ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">34</a>. Yield 93 mg (78%) as a dark-yellow oil. <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.54 (d, <i>J</i> = 8.2 Hz, 2H), 7.44 (d, <i>J</i> = 8.3 Hz, 2H), 4.13 (s, 2H), 3.60 (s, 1H). <sup>13</sup>C NMR (126 MHz, MeOD) δ 133.56, 132.27 (2C), 128.71 (2C), 123.34, 82.10, 78.58, 42.51. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>9</sub>H<sub>10</sub>N 132.0813, found 132.0809.</div></div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> General Procedure for Reduction of Aromatic Nitriles</h3><div class="NLM_p">Benzonitriles (e.g., <b>7a</b>–<b>7c</b>, 0.7 M in THF, 1 equiv) were added dropwise to a stirred solution of LiAlH<sub>4</sub> (0.5 M in dry THF, 5 equiv) at 0 °C. The reaction mixture warmed to rt and stirred for 12 h. H<sub>2</sub>O (1 mL/g of LiAlH<sub>4</sub>) was added dropwise to quench the excess hydride, followed by 4 M NaOH (1 mL/g of LiAlH<sub>4</sub>) and EtOAc (3 mL/g of LiAlH<sub>4</sub>). The resulting suspension was filtered through a pad of Celite and the Celite washed with warm EtOAc (30 mL) and the eluent concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 1:49, MeOH:DCM to 1:20, MeOH:DCM) to afford the desired product as oils.</div><div id="sec7_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (2-Ethylphenyl)methanamine (<b>6b</b>)</h4><div class="NLM_p last">Yield 653 mg (79%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, MeOD) δ 6.77–6.69 (m, 1H), 6.63–6.56 (m, 2H), 6.58–6.48 (m, 1H), 4.51 (s, 2H), 2.07 (q, <i>J</i> = 7.6 Hz, 2H), 0.60 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (126 MHz, MeOD) δ 143.24, 129.80, 129.39, 129.10, 127.47, 126.97, 42.31, 26.37, 15.96. HRSM (ESI) <i>m</i>/<i>z</i> [M + NH<sub>4</sub>]<sup>+</sup> for C<sub>9</sub>H<sub>17</sub>N<sub>2</sub> 153.1392, found 153.1395.</div></div><div id="sec7_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (2-Ethoxyphenyl)methanamine (<b>6c</b>)</h4><div class="NLM_p last">Yield 215 mg (59%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.25–7.16 (m, 2H), 6.90 (t, <i>J</i> = 7.4 Hz, 1H), 6.85 (d, <i>J</i> = 8.5 Hz, 1H), 4.07 (q, <i>J</i> = 7.6, 7.1 Hz, 2H), 3.82 (s, 2H), 1.73 (br s, 2H), 1.44 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 156.82, 131.81, 128.52, 128.05, 120.37, 111.07, 63.33, 42.88, 14.98. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>9</sub>H<sub>14</sub>NO 152.1075, found 152.1077.</div></div><div id="sec7_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (2-Isopropoxyphenyl)methanamine (<b>6d</b>)</h4><div class="NLM_p last">Yield 243 mg (59%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.19 (t, <i>J</i> = 6.6 Hz, 2H), 6.92–6.83 (m, 2H), 4.59 (hept, <i>J</i> = 6.0 Hz, 1H), 3.79 (s, 2H), 1.74 (br s, 2H), 1.36 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 155.74, 132.68, 128.74, 127.95, 120.24, 112.53, 69.73, 43.07, 22.23 (2C). MS (EI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>10</sub>H<sub>15</sub>NO 165.1, found 165.2.</div></div><div id="sec7_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (2-Propoxyphenyl)methanamine (<b>6e</b>)</h4><div class="NLM_p last">Yield 265 mg (67%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.24–7.16 (m, 2H), 6.90 (t, <i>J</i> = 7.4 Hz, 1H), 6.85 (d, <i>J</i> = 8.5 Hz, 1H), 3.96 (t, <i>J</i> = 6.4 Hz, 2H), 3.83 (s, 2H), 1.90–1.78 (m, 4H), 1.06 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 156.94, 131.72, 128.50, 128.08, 120.33, 111.02, 69.26, 42.85, 22.70, 10.78. MS (EI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>10</sub>H<sub>15</sub>NO 165.1, found: 165.2.</div></div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for Staudinger Reduction</h3><div class="NLM_p">PPh<sub>3</sub> (1.1 equiv) was added to a stirred solution of the benzyl azide (1 equiv) in THF:H<sub>2</sub>O (0.1 M, 10:1) and stirred at rt for 12 h. The reaction mixture was concentrated, and the residue was purified via flash chromatography (SiO<sub>2</sub>, 1:49, MeOH:DCM to 1:20, MeOH:DCM) to afford the desired product as oils.</div><div id="sec7_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (2-Methoxy-4-methylphenyl)methanamine (<b>6f</b>)</h4><div class="NLM_p last">Yield 99 mg (73%) as a colorless oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.08 (d, <i>J</i> = 7.4 Hz, 1H), 6.72 (d, <i>J</i> = 7.4 Hz, 1H), 6.69 (s, 1H), 3.83 (s, 3H), 3.77 (s, 2H), 2.34 (s, 3H), 1.87 (br s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 157.32, 138.16, 128.47, 120.96, 111.24, 74.80, 55.12, 42.39, 21.55. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>9</sub>H<sub>14</sub>NO 152.1075, found 152.1076.</div></div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for Oxime Reduction</h3><div class="NLM_p">Aryl oximes (e.g., <b>66a</b>–<b>66e</b>, 0.7 M in THF, 1 equiv) were added dropwise to a stirred solution of LiAlH<sub>4</sub> (0.5 M in dry THF, 5 equiv) at 0 °C. The reaction mixture warmed to rt and stirred for 12 h. H<sub>2</sub>O (1 mL/g of LiAlH<sub>4</sub>) was added dropwise to quench the excess hydride, followed by 4 M NaOH (1 mL/g of LiAlH<sub>4</sub>) and EtOAc (3 mL/g of LiAlH<sub>4</sub>). The resulting suspension was then filtered through a pad of Celite and the Celite washed with warm EtOAc (30 mL), and the eluent was concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 1:49, MeOH:DCM to 1:20, MeOH:DCM) to afford the desired products as oils.</div><div id="sec7_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (5-Chlorofuran-2-yl)methanamine (<b>6g</b>)</h4><div class="NLM_p last">Yield 93 mg (47%), yellow oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.12 (d, <i>J</i> = 3.2 Hz, 1H), 6.06 (d, <i>J</i> = 3.2 Hz, 1H), 3.76 (d, <i>J</i> = 0.8 Hz, 2H), 1.58 (br s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 156.24, 156.23, 135.05, 107.49, 106.62, 39.35. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>5</sub>H<sub>7</sub>ClNO 132.0216, found 132.0221.</div></div><div id="sec7_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Thiazol-2-ylmethanamine (<b>6h</b>)</h4><div class="NLM_p last">Yield 42 mg (9%) as a red oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72 (d, <i>J</i> = 3.1 Hz, 1H), 7.26 (d, <i>J</i> = 3.2 Hz, 1H), 4.20 (s, 2H), 1.80 (br, s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 174.02, 142.60, 118.56, 44.04. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>4</sub>H<sub>7</sub>N<sub>2</sub>S 115.0330, found 115.0331.</div></div><div id="sec7_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (5-Methylthiophen-2-yl)methanamine (<b>6i</b>)</h4><div class="NLM_p last">Yield 72 mg (16%) as a yellow oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 6.70 (d, <i>J</i> = 3.4 Hz, 1H), 6.57 (dd, <i>J</i> = 3.3, 1.3 Hz, 1H), 3.96 (s, 2H), 2.72 (br s, 2H), 2.44 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 143.88, 138.89, 124.79, 124.03, 41.20, 15.40. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>6</sub>H<sub>10</sub>NS 128.0534, found 128.0532.</div></div><div id="sec7_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (3-Vinylthiophen-2-yl)methanamine (<b>6j</b>)</h4><div class="NLM_p last">Yield 152 mg (42%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.20–7.07 (m, 1H), 6.73 (dd, <i>J</i> = 17.5, 11.0 Hz, 1H), 5.54 (dd, <i>J</i> = 17.4, 1.3 Hz, 1H), 5.24 (dd, <i>J</i> = 11.0, 1.3 Hz, 1H), 4.07 (s, 1H), 2.03 (s, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 142.46, 135.23, 128.76, 125.43, 123.24, 114.19, 38.92. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>7</sub>H<sub>10</sub>NS 140.0534, found 140.0531.</div></div><div id="sec7_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (3-Vinylfuran-2-yl)methanamine (<b>6k</b>)</h4><div class="NLM_p last">Yield 57 mg (24%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.29 (dd, <i>J</i> = 2.0, 0.7 Hz, 1H), 6.57 (dd, <i>J</i> = 17.3, 10.7 Hz, 1H), 6.50 (d, <i>J</i> = 2.0 Hz, 1H), 5.42 (dd, <i>J</i> = 17.4, 1.4 Hz, 1H), 5.14 (dd, <i>J</i> = 10.8, 1.4 Hz, 1H), 3.85 (s, 2H), 1.67 (br s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 152.77, 141.68, 126.24, 119.34, 113.23, 107.72, 37.05. HRMS (ESI) [M + H]<sup>+</sup> for C<sub>7</sub>H<sub>10</sub>NO 124.0762, found 124.0768.</div></div><div id="sec7_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (3-Ethylthiophen-2-yl)methanamine (<b>6l</b>)</h4><div class="NLM_p last">Pd/C 10% (5 mol %) was added to a stirred solution of (3-vinylthiophen-2-yl)methanamine (<b>6k</b>, 50 mg, 0.36 mmol) in MeOH (5 mL) and stirred at rt under a hydrogen atmosphere for 12 h. The reaction mixture was filtered through a pad of Celite, and the eluent was concentrated to produce the title compound which was used without further purification. Yield 45 mg (89%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.16 (d, <i>J</i> = 5.1 Hz, 1H), 6.87 (d, <i>J</i> = 5.2 Hz, 1H), 4.56 (s, 2H), 4.05 (s, 2H), 2.61 (q, <i>J</i> = 7.6 Hz, 2H), 1.20 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 141.48, 134.90, 128.62, 123.84, 37.77, 21.46, 15.29. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>7</sub>H<sub>12</sub>NS 147.0690, found 147.0692.</div></div><div id="sec7_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (5-Chlorothiophen-2-yl)methanamine (<b>6m</b>)</h4><div class="NLM_p last">A solution of thiophene-2-ylmethanamine (1 mL, 9.7 mmol, 1 equiv) in AcOH:Et<sub>2</sub>O (9:1, 0.5 M) was cooled to 5 °C followed by the dropwise addition of SO<sub>2</sub>Cl<sub>2</sub> (1.18 mL, 14.6 mmol, 1.5 equiv), maintaining the reaction temperature under 20 °C. The reaction was stirred at rt for 1 h, at which time Et<sub>2</sub>O (20 mL) was added and stirred for an additional 30 min. The precipitate (hydrochloride salt of desired product) was filtered and the solid washed with Et<sub>2</sub>O. The isolated solid was dissolved in DCM (25 mL) and washed with sat’d NaHCO<sub>3</sub> (2 × 30 mL). The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 1:49 MeOH:DCM to 1:20 MeOH:DCM) to provide the title compound. Yield 658 mg (37%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD) δ 5.51 (d, <i>J</i> = 3.0 Hz, 1H), 5.40 (d, <i>J</i> = 3.8 Hz, 1H), 2.69 (s, 2H), 1.73 (br s, 2H). <sup>13</sup>C NMR (126 MHz, MeOD) δ 134.70, 132.71, 130.62, 127.93, 38.70. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>5</sub>H<sub>6</sub>ClNS 148.9990, found 148.9988.</div></div><div id="sec7_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Isoxazol-5-ylmethanamine (<b>6n</b>)</h4><div class="NLM_p last">Yield 159 mg (77%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1H), 6.13 (s, 1H), 4.00 (s, 2H), 1.53 (br, s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 172.47, 150.28, 100.04, 37.62. MS (EI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>4</sub>H<sub>6</sub>N<sub>2</sub>O 98.0, found 98.1.</div></div><div id="sec7_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (3,5-Dimethylfuran-2-yl)methanamine (<b>6o</b>)</h4><div class="NLM_p last">Yield 98 mg (65%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, MeOD) δ 5.78 (s, 1H), 3.70 (s, 2H), 2.17 (s, 3H), 1.92 (s, 3H). <sup>13</sup>C NMR (126 MHz, MeOD) δ 152.01, 147.87, 118.48, 110.06, 36.39, 13.41, 9.78. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>7</sub>H<sub>12</sub>NO 126.0919, found 126.0924.</div></div><div id="sec7_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (3-Chlorothiophen-2-yl)methanamine (<b>6p</b>)</h4><div class="NLM_p last">Yield 113 mg (59%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.15 (dd, <i>J</i> = 5.2, 1.2 Hz, 1H), 6.86 (dd, <i>J</i> = 5.3, 1.1 Hz, 1H), 3.98 (s, 2H), 1.79 (br s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 148.24, 124.45, 123.90, 118.33, 41.51. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>5</sub>H<sub>7</sub>ClNS 147.9988, found 147.9990.</div></div><div id="sec7_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (4-Chlorothiophen-2-yl)methanamine (<b>6q</b>)</h4><div class="NLM_p last">Yield 79 mg (67%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 6.96 (s, 1H), 6.78 (s, 1H), 3.99 (s, 2H), 1.71 (br s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 148.24, 124.45, 123.90, 118.33, 41.51. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>5</sub>H<sub>7</sub>ClNS 147.9988, found 147.9995.</div></div></div><div id="sec7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> General Procedure for Alkylation of 2-Hydroxybenzonitrile</h3><div class="NLM_p">Alkyl iodides (3.7 mmol, 1.1 equiv) and K<sub>2</sub>CO<sub>3</sub> (930 mg, 6.7 mmol, 2 equiv) were added to a stirred solution of 2-hydroxybenzonitrile (400 mg, 3.4 mmol) in DMF (20 mL) at rt and stirred for 4 h. The reaction was quenched with the addition of H<sub>2</sub>O (20 mL) and EtOAc (40 mL). The organic layer was washed with water (5 × 40 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The residue was purified by column chromatography (SiO<sub>2</sub>, 4:1 Hex:EtOAc) to afford the desired alkyl ethers as colorless oils.</div><div id="sec7_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Ethoxybenzonitrile (<b>7a</b>)</h4><div class="NLM_p last">Yield 360 mg (71%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.63–7.45 (m, 2H), 7.04–6.89 (m, 2H), 4.15 (q, <i>J</i> = 7.1 Hz, 2H), 1.48 (t, <i>J</i> = 7.0 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 161.02, 134.65, 134.17, 120.91, 116.99, 112.49, 102.36, 64.99, 14.91. MS (EI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>9</sub>H<sub>9</sub>NO 147.1, found 147.1; [M + H]<sup>+</sup> for C<sub>9</sub>H<sub>10</sub>NO 148.1, found 148.1.</div></div><div id="sec7_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Isopropoxybenzonitrile (<b>7b</b>)</h4><div class="NLM_p last">Yield 405 mg (71%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.57 (dt, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.52 (td, <i>J</i> = 7.9, 7.3, 1.5 Hz, 1H), 6.99 (dd, <i>J</i> = 8.2, 5.2 Hz, 2H), 4.68 (hept, <i>J</i> = 6.1 Hz, 1H), 1.43 (d, <i>J</i> = 6.1 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 159.92, 134.11, 133.94, 120.45, 116.77, 113.64, 102.99, 71.78, 21.86 (2C). MS (EI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>10</sub>H<sub>11</sub>NO 161.1, found 161.1; [M + H]<sup>+</sup> for C<sub>10</sub>H<sub>12</sub>NO 162.1, found 162.1.</div></div><div id="sec7_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Propoxybenzonitrile (<b>7c</b>)</h4><div class="NLM_p last">Yield 385 mg (71%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.55 (d, <i>J</i> = 7.8 Hz, 1H), 7.50 (td, <i>J</i> = 8.1, 7.4, 1.5 Hz, 1H), 7.00–6.93 (m, 2H), 4.03 (t, <i>J</i> = 6.5 Hz, 2H), 1.88 (h, <i>J</i> = 7.0 Hz, 2H), 1.08 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 160.83, 134.27, 133.76, 120.52, 116.56, 112.19, 102.00, 70.45, 22.33, 10.46. MS (EI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>10</sub>H<sub>11</sub>NO 161.1, found 161.1; [M + H]<sup>+</sup> for C<sub>10</sub>H<sub>12</sub>NO 162.1, found 162.1.</div></div></div><div id="sec7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Procedure for the Reduction of Carboxylic Acids</h3><div class="NLM_p">The aromatic carboxylic acids (e.g., <b>68</b>, 0.7 M in THF, 1 equiv) were added dropwise to a stirred solution of LiAlH<sub>4</sub> (0.5 M in THF, 5 equiv) at 0 °C. The reaction warmed to rt and stirred for 12 h. H<sub>2</sub>O (1 mL/g of LiAlH<sub>4</sub>) was added, to quench the excess hydride, then 4 M NaOH (1 mL/g of LiAlH<sub>4</sub>) and EtOAc (3 mL/g of LiAlH<sub>4</sub>). The resulting suspension was filtered through a pad of Celite then the Celite was washed with warm EtOAc and the eluent concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 3:10 EtOAc:hexanes to 3:5 EtOAc:hexanes) to provide the desired alcohol as colorless oils:</div><div id="sec7_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (2-Methoxy-4-methylphenyl)methanol (<b>8</b>)</h4><div class="NLM_p last">Yield 187 mg (50%), colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.14 (d, <i>J</i> = 7.5 Hz, 1H), 6.78 (dd, <i>J</i> = 7.5, 0.8 Hz, 1H), 6.75 (s, 1H), 4.32 (s, 2H), 3.86 (s, 3H), 2.38 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 157.58, 140.13, 130.11, 121.13, 120.80, 111.52, 55.33, 50.01, 21.71. HRSM (ESI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>9</sub>H<sub>12</sub>O<sub>2</sub> 152.0837, found 152.0846.</div></div><div id="sec7_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl 4,6-Bis((<i>tert</i>-butyldimethylsilyl)oxy)-3-chloro-2-(3-oxopropyl)benzoate (<b>9</b>)</h4><div class="NLM_p last"><b>9</b> was synthesized following procedures detailed in refs <a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">28</a> and <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a>. Yield 1.8 g (68%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, chloroform-<i>d</i>) δ 9.80 (s, 1H), 6.31 (s, 1H), 3.84 (s, 3H), 2.96–2.92 (m, 2H), 2.80–2.74 (m, 2H), 1.02 (s, 9H), 0.95 (s, 9H), 0.23 (s, 6H), 0.21 (s, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 201.47, 168.36, 153.48, 151.94, 138.10, 121.44, 118.81, 110.15, 109.97, 52.69, 43.83, 26.00 (3C), 25.83 (3C), 18.74, 18.43, −3.96 (2C), −4.00 (2C). HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>23</sub>H<sub>40</sub>ClO<sub>5</sub>Si<sub>2</sub> 487.2103, found 487.2120.</div></div><div id="sec7_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Methyl 3-Chloro-2-(2-(1-(4-fluorobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>10</b>)</h4><div class="NLM_p last">Yield 22 mg (21%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.07–6.94 (m, 5H), 6.86 (d, <i>J</i> = 1.4 Hz, 1H), 6.29 (s, 1H), 5.00 (s, 2H), 3.69 (s, 3H), 3.22–3.19 (m, 2H), 2.84 (m, 2H). <sup>13</sup>C NMR (126 MHz, MeOD) δ 171.22, 164.76, 162.81, 160.69, 158.81, 148.82, 141.37, 134.18, 130.01, 129.94, 127.28, 121.71, 116.75, 116.58, 112.63 (d, <i>J</i> = 558.4 Hz), 103.34, 52.85, 31.45, 27.26. HRMS (ESI) <i>m</i>/<i>z</i> [M + H] for C<sub>20</sub>H<sub>19</sub>ClFN<sub>2</sub>O<sub>4</sub> 405.1017, found 405.1009.</div></div><div id="sec7_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Methyl 3-Chloro-2-(2-(1-(4-chlorobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>11</b>)</h4><div class="NLM_p last">Yield 28 mg, (25%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.24 (d, <i>J</i> = 8.4 Hz, 2H), 6.98 (d, <i>J</i> = 1.4 Hz, 1H), 6.90 (d, <i>J</i> = 8.4 Hz, 2H), 6.78 (d, <i>J</i> = 1.4 Hz, 1H), 6.40 (s, 1H), 4.97 (s, 2H), 3.81 (s, 3H), 3.46–3.40 (m, 2H), 2.89–2.80 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.63, 162.31, 157.66, 147.56, 141.56, 134.60, 134.02, 129.19 (2C), 127.92 (2C), 127.05, 120.00, 114.57, 106.08, 102.68, 52.59, 30.87, 29.69, 26.04 HRMS (ESI) <i>m</i>/<i>z</i> [M + H] for C<sub>20</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub> 421.0722, found 421.0714.</div></div><div id="sec7_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl 2-(2-(1-(4-Bromobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate (<b>12</b>)</h4><div class="NLM_p last">Yield 45 mg (38%), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.36 (d, <i>J</i> = 8.4 Hz, 2H), 6.91 (d, <i>J</i> = 1.4 Hz, 1H), 6.82 (d, <i>J</i> = 8.5 Hz, 2H), 6.77 (d, <i>J</i> = 1.5 Hz, 1H), 6.35 (s, 1H), 4.93 (s, 2H), 3.78 (s, 3H), 3.42–3.34 (m, 2H), 2.84–2.77 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>, MeOD) δ 170.23, 161.42, 157.64, 147.25, 141.09, 134.83, 131.69 (2C), 127.85 (2C), 126.55, 121.59, 119.68, 114.27, 102.14, 99.99, 52.03, 30.38, 25.69. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>19</sub>BrClN<sub>2</sub>O<sub>4</sub> 465.0217, found 465.0237. <i>t</i><sub>R</sub> = 4.17 min, 95.3%.</div></div><div id="sec7_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(4-iodobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>13</b>)</h4><div class="NLM_p last">Yield 22 mg (35%), white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD): δ 7.59–7.57 (dd, <i>J</i> = 11.6 Hz, 2H), 7.14–7.11 (dd, <i>J</i> = 10.0 Hz, 2H), 7.05 (s, 1H), 6.86 (s, 1H), 6.44 (s, 1H), 5.14 (s, 2H), 3.87 (s, 3H), 3.48–3.44 (t, <i>J</i> = 16.8, 2H), 2.91–2.87 (t, <i>J</i> = 18.4 Hz, 2H.). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>, MeOD): δ 170.6, 162.4, 157.6, 147.6, 141.5, 138.1, 128.4, 127.2, 120.0, 114.6, 106.1, 102.7, 93.6, 52.6, 52.2, 49.0, 30.9, 26.1, 25.2, 20.1. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>18</sub>ClIN<sub>2</sub>O<sub>4</sub> 513.0020, found 513.0070.</div></div><div id="sec7_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(4-methylbenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>14</b>)</h4><div class="NLM_p last">Yield 44 mg (43%), off-white amorphous solid. <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.15 (d, <i>J</i> = 7.9 Hz, 2H), 7.03 (d, <i>J</i> = 1.4 Hz, 1H), 7.00–6.96 (m, 2H), 6.94 (d, <i>J</i> = 1.5 Hz, 1H), 6.39 (s, 1H), 5.05 (s, 2H), 3.77 (s, 3H), 3.37–3.30 (m, 2H), 2.97–2.89 (m, 2H), 2.31 (s, 3H). <sup>13</sup>C NMR(125 MHz, MeOD) δ 171.3, 160.9, 159.0, 148.8, 141.5, 138.9, 135.1, 130.5 (2C), 127.9 (2C), 127.1, 121.8, 115.0, 110.1, 103.3, 52.8, 50.1, 31.5, 27.3, 21.1. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>21</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>4</sub> 401.1268, found 401.1266.</div></div><div id="sec7_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Methyl 3-Chloro-2-(2-(1-(4-ethylbenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>15</b>)</h4><div class="NLM_p last">Yield 37 mg (39%), off white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.14 (d, <i>J</i> = 8.1 Hz, 2H), 7.11–7.08 (m, 1H), 6.98–6.91 (m, 2H), 6.85 (d, <i>J</i> = 1.5 Hz, 1H), 6.44 (s, 1H), 4.96 (s, 3H), 3.54–3.45 (m, 2H), 3.04 (t, <i>J</i> = 7.9 Hz, 2H), 2.59 (q, <i>J</i> = 7.6 Hz, 2H), 1.17 (td, <i>J</i> = 7.6, 1.0 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>, MeOD) δ 170.6, 162.1, 158.2, 147.2, 145.0, 140.9, 132.1, 128.8 (2C), 127.2 (2C), 124.2, 120.6, 114.9, 106.2, 103.0, 50.0, 49.9, 30.7, 28.6, 25.6, 15.6. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>22</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>4</sub> 415.1425, found 415.1432.</div></div><div id="sec7_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(4-isopropylbenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>16</b>)</h4><div class="NLM_p last">Yield 25 mg (22%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.13 (d, <i>J</i> = 8.1 Hz, 2H), 7.03 (s, 1H), 6.90 (d, <i>J</i> = 8.2 Hz, 2H), 6.80 (d, <i>J</i> = 1.5 Hz, 1H), 6.49 (s, 1H), 4.95 (s, 2H), 3.79 (s, 3H), 3.50 (t, <i>J</i> = 7.9 Hz, 2H), 3.00–2.92 (m, 2H), 2.82 (hept, <i>J</i> = 6.9 Hz, 1H), 1.16 (d, <i>J</i> = 7.0 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.63, 162.91, 157.32, 149.25, 147.18, 127.20 (2C), 126.81 (2C), 120.19, 114.50, 106.24, 103.00, 99.98, 52.76, 49.56, 33.81, 30.77, 29.72, 23.93 (2C). HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>23</sub>H<sub>26</sub>ClN<sub>2</sub>O<sub>4</sub> 429.1581, found 429.1588.</div></div><div id="sec7_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Methyl 3-Chloro-2-(2-(1-(4-cyanobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>17</b>)</h4><div class="NLM_p last">Yield 37 mg (39%), off white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.79 (q, <i>J</i> = 7.8, 6.0 Hz, 2H), 7.61–7.36 (m, 2H), 7.20–7.12 (m, 1H), 7.05 (s, 1H), 6.57 (s, 1H), 5.44–5.25 (m, 2H), 4.00 (s, 3H), 3.57 (q, <i>J</i> = 7.7 Hz, 2H), 3.02 (t, <i>J</i> = 7.9 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>): 170.4, 161.5, 158.0, 147.8, 142.0, 141.2, 132.8, (2C), 127.7, 127.4, 127.0 (2C), 120.2, 118.2, 114.5, 111.6, 102.4, 52.4, 52.3, 30.8, 26.0. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>21</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>4</sub> 412.1064, found 412.1049.</div></div><div id="sec7_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Methyl 3-Chloro-2-(2-(1-(4-ethynylbenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>18</b>)</h4><div class="NLM_p last">Yield 37 mg (35%), tan amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.46 (d, <i>J</i> = 8.3 Hz, 1H), 7.06 (d, <i>J</i> = 1.4 Hz, 1H), 7.00 (d, <i>J</i> = 8.2 Hz, 1H), 6.86 (d, <i>J</i> = 1.4 Hz, 1H), 6.48 (s, 1H), 5.12 (s, 1H), 3.84 (s, 2H), 3.50 (dd, <i>J</i> = 9.3, 6.7 Hz, 1H), 3.09 (s, 1H), 2.94 (dd, <i>J</i> = 9.0, 7.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.71, 162.73, 158.41, 147.66, 141.27, 136.69, 132.78, 129.10, 126.79, 126.61, 126.52, 122.09, 120.19, 120.15, 114.98, 105.65, 102.81, 82.85, 52.61, 49.28, 30.86, 26.01. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>22</sub>H<sub>20</sub>ClN<sub>2</sub>O<sub>4</sub> 411.1112, found 411.1121.</div></div><div id="sec7_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(4-(trifluoromethyl)benzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>19</b>)</h4><div class="NLM_p last">Yield 24 mg (36%), white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD): δ 7.56–7.55 (dd, <i>J</i> = 9.7 Hz, 2H), 7.15 (s, 1H), 7.10–7.08 (dd, <i>J</i> = 11.3 Hz, 2H), 6.86 (s, 1H), 6.44 (s, 1H), 5.06 (s, 2H), 3.86 (s, 3H), 3.47–3.43 (t, <i>J</i> = 16.3 Hz, 2H), 3.04–3.00 (t, <i>J</i> = 16.3 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>, MeOD) δ 170.2, 162.1, 157.8, 147.3, 140.3, 138.7, 131.1, 130.8, 127.1, 126.3, 126.2, 124.7, 122.6, 120.5, 114.6, 111.4, 106.1, 103.1, 52.9, 30.6, 25.3. HRMS (ESI) <i>m</i>/<i>z</i> [M + H<sup>+</sup>] for C<sub>21</sub>H<sub>18</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> 455.0937, found 455.0972.</div></div><div id="sec7_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Methyl 2-(2-(1-([1,1′-Biphenyl]-4-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate (<b>20</b>)</h4><div class="NLM_p last">Yield 35 mg (29%), tan amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.54–7.48 (m, 4H), 7.39 (ddd, <i>J</i> = 8.0, 7.0, 1.7 Hz, 2H), 7.31 (td, <i>J</i> = 7.2, 1.4 Hz, 1H), 7.07 (dd, <i>J</i> = 8.3, 1.6 Hz, 2H), 6.98 (s, 1H), 6.86 (s, 1H), 6.41 (s, 1H), 5.07 (s, 2H), 3.83 (s, 3H), 3.52–3.45 (m, 2H), 2.92–2.87 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.80, 162.08, 157.84, 147.65, 141.83, 140.99, 140.24, 135.21, 128.81 (2C), 127.62 (2C), 127.52, 127.16, 127.00 (2C), 126.98 (2C), 120.08, 114.67, 106.06, 102.49, 52.50, 49.64, 30.89, 26.17. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>26</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>4</sub> 463.1425, found 463.1447.</div></div><div id="sec7_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(4-methoxybenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>21</b>)</h4><div class="NLM_p last">Yield 25 mg (23%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 6.86–6.84 (m, 1H), 6.82 (d, <i>J</i> = 1.4 Hz, 1H), 6.74–6.69 (m, 4H), 6.31 (s, 1H), 4.85 (s, 2H), 3.72 (s, 3H), 3.65 (s, 3H), 3.38–3.32 (m, 2H), 2.82–2.76 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 174.64, 165.64, 163.22, 162.05, 151.40, 145.46, 135.37, 132.06 (2C), 132.02, 130.37, 123.92, 118.20 (2C), 110.16, 106.36, 99.99, 59.12, 56.29, 34.61, 30.03. HRMS (ESI) <i>m</i>/<i>z</i> [M–H]<sup>−</sup> for C<sub>21</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>5</sub> 415.1061, found 415.1061.</div></div><div id="sec7_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Methyl 3-Chloro-2-(2-(1-(3,4-dichlorobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>22</b>)</h4><div class="NLM_p last">Yield 27 mg (23%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.30 (d, <i>J</i> = 8.3 Hz, 1H), 7.05 (d, <i>J</i> = 1.9 Hz, 2H), 6.92 (d, <i>J</i> = 1.7 Hz, 1H), 6.81 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 6.32 (s, 1H), 4.94 (s, 2H), 3.76 (s, 3H), 3.36–3.29 (m, 2H), 2.95 (t, <i>J</i> = 7.8 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 173.55, 164.94, 161.93, 141.26, 137.43, 135.20, 133.07, 130.90, 130.47, 125.31 (2C), 118.43, 116.40, 110.96, 107.00 (2C), 56.54, 53.05, 33.98, 28.86. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>18</sub>Cl<sub>3</sub>N<sub>2</sub>O<sub>4</sub> 455.0332, found 455.0354.</div></div><div id="sec7_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(naphthalen-1-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>23</b>)</h4><div class="NLM_p last">Yield 32 mg (28%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.79 (dd, <i>J</i> = 6.8, 2.5 Hz, 1H), 7.71 (dd, <i>J</i> = 8.0, 3.9 Hz, 2H), 7.48–7.40 (m, 2H), 7.28 (d, <i>J</i> = 1.2 Hz, 1H), 6.93 (d, <i>J</i> = 1.4 Hz, 1H), 6.72 (d, <i>J</i> = 1.5 Hz, 1H), 6.71–6.67 (m, 1H), 6.32 (s, 1H), 5.43 (s, 2H), 3.73 (s, 3H), 3.45–3.35 (m, 2H), 2.94–2.84 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.58, 161.56, 158.02, 147.88, 141.47, 133.57, 131.62, 130.34, 128.92, 128.68, 126.80 (2C), 126.15, 125.35, 123.93, 121.99, 120.36, 114.62, 106.32, 102.38, 52.29, 47.31, 30.74, 26.17. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>24</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>4</sub> 437.1268, found 437.1250.</div></div><div id="sec7_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(naphthalen-2-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>24</b>)</h4><div class="NLM_p last">Yield 28 mg (25%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.88 (dd, <i>J</i> = 9.1, 4.0 Hz, 2H), 7.83–7.78 (m, 1H), 7.51–7.46 (m, 1H), 7.25 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 7.18 (d, <i>J</i> = 1.3 Hz, 1H), 6.85 (d, <i>J</i> = 1.3 Hz, 1H), 6.42 (s, 1H), 5.29 (s, 2H), 3.57 (s, 3H), 2.92–2.86 (m, 2H), 2.77–2.71 (m, 2H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.86, 155.00, 154.47, 146.42, 137.73, 135.17, 132.79, 132.21, 128.35, 127.60 (2C), 127.54, 126.80, 126.43 (2C), 126.04, 124.94, 124.84, 120.56, 113.74, 110.78, 101.68, 51.80, 48.38, 29.92, 26.18. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>24</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>4</sub> 437.1268, found 437.1280.</div></div><div id="sec7_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(quinolin-5-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>25</b>)</h4><div class="NLM_p last">Yield 29 mg (25%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 8.87 (dd, <i>J</i> = 4.3, 1.6 Hz, 1H), 8.20–8.16 (m, 1H), 8.00 (d, <i>J</i> = 8.5 Hz, 1H), 7.60 (dd, <i>J</i> = 8.5, 7.2 Hz, 1H), 7.49–7.44 (m, 1H), 6.99 (s, 1H), 6.86–6.83 (m, 1H), 6.76 (s, 1H), 6.36 (s, 1H), 5.48 (s, 2H), 3.83 (s, 3H), 3.48–3.44 (m, 2H), 2.95–2.89 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.55, 161.86, 157.87, 150.21, 147.86, 141.56, 132.32, 131.06, 129.45, 129.37, 127.44, 125.58, 124.79, 121.64, 120.13, 114.59, 106.08, 102.48, 99.99, 52.49, 46.63, 30.93, 26.20. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>23</sub>H<sub>21</sub>ClN<sub>3</sub>O<sub>4</sub> 438.1221, found 438.1207.</div></div><div id="sec7_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Methyl 3-Chloro-2-(2-(1-(3-fluorobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>26</b>)</h4><div class="NLM_p last">Yield 26 mg (25%), pale-yellow amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.29–7.20 (m, 1H), 7.01 (d, <i>J</i> = 1.4 Hz, 1H), 6.92 (m, 1H), 6.82 (d, <i>J</i> = 1.4 Hz, 1H), 6.75 (m, 1H), 6.70–6.58 (m, 1H), 6.46 (s, 1H), 5.01 (s, 2H), 3.80 (s, 3H), 3.52–3.40 (m, 2H), 2.88–2.74 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 157.05, 147.61, 141.78, 130.85, 127.79, 122.12, 120.22 (2C), 115.28, 115.12, 113.69, 113.51, 106.66, 102.98 (2C), 100.13, 53.58, 48.96, 31.01, 26.26. HRMS (ESI) <i>m</i>/<i>z</i> [M + H] for C<sub>20</sub>H<sub>19</sub>ClFN<sub>2</sub>O<sub>4</sub> 405.1017, found 405.1009.</div></div><div id="sec7_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Methyl 3-Chloro-2-(2-(1-(3-chlorobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>27</b>)</h4><div class="NLM_p last">Yield 47 mg (44%), pale-yellow amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.25–7.20 (m, 2H), 7.03 (d, <i>J</i> = 1.6 Hz, 1H), 6.99- 6.96 (m, 1H), 6.91–6.84 (m, 2H), 6.40 (s, 1H), 5.00 (s, 2H), 3.82 (s, 3H), 3.49–3.33 (m, 2H), 3.01–2.83 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>, MeOD) δ 170.6, 161.9, 158.2, 147.5, 141.1, 137.7, 135.1, 130.5, 128.5, 126.8, 125.9, 124.9, 120.5, 114.8, 106.2, 102.7, 52.6 (2C), 30.6, 25.8. HRMS (ESI) <i>m/</i>z [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub> 421.0722, found 421.0728.</div></div><div id="sec7_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Methyl 2-(2-(1-(3-Bromobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate (<b>28</b>)</h4><div class="NLM_p last">Yield 23 mg (19%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.38 (m, 1H), 7.19–7.09 (m, 2H), 6.99 (d, <i>J</i> = 1.5 Hz, 1H), 6.91 (m, 1H), 6.84 (d, <i>J</i> = 1.5 Hz, 1H), 6.40 (s, 1H), 5.00 (s, 2H), 3.83 (s, 3H), 3.46–3.38 (m, 2H), 2.92–2.79 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 168.02, 159.25, 155.49, 145.00, 138.77, 135.70, 128.71, 128.01, 126.95, 124.05, 122.60, 120.52, 117.64, 112.15, 103.58, 100.01, 49.95, 46.22, 28.09, 23.35. HRMS (ESI) <i>m</i>/<i>z</i> [M + H] for C<sub>20</sub>H<sub>19</sub>BrClN<sub>2</sub>O<sub>4</sub> 465.0217, found 465.0225.</div></div><div id="sec7_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(3-iodobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>29</b>)</h4><div class="NLM_p last">Yield 4 mg (11%), white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.67–7.64 (dd, <i>J</i> = 7.05 Hz, 1H), 7.43 (s, 1H), 7.18–7.14 (m, 2H), 7.08–7.06 (dd, <i>J</i> = 9.24 Hz, 1H), 6.86 (s, 1H), 6.47 (s, 1H), 5.14 (s, 2H), 3.68 (s, 3H), 2.92–2.88 (t, <i>J</i> = 16.3 Hz, 2H), 2.73–2.67 (t, <i>J</i> = 18.2 Hz, 2H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>, MeOD): δ 167.9, 155.0, 154.5, 146.4, 140.2, 137.7, 136.2, 135.1, 130.9, 126.0, 120.6, 113.8, 110.8, 101.8, 99.5, 95.2, 52.0, 47.4, 29.8, 26.1. HRMS (ESI) <i>m</i>/<i>z</i> [M + H<sup>+</sup>] for C<sub>20</sub>H<sub>18</sub>ClIN<sub>2</sub>O<sub>4</sub> 513.0023, found 513.0065.</div></div><div id="sec7_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Methyl 2-(2-(1-(3-Methoxybenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate (<b>30</b>)</h4><div class="NLM_p last">Yield 32 mg (31%), white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.06 (s, 1H), 6.88 (s, 1H), 6.82 (d, <i>J</i> = 9.0 Hz, 1H), 6.62 (d, <i>J</i> = 7.7 Hz, 1H), 6.55 (s, 1H), 6.53 (s, 1H), 5.04 (s, 2H), 3.85 (s, 3H), 3.76 (s, 3H), 3.59–3.51 (m, 2H), 2.95–2.89 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.68, 162.88, 160.13, 157.00, 147.45, 141.62, 137.81, 130.13, 127.12, 120.17, 118.69, 114.33, 113.03, 112.49, 106.43, 102.82, 55.26, 52.64, 49.34, 30.90, 26.09. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>21</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>5</sub> 417.1217, found 417.1221.</div></div><div id="sec7_7_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(3-methylbenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>31</b>)</h4><div class="NLM_p last">Yield 18 mg (17%), tan amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.06 (t, <i>J</i> = 7.6 Hz, 1H), 6.95 (d, <i>J</i> = 7.7 Hz, 1H), 6.85 (d, <i>J</i> = 1.5 Hz, 1H), 6.75 (d, <i>J</i> = 1.5 Hz, 1H), 6.72–6.66 (m, 2H), 6.30 (s, 1H), 4.87 (s, 2H), 3.69 (s, 3H), 3.36–3.30 (m, 2H), 2.81 (dd, <i>J</i> = 9.2, 6.9 Hz, 2H), 2.16 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 174.49, 165.52, 161.99, 151.39, 145.16, 142.73, 139.62, 132.79 (2C), 131.28, 129.76, 127.67, 124.32, 118.57, 110.31, 106.43, 56.27, 53.48, 34.48, 29.85, 25.07. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>21</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>4</sub> 401.1268, found 401.1255.</div></div><div id="sec7_7_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Methyl 2-(2-(1-([1,1′-Biphenyl]-3-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate (<b>32</b>)</h4><div class="NLM_p last">Yield 46 mg (39%), pale-yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.53–7.47 (m, 3H), 7.41 (dd, <i>J</i> = 9.1, 7.3 Hz, 3H), 7.38–7.33 (m, 1H), 7.23 (s, 1H), 7.03 (d, <i>J</i> = 1.3 Hz, 1H), 6.99 (d, <i>J</i> = 7.8 Hz, 1H), 6.89 (d, <i>J</i> = 1.4 Hz, 1H), 6.46 (s, 1H), 5.12 (s, 2H), 3.82 (s, 3H), 3.56–3.46 (m, 2H), 2.97–2.89 (m, 2H). <sup>13</sup>C NMR δ (100 MHz, CDCl<sub>3</sub>): 170.8, 163.0, 157.9, 147.7, 142.4, 141.5, 140.5, 136.6, 129.8 (3C), 129.1(2C), 128.0, 127.3, 127.3, 125.7, 125.6, 120.5, 114.9, 106.3, 103.2, 52.8, 49.9, 31.1, 26.2. HRMS (ESI) <i>m</i>/<i>z</i> [M – H]<sup>−</sup> for C<sub>26</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>4</sub> 461.1268, found 461.1259.</div></div><div id="sec7_7_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Methyl 3-Chloro-2-(2-(1-(2-fluorobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>33</b>)</h4><div class="NLM_p last">Yield 23 mg (22%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.27–7.23 (m, 1H), 7.06–6.98 (m, 2H), 6.94 (d, <i>J</i> = 1.4 Hz, 1H), 6.81 (d, <i>J</i> = 1.4 Hz, 1H), 6.78 (dd, <i>J</i> = 7.5, 1.7 Hz, 1H), 6.40 (s, 1H), 5.05 (s, 2H), 3.82 (s, 3H), 3.64–3.38 (m, 2H), 3.05–2.68 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.80, 162.21, 157.79, 147.67, 141.77, 130.04, 128.42, 127.27, 124.63, 123.62, 123.50, 119.93, 115.60 (d, <i>J</i> = 21.0 Hz), 114.66, 106.02, 102.55, 52.51, 43.46, 30.83, 26.04. HRMS (ESI) <i>m</i>/<i>z</i> [M + H] for C<sub>20</sub>H<sub>18</sub>ClFN<sub>2</sub>O<sub>4</sub> 405.1029, found 405.1017.</div></div><div id="sec7_7_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Methyl 2-(2-(1-(2-Chlorobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate (<b>34</b>)</h4><div class="NLM_p last">Yield 23 mg (21%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.27 (s, 1H), 7.24–7.16 (m, 2H), 7.01 (d, <i>J</i> = 1.6 Hz, 1H), 6.94 (dd, <i>J</i> = 1.9, 1.0 Hz, 1H), 6.84 (m, 2H), 6.38 (s, 1H), 4.98 (s, 2H), 3.80 (s, 3H), 3.45–3.35 (m, 2H), 2.94–2.85 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.58, 162.43, 157.43, 147.63, 141.17, 133.48, 132.58, 129.83, 129.62, 127.72, 127.52, 126.18, 120.16, 114.51, 106.20, 102.85, 52.73, 47.48, 30.89, 25.78. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub> 421.0722, found 421.0714.</div></div><div id="sec7_7_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Methyl 2-(2-(1-(2-Bromobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate (<b>35</b>)</h4><div class="NLM_p last">Yield 26 mg (22%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.54 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 7.24–7.20 (m, 1H), 7.15 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.10 (d, <i>J</i> = 1.6 Hz, 1H), 6.78 (d, <i>J</i> = 1.6 Hz, 1H), 6.67–6.57 (m, 1H), 6.48 (s, 1H), 5.06 (s, 2H), 3.85 (s, 3H), 3.48–3.33 (m, 2H), 3.06–2.89 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.47, 162.64, 157.77, 147.55, 140.60, 133.23 (2C), 130.08, 128.23 (2C), 122.57, 120.27 (2C), 114.71, 105.94, 103.08, 52.85, 50.15, 30.78, 25.58. HRMS (ESI) <i>m</i>/<i>z</i> [M + H] for C<sub>20</sub>H<sub>19</sub>BrClN<sub>2</sub>O<sub>4</sub> 465.0217, found 465.0231.</div></div><div id="sec7_7_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(2-methylbenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>36</b>)</h4><div class="NLM_p last">Yield 32 mg (31%), tan amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.25 (s, 1H), 7.08–7.02 (m, 2H), 6.88–6.83 (m, 1H), 6.66–6.58 (m, 1H), 6.47 (t, <i>J</i> = 6.7 Hz, 1H), 6.29 (s, 1H), 4.87 (s, 2H), 3.72 (s, 3H), 3.35–3.25 (m, 2H), 2.81 (dd, <i>J</i> = 10.9, 5.1 Hz, 2H), 2.10 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 174.43, 165.45, 161.97, 151.53, 145.12, 139.32, 137.71, 134.49, 132.09, 130.45, 130.31, 129.87, 124.09, 118.52, 110.38, 106.41, 56.28, 51.65, 34.50, 29.86, 22.59. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>21</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>4</sub> 401.1268, found 401.1261.</div></div><div id="sec7_7_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Methyl 2-(2-(1-(2-Aminobenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-3-chloro-4,6-dihydroxybenzoate (<b>37</b>)</h4><div class="NLM_p last">Yield 20 mg (19%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, MeOD) δ 7.07 (td, <i>J</i> = 7.8, 1.6 Hz, 1H), 6.98 (dd, <i>J</i> = 7.8, 1.4 Hz, 2H), 6.78 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 6.65 (td, <i>J</i> = 7.5, 1.2 Hz, 1H), 6.52 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 6.39 (s, 1H), 5.03 (s, 2H), 3.79 (s, 3H), 3.37–3.33 (m, 2H), 3.01–2.96 (m, 2H). <sup>13</sup>C NMR (126 MHz, MeOD) δ 169.90, 159.44, 157.47, 147.55, 145.00, 140.02, 128.56, 127.00, 125.07, 120.41, 120.32, 117.92, 116.00, 113.55, 108.77, 101.92, 51.46, 45.78, 29.89, 25.71. HRMS (ESI) <i>m</i>/<i>z</i> [M + H] for C<sub>20</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub> 402.1221, found 402.1230.</div></div><div id="sec7_7_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(2-methoxybenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>38</b>)</h4><div class="NLM_p last">Yield 46 mg (42%), tan amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.26–7.23 (m, 1H), 6.97 (d, <i>J</i> = 1.4 Hz, 1H), 6.89–6.84 (m, 2H), 6.83 (d, <i>J</i> = 1.4 Hz, 1H), 6.70 (dd, <i>J</i> = 7.8, 1.7 Hz, 1H), 6.44 (s, 1H), 5.03 (s, 2H), 3.84 (s, 3H), 3.81 (s, 3H), 3.49–3.44 (m, 2H), 2.94–2.90 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.96, 162.35, 157.84, 156.56, 147.74, 141.91, 129.33, 127.59, 126.69, 124.66, 120.72, 120.13, 114.71, 110.27, 105.90, 102.51, 55.27, 52.50, 44.85, 30.85, 26.04. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>21</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>5</sub> 417.1217, found 417.1211.</div></div><div id="sec7_7_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Methyl 3-Chloro-2-(2-(1-(2-ethylbenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>39</b>)</h4><div class="NLM_p last">Yield 33 mg (31%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.43 (d, <i>J</i> = 2.1 Hz, 1H), 7.40 (d, <i>J</i> = 3.0 Hz, 1H), 7.32–7.28 (m, 1H), 7.26 (d, <i>J</i> = 7.7 Hz, 1H), 6.83 (d, <i>J</i> = 7.7 Hz, 1H), 6.79 (s, 1H), 6.55 (s, 1H), 4.98 (s, 2H), 4.02 (s, 3H), 3.68 (t, <i>J</i> = 7.3 Hz, 2H), 3.45 (t, <i>J</i> = 7.1 Hz, 3H), 2.52 (q, <i>J</i> = 7.5 Hz, 3H), 1.19 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 169.85, 161.95, 158.20, 146.18, 145.33, 142.11, 138.91, 129.92, 129.32, 128.17, 127.04, 120.75, 119.05, 114.84, 106.28, 103.49, 53.17, 30.86, 30.04, 25.20, 24.25, 14.49. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>22</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>4</sub> 415.1425, found 415.1419. <i>t</i><sub>R</sub> = 4.27 min, 95.3%.</div></div><div id="sec7_7_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Methyl 3-Chloro-2-(2-(1-(2-ethoxybenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>40</b>)</h4><div class="NLM_p last">Yield 44 mg (39%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.18 (t, <i>J</i> = 8.0 Hz, 1H), 6.88 (d, <i>J</i> = 1.9 Hz, 1H), 6.83–6.76 (m, 3H), 6.67 (d, <i>J</i> = 7.6 Hz, 1H), 6.38 (s, 1H), 4.99 (s, 2H), 3.97 (q, <i>J</i> = 7.7, 6.8 Hz, 2H), 3.80 (s, 3H), 3.45–3.39 (m, 2H), 2.88 (t, <i>J</i> = 8.1 Hz, 2H), 1.32 (t, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.97, 162.15, 157.97, 155.99, 147.73, 141.95, 129.25, 127.68, 126.65, 124.63, 120.46, 120.13, 114.73, 111.01, 105.90, 102.43, 63.51, 52.45, 44.95, 30.86, 26.12, 14.69. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>22</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>5</sub> 431.1374, found 431.1378. <i>t</i><sub>R</sub> = 2.71 min, 98.3%.</div></div><div id="sec7_7_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(2-isopropoxybenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>41</b>)</h4><div class="NLM_p last">Yield 18 mg (16%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.21 (t, <i>J</i> = 8.0 Hz, 1H), 6.95 (s, 1H), 6.86–6.78 (m, 3H), 6.72 (d, <i>J</i> = 7.5 Hz, 1H), 6.44 (s, 1H), 5.00 (s, 2H), 4.56 (hept, <i>J</i> = 10.8, 5.3 Hz, 1H), 3.85 (s, 3H), 3.52–3.45 (m, 2H), 2.97–2.87 (m, 2H), 1.27 (d, <i>J</i> = 6.0 Hz, 6H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.97, 162.15, 157.97, 156.00, 147.73, 141.95, 129.25, 127.68, 126.65, 124.63, 120.46, 120.13, 114.73, 111.01, 105.90, 102.43, 99.99, 63.51, 52.45, 44.95, 30.86, 26.12, 14.69. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>23</sub>H<sub>26</sub>ClN<sub>2</sub>O<sub>5</sub> 445.1530, found 445.1521. <i>t</i><sub>R</sub> = 2.70 min, 97.7%.</div></div><div id="sec7_7_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(2-propoxybenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>42</b>)</h4><div class="NLM_p last">Yield 34 mg (29%), tan amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.29–7.26 (m, 1H), 7.02 (d, <i>J</i> = 1.4 Hz, 1H), 6.90–6.85 (m, 3H), 6.76–6.73 (m, 1H), 6.49 (s, 1H), 5.10 (s, 2H), 3.95 (t, <i>J</i> = 6.5 Hz, 2H), 3.84 (s, 3H), 3.56–3.50 (m, 2H), 3.03–2.96 (m, 2H), 1.80 (qt, <i>J</i> = 7.4, 6.5 Hz, 2H), 1.01 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.91, 162.91, 157.83, 156.11, 147.58, 141.58, 129.36, 127.76, 126.49, 124.55, 120.56, 120.15, 114.73, 111.04, 105.90, 102.72, 69.53, 52.55, 45.00, 30.85, 26.04, 22.57, 10.61. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>23</sub>H<sub>26</sub>ClN<sub>2</sub>O<sub>5</sub> 445.1530, found 445.1539. <i>t</i><sub>R</sub> = 2.73 min, 98.0%.</div></div><div id="sec7_7_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(2-(trifluoromethyl)benzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>43</b>)</h4><div class="NLM_p last">Yield 25 mg (21%), white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.65 (d, <i>J</i> = 7.7 Hz, 1H), 7.43 (t, <i>J</i> = 7.6 Hz, 1H), 7.36 (t, <i>J</i> = 7.7 Hz, 1H), 7.02 (s, 1H), 6.79 (s, 1H), 6.57 (d, <i>J</i> = 7.8 Hz, 1H), 6.39 (s, 1H), 5.25 (s, 2H), 3.85 (s, 3H), 3.50–3.41 (m, 2H), 2.93–2.79 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.72, 162.08, 157.95, 148.07, 141.52, 134.95, 132.62, 127.97, 127.61, 126.91, 126.26 (q, <i>J</i> = 5.6 Hz), 125.20, 123.03, 120.21, 114.70, 105.88, 102.50, 52.46, 45.88, 30.87, 25.83. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>21</sub>H<sub>19</sub>ClF<sub>3</sub>N<sub>2</sub>O<sub>4</sub> 455.0985, found 455.0979.</div></div><div id="sec7_7_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(2-methoxy-4-methylbenzyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>44</b>)</h4><div class="NLM_p last">Yield 45 mg (40%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.28 (d, <i>J</i> = 2.1 Hz, 1H), 6.94 (d, <i>J</i> = 7.6 Hz, 1H), 6.85 (d, <i>J</i> = 2.1 Hz, 1H), 6.76 (d, <i>J</i> = 7.3 Hz, 1H), 6.69 (s, 1H), 6.56 (s, 1H), 4.81 (s, 2H), 3.99 (s, 3H), 3.74 (s, 3H), 3.63 (t, <i>J</i> = 7.4 Hz, 2H), 3.44 (t, <i>J</i> = 7.4 Hz, 2H), 2.34 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 169.87, 161.98, 157.11, 151.39, 145.68, 142.01, 140.11, 129.96, 129.53, 121.73, 121.63, 120.51, 118.55, 112.14, 111.93, 55.44, 54.21, 46.62, 30.48, 29.73, 23.96, 21.75. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>22</sub>H<sub>24</sub>ClN<sub>2</sub>O<sub>5</sub> 431.1374, found 431.1370.</div></div><div id="sec7_7_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Methyl 3-Chloro-2-(2-(1-(furan-3-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>45</b>)</h4><div class="NLM_p last">Yield 40 mg (41%), off-white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.30 (d, <i>J</i> = 1.6 Hz, 1H), 7.20 (s, 1H), 6.84 (dd, <i>J</i> = 2.7, 1.4 Hz, 1H), 6.78 (d, <i>J</i> = 1.4 Hz, 1H), 6.36 (d, <i>J</i> = 2.0 Hz, 1H), 6.15 (d, <i>J</i> = 1.9 Hz, 1H), 4.80 (s, 2H), 3.78 (d, <i>J</i> = 1.9 Hz, 3H), 3.39 (tt, <i>J</i> = 8.9, 2.5 Hz, 2H), 2.95–2.80 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>, MeOD): δ 170.8, 161.8, 158.1, 147.3, 144.1, 141.6, 141.6, 140.1, 126.7, 121.0, 119.6, 114.7, 109.4, 106.2, 102.5, 52.4, 41.0, 30.8, 26.1. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>5</sub> 377.0904, found 377.0905.</div></div><div id="sec7_7_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Methyl 3-Chloro-2-(2-(1-(furan-2-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>46</b>)</h4><div class="NLM_p last">Yield 44 mg (45%), off-white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.31 (dt, <i>J</i> = 2.4, 1.2 Hz, 1H), 6.87 (dd, <i>J</i> = 2.4, 1.4 Hz, 1H), 6.83 (d, <i>J</i> = 1.5 Hz, 1H), 6.40 (d, <i>J</i> = 1.8 Hz, 1H), 6.26 (dt, <i>J</i> = 3.5, 1.7 Hz, 1H), 6.18 (d, <i>J</i> = 3.3 Hz, 1H), 4.94 (d, <i>J</i> = 1.6 Hz, 2H), 3.82 (d, <i>J</i> = 1.9 Hz, 3H), 3.46 (ddd, <i>J</i> = 10.2, 6.1, 2.0 Hz, 2H), 2.95 (ddd, <i>J</i> = 9.8, 5.9, 1.5 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>, MeOD) δ 170.9, 162.0, 158.2, 149.1, 147.4, 143.2, 141.8, 126.9, 119.7, 114.8, 110.6, 108.8, 106.2, 102.6, 52.6, 42.6, 30.8, 26.1. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>5</sub> 377.0904, found 377.0911.</div></div><div id="sec7_7_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-((5-methylfuran-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>47</b>)</h4><div class="NLM_p last">Yield 46 mg (46%), off white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 6.87 (d, <i>J</i> = 1.4 Hz, 1H), 6.84 (d, <i>J</i> = 1.4 Hz, 1H), 6.41 (s, 1H), 6.08 (d, <i>J</i> = 3.1 Hz, 1H), 5.84 (dd, <i>J</i> = 3.0, 1.2 Hz, 1H), 4.88 (s, 2H), 3.84 (s, 3H), 3.49–3.42 (m, 2H), 3.08–2.93 (m, 2H), 2.18 (d, <i>J</i> = 1.0 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>, MeOD) δ 171.0, 162.2, 158.3, 153.1, 147.3, 147.1, 141.9, 126.7, 119.7, 114.9, 109.7, 106.5, 106.1, 102.6, 52.6, 42.7, 30.9, 26.2, 13.5. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>20</sub>ClN<sub>2</sub>O<sub>5</sub> 391.1061, found 391.1066. <i>t</i><sub>R</sub> = 3.05 min, 95.1%.</div></div><div id="sec7_7_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Methyl 3-Chloro-2-(2-(1-((5-chlorofuran-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>48</b>)</h4><div class="NLM_p last">Yield 50 mg (47%), white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 6.91 (s, 2H), 6.31 (s, 1H), 6.23 (d, <i>J</i> = 3.4 Hz, 1H), 5.98 (d, <i>J</i> = 3.3 Hz, 1H), 4.87 (s, 2H), 3.73 (s, 3H), 3.37–3.27 (m, 2H), 2.99 (t, <i>J</i> = 7.9 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 173.88, 165.00, 161.93, 151.08, 150.68, 143.82, 141.62, 124.59, 118.45, 116.26, 111.28 (2C), 106.80 (2C), 56.40, 46.86, 34.09, 29.14. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>5</sub> 411.0515, found 411.0527. <i>t</i><sub>R</sub> = 4.15 min, 95.5%.</div></div><div id="sec7_7_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Methyl 3-Chloro-2-(2-(1-((3,5-dimethylfuran-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>49</b>)</h4><div class="NLM_p last">Yield 36 mg (25%), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.28 (d, <i>J</i> = 2.0 Hz, 1H), 6.92 (s, 1H), 6.44 (s, 1H), 5.77 (s, 1H), 4.80 (s, 2H), 3.89 (s, 3H), 3.59–3.48 (m, 2H), 3.37 (t, <i>J</i> = 7.1 Hz, 2H), 2.11 (s, 3H), 1.92 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 169.87, 161.98, 157.11, 151.39, 145.68, 140.11, 129.96, 121.63, 120.51, 118.85, 118.55, 112.14, 111.93, 55.44, 54.21, 46.62, 30.48, 29.73, 23.96, 21.75. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>5</sub> 405.1217, found 405.1210. <i>t</i><sub>R</sub> = 3.24 min, 95.5%.</div></div><div id="sec7_7_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(thiophen-2-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>50</b>)</h4><div class="NLM_p last">Yield 37 mg (37%), yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.23 (dd, <i>J</i> = 5.1, 1.3 Hz, 1H), 6.95 (d, <i>J</i> = 1.5 Hz, 1H), 6.92 (dd, <i>J</i> = 5.1, 3.5 Hz, 1H), 6.87 (dd, <i>J</i> = 3.5, 1.9 Hz, 2H), 6.43 (s, 1H), 5.17 (d, <i>J</i> = 0.9 Hz, 2H), 3.84 (s, 3H), 3.56–3.44 (m, 2H), 3.01–2.92 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>, MeOD) δ 170.9, 162.1, 158.2, 147.3, 141.7, 138.5, 127.2, 126.9, 126.4, 126.2, 119.7, 114.9, 106.2, 102.7, 52.6, 44.7, 30.9, 26.2. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>4</sub>S 393.0676, found 393.0674.</div></div><div id="sec7_7_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(thiophen-3-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>51</b>)</h4><div class="NLM_p last">Yield 28 mg (27%), yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.25 (d, <i>J</i> = 4.8 Hz, 1H), 6.98–6.92 (m, 2H), 6.83 (d, <i>J</i> = 1.5 Hz, 1H), 6.81–6.78 (m, 1H), 6.37 (s, 1H), 4.97 (s, 2H), 3.79 (s, 3H), 3.43–3.37 (m, 2H), 2.95–2.88 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 174.48, 165.67, 162.02, 151.06, 145.03, 140.31, 131.26, 130.04, 129.39, 126.69, 124.00, 118.61, 110.15, 106.53, 56.40, 49.27, 34.49, 29.68. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>18</sub>ClN<sub>2</sub>O<sub>4</sub>S 393.0676, found 393.0693.</div></div><div id="sec7_7_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-((5-methylthiophen-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>52</b>)</h4><div class="NLM_p last">Yield 23 mg (22%), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.34 (d, <i>J</i> = 1.8 Hz, 1H), 7.02–6.96 (m, 1H), 6.79 (d, <i>J</i> = 4.1 Hz, 1H), 6.60 (d, <i>J</i> = 2.7 Hz, 1H), 6.48 (s, 1H), 5.03 (s, 2H), 3.95 (s, 3H), 3.58 (t, <i>J</i> = 7.2 Hz, 2H), 3.39 (t, <i>J</i> = 7.2 Hz, 2H), 2.41 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 169.83, 161.87, 158.19, 145.63, 138.77, 131.10, 129.14 (2C), 125.60 (2C), 120.60, 119.05, 106.34, 103.54, 53.15, 46.03, 30.05, 24.21, 15.28. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>19</sub>H<sub>20</sub>ClN<sub>2</sub>O<sub>4</sub>S 407.0832, found 407.0839.</div></div><div id="sec7_7_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> Methyl 3-Chloro-2-(2-(1-((5-chlorothiophen-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>53</b>)</h4><div class="NLM_p last">Yield 20 mg (18%), yellow amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 6.95 (s, 1H), 6.87 (s, 1H), 6.68 (d, <i>J</i> = 3.5 Hz, 1H), 6.63 (d, <i>J</i> = 3.5 Hz, 1H), 6.37 (s, 1H), 5.03 (s, 2H), 3.81 (s, 3H), 3.47–3.37 (m, 2H), 3.02–2.92 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 174.29, 165.57, 162.00, 150.88, 144.73, 140.23, 134.89, 130.21, 130.09, 129.35, 123.74, 118.59, 110.29, 106.65, 56.47, 48.84, 34.48, 29.63. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S 427.0286, found 427.0292.</div></div><div id="sec7_7_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Methyl 3-Chloro-2-(2-(1-((4-chlorothiophen-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>54</b>)</h4><div class="NLM_p last">Yield 23 mg (21%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 6.97 (s, 1H), 6.90 (s, 1H), 6.83 (s, 1H), 6.67 (s, 1H), 6.38 (s, 1H), 5.07 (s, 2H), 3.81 (s, 3H), 3.45–3.39 (m, 2H), 2.88 (t, <i>J</i> = 8.2 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.61, 161.82, 158.12, 147.29, 141.48, 139.55, 127.34, 126.18, 125.05, 120.14, 119.50, 114.71, 106.03, 102.51, 52.44, 44.42, 30.76, 26.05. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S 427.0286, found 427.0290.</div></div><div id="sec7_7_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Methyl 3-Chloro-2-(2-(1-((3-chlorothiophen-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>55</b>)</h4><div class="NLM_p last">Yield 17 mg (15%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.21 (dd, <i>J</i> = 5.9, 2.3 Hz, 1H), 6.90 (d, <i>J</i> = 2.1 Hz, 1H), 6.86 (dt, <i>J</i> = 5.2, 1.8 Hz, 2H), 6.41 (s, 1H), 5.09 (s, 2H), 3.84 (s, 3H), 3.54–3.45 (m, 2H), 2.96 (dd, <i>J</i> = 11.9, 5.4 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.79, 162.08, 158.04, 147.22, 141.70, 131.26, 127.92, 127.32, 125.17, 124.20, 119.32, 114.80, 105.96, 102.55, 52.52, 42.02, 30.79, 26.15. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>18</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>4</sub>S 427.0286, found 427.0278.</div></div><div id="sec7_7_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(isoxazol-5-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>56</b>)</h4><div class="NLM_p last">Yield 15 mg (15%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 8.17 (s, 1H), 6.96 (s, 1H), 6.89 (s, 1H), 6.42 (s, 1H), 6.04 (s, 1H), 5.17 (s, 2H), 3.88 (s, 3H), 3.50–3.41 (m, 2H), 2.97–2.89 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.55, 166.32, 157.95, 150.41, 147.60, 141.46, 127.82, 119.70, 114.64, 106.11, 102.64, 102.47, 102.14, 52.57, 41.22, 30.85, 25.99. HRMS (ESI) [M + H]<sup>+</sup> for C<sub>17</sub>H<sub>17</sub>ClN<sub>3</sub>O<sub>5</sub> 378.0857, found 378.0866.</div></div><div id="sec7_7_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(thiazol-2-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>57</b>)</h4><div class="NLM_p last">Yield 41 mg (40%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.72 (d, <i>J</i> = 3.2 Hz, 1H), 7.30 (d, <i>J</i> = 3.3 Hz, 1H), 6.99 (s, 1H), 6.95 (s, 1H), 6.43 (s, 1H), 5.35 (s, 2H), 3.87 (s, 3H), 3.51–3.46 (m, 2H), 2.98–2.91 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.72, 165.84, 162.13, 157.91, 147.63, 143.06, 141.59, 127.84, 120.27, 119.78, 114.71, 106.01, 102.63, 52.57, 46.84, 30.83, 26.06. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>17</sub>H<sub>17</sub>ClN<sub>3</sub>O<sub>4</sub>S 394.0628, found 394.0630.</div></div><div id="sec7_7_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-((3-vinylthiophen-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>58</b>)</h4><div class="NLM_p last">Yield 35 mg (32%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.19 (d, <i>J</i> = 5.3 Hz, 1H), 7.15 (d, <i>J</i> = 5.3 Hz, 1H), 7.01 (s, 1H), 6.77 (s, 1H), 6.58 (dd, <i>J</i> = 17.3, 10.9 Hz, 1H), 6.45 (s, 1H), 5.56 (d, <i>J</i> = 17.3 Hz, 1H), 5.31 (d, <i>J</i> = 11.0 Hz, 1H), 5.11 (s, 2H), 3.87 (s, 3H), 3.58–3.49 (m, 2H), 3.07 (t, <i>J</i> = 7.8 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.94, 163.17, 156.14, 142.75, 140.72, 139.77, 138.46, 130.54, 128.69, 128.46, 126.69, 126.54, 126.04, 113.85, 106.68, 102.61, 52.59, 38.44, 33.98, 32.45. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>20</sub>ClN<sub>2</sub>O<sub>4</sub>S 419.0832, found 419.0844.</div></div><div id="sec7_7_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-((3-vinylfuran-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>59</b>)</h4><div class="NLM_p last">Yield 35 mg (33%), off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, MeOD) δ 7.30 (d, <i>J</i> = 2.0 Hz, 1H), 6.84 (d, <i>J</i> = 1.8 Hz, 1H), 6.51 (d, <i>J</i> = 2.0 Hz, 1H), 6.49 (s, 1H), 6.48–6.41 (m, 1H), 5.50 (d, <i>J</i> = 17.3 Hz, 1H), 5.26 (d, <i>J</i> = 11.0 Hz, 1H), 4.94 (s, 2H), 3.91 (s, 3H), 3.59 (t, <i>J</i> = 7.6 Hz, 2H), 3.22 (t, <i>J</i> = 7.7 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.35, 162.14, 157.96, 146.62, 143.64 (2C), 124.53 (2C), 123.65, 119.92 (2C), 116.57, 114.78, 108.33 (2C), 108.24, 106.19, 103.08, 52.84, 41.07, 30.43, 25.17. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>20</sub>ClN<sub>2</sub>O<sub>5</sub> 403.1061, found 403.1069.</div></div><div id="sec7_7_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Methyl 3-Chloro-2-(2-(1-((3-ethylthiophen-2-yl)methyl)-1<i>H</i>-imidazol-2-yl)ethyl)-4,6-dihydroxybenzoate (<b>60</b>)</h4><div class="NLM_p last">Yield 43 mg (39%), tan amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 7.16 (d, <i>J</i> = 5.2 Hz, 1H), 6.91 (d, <i>J</i> = 1.4 Hz, 1H), 6.86 (d, <i>J</i> = 5.2 Hz, 1H), 6.73 (d, <i>J</i> = 1.5 Hz, 1H), 6.45 (s, 1H), 5.04 (s, 2H), 3.86 (s, 3H), 3.56–3.50 (m, 2H), 3.00–2.95 (m, 2H), 2.53 (q, <i>J</i> = 7.6 Hz, 2H), 1.12 (t, <i>J</i> = 7.6 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.80, 162.20, 157.88, 147.06, 142.21, 141.84, 130.82, 128.69, 126.96, 124.60, 119.11, 114.70, 106.03, 102.57, 52.57, 42.34, 30.78, 26.25, 21.49, 14.92. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>20</sub>H<sub>22</sub>ClN<sub>2</sub>O<sub>4</sub>S 421.0989, found 421.0995.</div></div><div id="sec7_7_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(pyridin-2-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>61</b>)</h4><div class="NLM_p last">Yield 15 mg (15%), tan amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.57 (d, <i>J</i> = 5.0 Hz, 1H), 7.68 (td, <i>J</i> = 7.7, 1.9 Hz, 1H), 7.13 (d, <i>J</i> = 1.5 Hz, 1H), 6.99 (d, <i>J</i> = 1.6 Hz, 1H), 6.89 (d, <i>J</i> = 7.9 Hz, 1H), 6.51 (s, 1H), 5.23 (s, 2H), 3.89 (s, 3H), 3.52 (t, <i>J</i> = 7.9 Hz, 2H), 3.05 (t, <i>J</i> = 8.0 Hz, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 170.50, 162.80, 157.65, 149.98 (2C), 147.44, 137.50 (3C), 123.42, 121.11, 120.70, 114.63, 106.01, 103.24, 52.94, 51.53, 30.62, 25.40. HRMS (ESI) <i>m</i>/<i>z</i> [M–H]<sup>−</sup> for C<sub>19</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>4</sub> 386.0908, found 386.0899.</div></div><div id="sec7_7_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(pyridin-3-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>62</b>)</h4><div class="NLM_p last">Yield 25 mg (25%), yellow amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 8.44 (d, <i>J</i> = 4.3 Hz, 1H), 8.30 (s, 1H), 7.32 (d, <i>J</i> = 6.0 Hz, 1H), 7.31–7.24 (m, 1H), 6.98 (s, 1H), 6.83 (s, 1H), 6.38 (s, 1H), 5.06 (s, 2H), 3.83 (s, 3H), 3.48–3.37 (m, 2H), 2.90–2.84 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 174.42, 165.67, 162.04, 152.92, 152.83, 151.54, 145.18, 138.88, 136.30, 131.13, 128.14, 123.84, 118.57, 110.07, 106.52, 56.40, 50.83, 34.70, 29.95. HRMS (ESI) <i>m</i>/<i>z</i> [M – H]<sup>−</sup> C<sub>19</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>4</sub> 386.0908, found 386.0903.</div></div><div id="sec7_7_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(pyridin-4-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>63</b>)</h4><div class="NLM_p last">Yield 32 mg (30%), yellow amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 8.44–8.29 (m, 2H), 6.95 (d, <i>J</i> = 1.4 Hz, 1H), 6.88–6.82 (m, 2H), 6.81 (d, <i>J</i> = 1.5 Hz, 1H), 6.30 (s, 1H), 5.03 (s, 2H), 3.78 (s, 3H), 3.40–3.28 (m, 2H), 2.78–2.71 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 170.39, 161.48, 157.93, 149.56 (2C), 147.76, 146.40, 141.07, 127.39, 121.31 (2C), 120.18, 114.46, 106.24, 102.43, 52.34, 30.70, 25.91, 25.11, 19.88. HRMS (ESI) <i>m</i>/<i>z</i> [M–H]<sup>−</sup> C<sub>19</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>4</sub> 386.0908, found 386.0912.</div></div><div id="sec7_7_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> Methyl 3-Chloro-4,6-dihydroxy-2-(2-(1-(pyrimidin-5-ylmethyl)-1<i>H</i>-imidazol-2-yl)ethyl)benzoate (<b>64</b>)</h4><div class="NLM_p last">Yield 45 mg (45%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>, MeOD) δ 9.09 (s, 1H), 8.46 (s, 2H), 7.05 (s, 1H), 6.92 (s, 1H), 6.40 (s, 1H), 5.12 (s, 2H), 3.86 (s, 3H), 3.52–3.36 (m, 2H), 3.00–2.79 (m, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>, MeOD) δ 174.09, 165.38, 161.94, 159.48, 159.42, 159.38, 151.44, 144.71, 134.07, 130.84, 123.84, 118.47, 110.37, 106.66, 56.46, 48.81, 34.66, 29.80. HRMS (ESI) <i>m</i>/<i>z</i> [M – H]<sup>−</sup> C<sub>18</sub>H<sub>17</sub>ClN<sub>4</sub>O<sub>4</sub> 387.0860, found 387.0861.</div></div><div id="sec7_7_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 5-Chlorofuran-2-carbaldehyde (<b>65</b>)</h4><div class="NLM_p last">5-Nitrofuran-2-carbaldehyde (730 mg, 5.1 mmol) was stirred in conc HCl (40 mL) at 40 °C for 15 h. The reaction was poured into H<sub>2</sub>O (80 mL) and extracted with EtOAc (3 × 50 mL). The organic layers were combined, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 1:4 EtOAc:hexanes) to provide the title compound. Yield 266 mg (40%), yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.53 (s, 1H), 7.23 (d, <i>J</i> = 3.6 Hz, 1H), 6.42 (d, <i>J</i> = 3.6 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 176.37, 152.03, 144.15, 122.67, 109.77. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>5</sub>H<sub>4</sub>ClO<sub>2</sub> 130.9900, found 130.9900.</div></div></div><div id="sec7_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> General Procedure for Oxime Formation</h3><div class="NLM_p">NH<sub>2</sub>OH·HCl (3 equiv) and NaOAc (3 equiv) were added to a stirred solution of aromatic aldehydes (1 equiv) in MeOH (0.2 M) and stirred for 8 h at rt. The reaction was quenched with the addition of H<sub>2</sub>O (20 mL) and EtOAc (20 mL). The organic layer was washed with H<sub>2</sub>O (2 × 20 mL), separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via flash chromatography (1:10 EtOAc:hexanes to 1:3 EtOAc:hexanes) to provide the desired products as amorphous solids:</div><div id="sec7_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 5-Chlorofuran-2-carbaldehyde Oxime (<b>66a</b>)</h4><div class="NLM_p last">Yield 225 mg (75%) as a white amorphous solid, 1:1 mixture of isomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.91 (s, 1H), 7.46 (s, 1H), 7.35 (d, <i>J</i> = 3.5 Hz, 1H), 6.61 (d, <i>J</i> = 3.4 Hz, 1H), 6.36 (d, <i>J</i> = 3.5 Hz, 1H), 6.26 (d, <i>J</i> = 3.4 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 146.42, 144.40, 139.54, 139.11, 135.93, 121.19, 114.68, 109.78, 109.37, 108.45. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>5</sub>H<sub>5</sub>ClNO<sub>2</sub> 146.0009, found 146.0003.</div></div><div id="sec7_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Thiazole-2-carbaldehyde Oxime (<b>66b</b>)</h4><div class="NLM_p last">Yield 510 mg (91%), white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.37 (s, 1H), 7.86 (d, <i>J</i> = 3.2 Hz, 1H), 7.33 (dd, <i>J</i> = 3.3, 0.9 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 144.69, 143.24, 142.28, 140.70, 123.45, 119.96. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>4</sub>H<sub>5</sub>N<sub>2</sub>OS 129.0123, found 129.0124.</div></div><div id="sec7_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 5-Methylthiophene-2-carbaldehyde Oxime (<b>66c</b>)</h4><div class="NLM_p last">Yield 491 mg (76%), white amorphous solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.62 (s, 1H), 7.21 (d, <i>J</i> = 3.7 Hz, 1H), 6.77 (dd, <i>J</i> = 3.6, 1.1 Hz, 1H), 2.53 (d, <i>J</i> = 1.0 Hz, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 146.84, 141.47, 132.33, 128.93, 124.83, 15.32. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>6</sub>H<sub>8</sub>NOS 142.0327, found 142.0330.</div></div><div id="sec7_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 3-Vinylthiophene-2-carbaldehyde oxime (<b>66d</b>)</h4><div class="NLM_p last">Yield 407 mg (95%), white amorphous solid, 2:1 mixture of isomers. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.45 (s, 1H), 8.36 (s, 2H), 7.92 (s, 2H), 7.87 (s, 1H), 7.30 (d, <i>J</i> = 5.3 Hz, 2H), 7.25 (d, <i>J</i> = 5.4 Hz, 2H), 7.20 (d, <i>J</i> = 5.3 Hz, 1H), 7.01 (d, <i>J</i> = 5.4 Hz, 2H), 6.84 (dd, <i>J</i> = 17.4, 10.9 Hz, 1H), 5.65 (d, <i>J</i> = 17.3 Hz, 1H), 5.38 (d, <i>J</i> = 11.0 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 144.35, 143.69, 140.75, 130.66, 130.27, 130.16, 128.09, 127.53, 127.10, 125.61, 116.88, 113.85. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>7</sub>H<sub>8</sub>NOS 154.0327, found 154.0331.</div></div><div id="sec7_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 3-Vinylfuran-2-carboxaldehyde Oxime (<b>66e</b>)</h4><div class="NLM_p last">Yield 105 mg (48%), white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (s, 1H), 7.40 (d, <i>J</i> = 1.6 Hz, 1H), 6.76 (dd, <i>J</i> = 17.4, 10.9 Hz, 1H), 6.62 (d, <i>J</i> = 1.9 Hz, 1H), 5.59 (dd, <i>J</i> = 17.5, 1.2 Hz, 1H), 5.32 (dd, <i>J</i> = 10.8, 1.2 Hz, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 144.28, 143.04, 139.55, 126.52, 125.37, 116.55, 108.93. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>7</sub>H<sub>8</sub>NO<sub>2</sub> 138.0555, found 138.0549.</div></div><div id="sec7_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 5-(Bromomethyl)isoxazole (<b>67</b>)</h4><div class="NLM_p last"><i>N</i>-Bromosuccinimide (2.14 g, 12 mmol, 1 equiv) and benzoyl peroxide (290 mg, 1.2 mmol, 0.1 equiv) were added to a stirred solution of 5-methylisoxazole (1 g, 12 mmol) in CCl<sub>4</sub> (50 mL). The reaction was heated to 80 °C for 5 h then concentrated. The resulting residue was redissolved in EtOAc (30 mL) and washed with H<sub>2</sub>O (3 × 20 mL). The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 1:10 EtOAc:hexanes to 3:10 EtOAc:hexanes) to provide the title compound. Yield 725 mg (38%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (d, <i>J</i> = 1.6 Hz, 1H), 6.33 (d, <i>J</i> = 1.7 Hz, 1H), 4.49 (s, 2H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 166.90, 150.56, 103.07, 18.34. MS (EI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>4</sub>H<sub>4</sub>BrNO 160.9, found 161.0; [M – Br]<sup>+</sup> for C<sub>4</sub>H<sub>4</sub>NO 82.0, found 82.0.</div></div><div id="sec7_8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 3,5-Dimethylfuran-2-carboxylic Acid (<b>68</b>)</h4><div class="NLM_p last">A solution of 3-methylfuran-2-carboxylic acid (1 g, 8 mmol, 1 equiv) in THF (3 mL) was added to a stirred solution of LDA (1 M in THF, 16 mmol, 2.1 equiv) at −78 °C and stirred at this temperature for 15 min followed by the addition of iodomethane (1 mL, 16 mmol, 2 equiv). The reaction was stirred for an additional 15 min at −78 °C before removal of the ice bath and slowly warming to room temperature. The reaction was quenched with the addition of saturated NH<sub>4</sub>Cl (50 mL). The organic layer was separated, and the aqueous layer was extracted with EtOAc (2 × 40 mL). The organic layers were combined, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified via flash chromatography (SiO<sub>2</sub>, 3:10 EtOAc:hexanes to 3:5 EtOAc:hexanes) to provide the title compound. Yield 774 mg (69%) as a white amorphous solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.35 (br s, 1H), 6.00 (s, 1H), 2.31 (s, 3H), 2.30 (s, 3H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 164.38, 157.04, 138.03, 135.34, 112.39, 13.97, 11.83. HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>7</sub>H<sub>9</sub>O<sub>3</sub> 141.0552, found 141.0551.</div></div><div id="sec7_8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> (3,5-Dimethylfuran-2-yl)methanol (<b>69a</b>)</h4><div class="NLM_p last">Yield 575 mg (82%), colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.80 (s, 1H), 4.52 (s, 2H), 2.24 (s, 3H), 1.99 (s, 3H), 1.62 (br s, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 145.18, 124.22, 115.31, 108.96, 61.40, 13.55, 9.68. MS (EI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> for C<sub>7</sub>H<sub>11</sub>O<sub>2</sub> 127.1, found 127.1.</div></div><div id="sec7_8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> (3-Chlorothiophen-2-yl)methanol (<b>69b</b>)</h4><div class="NLM_p last">Yield 240 mg (36%), yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.25 (dd, <i>J</i> = 5.4, 1.1 Hz, 1H), 6.90 (dd, <i>J</i> = 5.4, 1.1 Hz, 1H), 4.81 (dd, <i>J</i> = 6.1, 1.3 Hz, 2H), 2.04 (br s, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 135.98, 127.80, 124.60, 123.00, 57.60. MS (EI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>5</sub>H<sub>5</sub>ClOS 148.0, found 148.0.</div></div><div id="sec7_8_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> (4-Chlorothiophen-2-yl)methanol (<b>69c</b>)</h4><div class="NLM_p last">Yield 165 mg (25%), yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.05 (s, 1H), 6.88 (s, 1H), 4.77 (d, <i>J</i> = 5.8 Hz, 2H), 1.92 (br s, 1H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 144.73, 125.54, 124.79, 119.88, 60.09. MS (EI) <i>m</i>/<i>z</i> [M]<sup>+</sup> for C<sub>5</sub>H<sub>5</sub>ClOS 148.0, found 148.0; [M + H]<sup>+</sup> for C<sub>5</sub>H<sub>6</sub>ClOS 149.0, found 149.0.</div></div></div><div id="sec7_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Fluorescence Polarization</h3><div class="NLM_p last">Assay was performed in 96-well format in black, flat bottom plates (Santa Cruz Biotechnology) with a final volume of 100 μL. 25 μL of assay buffer (20 mM HEPES, pH 7.3, 50 mM KCl, 5 mM MgCl<sub>2</sub>, 20 mM Na<sub>2</sub>MoO<sub>4</sub>, 2 mM DTT, 0.1 mg/mL BGG, and 0.01% NP-40) containing 6 nM FITC-GDA (fluorescent tracer, stock in DMSO and diluted in assay buffer) and 50 μL of assay buffer containing 10 nM of either Grp94 or Hsp90α were added to each well. Compounds were tested in triplicate wells (1% DMSO final concentration). For each plate, wells containing buffer only (background), tracer in buffer only (low polarization control), and protein and tracer in buffer with 1% DMSO (high polarization control) were included. Plates were incubated at 4 °C with rocking for 24 h. Polarization values (in mP units) was measured at 37 °C with an excitation filter at 485 nm and an emission filter at 528 nm. Polarization values were correlated to % tracer bound and compound concentrations. The concentration at which the tracer was 50% displaced by the inhibitor was determined using Graphpad Prism.</div></div><div id="sec7_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> X-ray Crystallography</h3><div class="NLM_p last">The gene for the truncated N-terminal domain of cGrp94, NΔ41 (amino acid residues 69–337, with residues 287–327 substituted with GGGG, as in Dollins et al.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a>) was synthesized and codon-optimized by DNA2.0 (Menlo Park, CA). The construct was designed with an N-terminal maltose binding protein (MBP) fusion, which is cleavable by tobacco etch virus (TEV) protease. Fidelity of the finalized MBR-TEV-NΔ41 plasmid was confirmed by Eurofins MWG Operon. The plasmid for MBP-TEV-NΔ41 was transformed in <i>Escherichia coli</i> BL21(DE3). Cells were grown in Luria–Bertani broth supplemented with 100 mg/L ampicillin (Amresco) at 37 °C with shaking at 225 rpm. Once cells reached an OD<sub>600</sub> = 0.6–0.8, they were induced with 0.5 mM isopropyl-β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside (Calbiochem) and were harvested by centrifugation after an additional 4 h of growth with shaking. Cells were solubilized in phosphate buffer (PBS, 10 mM Na<sub>2</sub>HPO<sub>4</sub>, 10 mM KH<sub>2</sub>PO<sub>4</sub>, 0.2 M NaCl, pH 7.2) containing protease inhibitor cocktail (Complete EDTA-free tablets, Roche), lysed with passage through a French Press, and the resulting lysate was clarified by ultracentrifugation. The MBP-TEV-NΔ41 fusion protein was purified using a 20 mL column packed with amylose resin (New England BioLabs) equilibrated with PBS. Protein was eluted with a buffer containing PBS supplemented with 1 mM EDTA and 10 mM maltose. MBP-TEV-NΔ41 was further fractionated with a prep grade Superdex 75 column (GE Healthcare) equilibrated with PBS. MBP-TEV-NΔ41 was cleaved by TEV protease (prepared in house using pRK793 plasmid<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a>), and the protease was removed by passing the mixture over a 5 mL HisTrap HP column (GE Healthcare) equilibrated with 50 mM Tris buffer with 0.5 M NaCl at pH 8.0. The mixture of MBP and NΔ41 were separated by amylose affinity purification, followed by a Superdex 75 polishing step, as above. Any fractions of NΔ41 containing trace amounts of MBP were subjected to a final round of amylose affinity purification. The NΔ41 protein purity was assessed by SDS-PAGE concentrated to 30 mg/mL in a 100 mM Tris buffer at pH 7.5, as quantified by the Bradford assay (reagents from Amresco) using BSA as a standard. Crystals of NΔ41 were grown by the handing drop method by equilibration against a reservoir solution containing 35% PEG400, 100 mM Tris at pH 7.5, and 120 mM MgCl<sub>2</sub>. Crystals were soaked for ∼30 min in a solution of mother liquor containing 10 mM compound <b>48</b> (diluted from a 100 mM stock prepared in DMSO). After soaking, 100% glycerol was added to the drop containing the crystals (to a total concentration of 25%) and the crystals were cryocooled in liquid nitrogen. Diffraction data were collected at the Advanced Photon Source, Argonne National Laboratories Beamline Southeast Region Collaborateve Access Team (SER-CAT) 22-BM. Data were processed using XDS/XSCALE.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The initial model was obtained by molecular replacement using the polypeptide chain of the Grp94-RDA structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD">2GFD</a>) the search model in Phaser.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The model was iteratively built and refined suing Coot and Phenix refine.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> PEG 400 and glycerol ligand models were prepared by inputting the corresponding SMILES string, and additional restraints were generated with eLBOW in Phenix refine.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The model of <b>48</b> was prepared using the PRODRG2 server, with additional restraints generated using eLBOW.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The structure has been deposited in the Protein Data Bank with the PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IN9">5IN9</a>.</div></div><div id="sec7_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Wound-Healing Scratch Assay</h3><div class="NLM_p last">MDA-MB-231 cells (ATCC) were grown to confluence and seeded at 200,000 cells/well/mL in a 12-well plate and grown to confluence. Each well was scratched twice with a 20–200 μL pipet tip. Compounds were then added (0.25% DMSO final concentration) and 0 h pictures were taken with an Olympus IX-71 microscope (10× objective) and the plates were returned to the incubator until 24 h pictures were taken. Images were processed and % wound closure was determined using ImageJ. All experiments were performed in quadruplicate.</div></div><div id="sec7_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> Anti-Proliferative Assay</h3><div class="NLM_p last">MDA-MB-231 cells were grown to confluence and seeded at 2000 cells/well/0.1 mL in a 96-well plate and placed back in the incubator for 24 h. Compounds or vehicle were administered at the desired concentrations (1% DMSO final concentration) and incubated for 72 h. The % viable cells was determined using the MTS/PMS cell proliferation kit (Promega) per the manufacturer’s instructions. Cells treated with vehicle were normalized to 100% proliferation and values adjusted accordingly.</div></div><div id="sec7_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> Western Blot Analysis</h3><div class="NLM_p last">MDA-MB-231 cells were grown to confluence and seeded at 200,000 cells/mL in a 10 cm dish and placed back in the incubator for 24 h. Compounds or vehicle were administered at the desired concentrations (0.25% DMSO final concentration) and incubated for 24 h. Cells were then harvested in cold PBS and lysed using MPER (Thermo Scientific) supplemented with protease inhibitors (Roche) according to the manufacturer’s instructions. Cell lysates were obtained by centrifugation at 14000<i>g</i> for 15 min at 4 °C. Protein concentrations for each sample were determined using the Pierce BCA assay kit following the manufacturer’s directions. Equal amounts of proteins (20 μg) were separated using gel electrophoresis under reducing conditions (10% acrylamide gels) then transferred to PVDF membranes and immunoblotted with the corresponding primary antibodies. Membranes were then incubated with the correct HRP-labeled secondary antibody, developed with a chemiluminescent substrate, and visualized.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i113"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00085">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82755" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82755" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00085" class="ext-link">10.1021/acs.jmedchem.6b00085</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra for all new compounds and HPLC traces for most active compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00085/suppl_file/jm6b00085_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00085/suppl_file/jm6b00085_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00085/suppl_file/jm6b00085_si_001.pdf">jm6b00085_si_001.pdf (17.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00085/suppl_file/jm6b00085_si_002.csv">jm6b00085_si_002.csv (5.61 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00085" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian S. J. Blagg</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, The University of
Kansas, 1251 Wescoe Hall
Drive, Malott Hall 4070, Lawrence, Kansas 66045-7563, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2b4949474a4c4c6b405e054e4f5e"><span class="__cf_email__" data-cfemail="fb9999979a9c9cbb908ed59e9f8e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent M. Crowley</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, The University of
Kansas, 1251 Wescoe Hall
Drive, Malott Hall 4070, Lawrence, Kansas 66045-7563, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anuj Khandelwal</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, The University of
Kansas, 1251 Wescoe Hall
Drive, Malott Hall 4070, Lawrence, Kansas 66045-7563, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanket Mishra</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, The University of
Kansas, 1251 Wescoe Hall
Drive, Malott Hall 4070, Lawrence, Kansas 66045-7563, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew R. Stothert</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Byrd Alzheimer’s Research Institute, University of South Florida, Tampa, Florida 33613, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dustin J. E. Huard</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Biochemistry, Georgia Institute
of Technology, Atlanta, Georgia 30332 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinbo Zhao</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, The University of
Kansas, 1251 Wescoe Hall
Drive, Malott Hall 4070, Lawrence, Kansas 66045-7563, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aaron Muth</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, The University of
Kansas, 1251 Wescoe Hall
Drive, Malott Hall 4070, Lawrence, Kansas 66045-7563, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam S. Duerfeldt</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, The University of
Kansas, 1251 Wescoe Hall
Drive, Malott Hall 4070, Lawrence, Kansas 66045-7563, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James L. Kizziah</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Biochemistry, Georgia Institute
of Technology, Atlanta, Georgia 30332 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raquel L. Lieberman</span> - <span class="hlFld-Affiliation affiliation">School
of Chemistry and Biochemistry, Georgia Institute
of Technology, Atlanta, Georgia 30332 United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chad A. Dickey</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Medicine and Byrd Alzheimer’s Research Institute, University of South Florida, Tampa, Florida 33613, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2142e6465-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i114">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41285" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41285" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from The National Institutes of Health to CA109265 (B.S.J.B.), EY024232 (B.S.J.B. and C.A.D.), and EY021205 (R.L.L.). Support for the NMR instrumentation was provided by NIH Shared Instrumentation Grants (S10OD016360, S10RR024664) and NSF Major Research Instrumentation Grant (0320648).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i115" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i115"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i116" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i116"> Abbreviations Used</h2><tr><td class="NLM_term">Grp94</td><td class="NLM_def"><p class="first last">glucose-regulated protein 94</p></td></tr><tr><td class="NLM_term">Hsp90 and Hsp70</td><td class="NLM_def"><p class="first last">heat shock protein 90 and 70</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">endoplasmic reticulum</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">toll-like receptor</p></td></tr><tr><td class="NLM_term">IGF</td><td class="NLM_def"><p class="first last">insulin-like growth factor</p></td></tr><tr><td class="NLM_term">NECA</td><td class="NLM_def"><p class="first last"><i>N</i>-ethylcarboxamideadenosine</p></td></tr><tr><td class="NLM_term">RDA</td><td class="NLM_def"><p class="first last">radamide</p></td></tr><tr><td class="NLM_term">GDA</td><td class="NLM_def"><p class="first last">geldanamycin</p></td></tr><tr><td class="NLM_term">POAG</td><td class="NLM_def"><p class="first last">primary open angle glaucoma</p></td></tr><tr><td class="NLM_term">ERAD</td><td class="NLM_def"><p class="first last">endoplasmic reticulum associated degradation</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">trabecular meshwork</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i117">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21605" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21605" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Structure, function and regulation of the Hsp90 machinery</span> <span class="citation_source-journal">Biomed. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.4103/2319-4170.113230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.4103%2F2319-4170.113230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23806880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A280%3ADC%252BC3sjmtlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=106-117&author=J.+Liauthor=J.+Buchner&title=Structure%2C+function+and+regulation+of+the+Hsp90+machinery&doi=10.4103%2F2319-4170.113230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, function and regulation of the hsp90 machinery</span></div><div class="casAuthors">Li Jing; Buchner Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">106-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an ATP-dependent molecular chaperone which is essential in eukaryotes.  It is required for the activation and stabilization of a wide variety of client proteins and many of them are involved in important cellular pathways.  Since Hsp90 affects numerous physiological processes such as signal transduction, intracellular transport, and protein degradation, it became an interesting target for cancer therapy.  Structurally, Hsp90 is a flexible dimeric protein composed of three different domains which adopt structurally distinct conformations.  ATP binding triggers directionality in these conformational changes and leads to a more compact state.  To achieve its function, Hsp90 works together with a large group of cofactors, termed co-chaperones.  Co-chaperones form defined binary or ternary complexes with Hsp90, which facilitate the maturation of client proteins.  In addition, posttranslational modifications of Hsp90, such as phosphorylation and acetylation, provide another level of regulation.  They influence the conformational cycle, co-chaperone interaction, and inter-domain communications.  In this review, we discuss the recent progress made in understanding the Hsp90 machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGO1vbg1ywaVm8bhe6roZYfW6udTcc2ebCgBWYTIGzHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjmtlelsg%253D%253D&md5=239f9f8865489ee74f5f8163ea1007ce</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4103%2F2319-4170.113230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2319-4170.113230%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DStructure%252C%2520function%2520and%2520regulation%2520of%2520the%2520Hsp90%2520machinery%26jtitle%3DBiomed.%2520J.%26date%3D2013%26volume%3D36%26spage%3D106%26epage%3D117%26doi%3D10.4103%2F2319-4170.113230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Centenera, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, L. M.</span><span> </span><span class="NLM_article-title">Hsp90: still a viable target in prostate cancer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1835</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span><span class="refDoi"> DOI: 10.1016/j.bbcan.2012.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.bbcan.2012.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23287571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVegsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1835&publication_year=2013&pages=211-218&author=M.+M.+Centeneraauthor=A.+K.+Fitzpatrickauthor=W.+D.+Tilleyauthor=L.+M.+Butler&title=Hsp90%3A+still+a+viable+target+in+prostate+cancer&doi=10.1016%2Fj.bbcan.2012.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90: Still a viable target in prostate cancer</span></div><div class="casAuthors">Centenera, Margaret M.; Fitzpatrick, Alyssa K.; Tilley, Wayne D.; Butler, Lisa M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1835</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-218</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is a mol. chaperone that regulates the maturation, activation and stability of crit. signaling proteins that drive the development and progression of prostate cancer, including the androgen receptor.  Despite robust preclin. data demonstrating anti-tumor activity of first-generation Hsp90 inhibitors in prostate cancer, poor clin. responses initially cast doubt over the clin. utility of this class of agent.  Recent advances in compd. design and development, use of novel preclin. models and further biol. insights into Hsp90 structure and function have now stimulated a resurgence in enthusiasm for these drugs as a therapeutic option.  This review highlights how the development of new-generation Hsp90 inhibitors with improved phys. and pharmacol. properties is unfolding, and discusses the potential contexts for their use either as single agents or in combination, for men with metastatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAD5tSTFibe7Vg90H21EOLACvtfcHk0lidmAwjrP_aqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVegsr4%253D&md5=4cde3dedb6e6450dd3c4b44663953a72</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2012.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2012.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCentenera%26aufirst%3DM.%2BM.%26aulast%3DFitzpatrick%26aufirst%3DA.%2BK.%26aulast%3DTilley%26aufirst%3DW.%2BD.%26aulast%3DButler%26aufirst%3DL.%2BM.%26atitle%3DHsp90%253A%2520still%2520a%2520viable%2520target%2520in%2520prostate%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2013%26volume%3D1835%26spage%3D211%26epage%3D218%26doi%3D10.1016%2Fj.bbcan.2012.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Essential roles of Grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">6877</span><span class="NLM_x">–</span> <span class="NLM_lpage">6882</span><span class="refDoi"> DOI: 10.1073/pnas.1302933110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1073%2Fpnas.1302933110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23572575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6877-6882&author=B.+Liuauthor=M.+Staronauthor=F.+Hongauthor=B.+X.+Wuauthor=S.+Sunauthor=C.+Moralesauthor=C.+E.+Crossonauthor=S.+Tomlinsonauthor=I.+Kimauthor=D.+Wuauthor=Z.+Li&title=Essential+roles+of+Grp94+in+gut+homeostasis+via+chaperoning+canonical+Wnt+pathway&doi=10.1073%2Fpnas.1302933110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span></div><div class="casAuthors">Liu, Bei; Staron, Matthew; Hong, Feng; Wu, Bill X.; Sun, Shaoli; Morales, Crystal; Crosson, Craig E.; Tomlinson, Stephen; Kim, Ingyu; Wu, Dianqing; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6877-6882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Increasing evidence points to a role for the protein quality control in the endoplasmic reticulum (ER) in maintaining intestinal homeostasis.  However, the specific role for general ER chaperones in this process remains unknown.  Herein, we report that a major ER heat shock protein grp94 interacts with MesD, a crit. chaperone for the Wnt coreceptor low-d. lipoprotein receptor-related protein 6 (LRP6).  Without grp94, LRP6 fails to export from the ER to the cell surface, resulting in a profound loss of canonical Wnt signaling.  The significance of this finding is demonstrated in vivo in that grp94 loss causes a rapid and profound compromise in intestinal homeostasis with gut-intrinsic defect in the proliferation of intestinal crypts, compromise of nuclear β-catenin translocation, loss of crypt-villus structure, and impaired barrier function.  Taken together, our work has uncovered the role of grp94 in chaperoning LRP6-MesD in coordinating intestinal homeostasis, placing canonical Wnt-signaling pathway under the direct regulation of the general protein quality control machinery in the ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7emg80iB5gLVg90H21EOLACvtfcHk0lidmAwjrP_aqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D&md5=221593fe9162fee07b700367633663e1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302933110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302933110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DCrosson%26aufirst%3DC.%2BE.%26aulast%3DTomlinson%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEssential%2520roles%2520of%2520Grp94%2520in%2520gut%2520homeostasis%2520via%2520chaperoning%2520canonical%2520Wnt%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6877%26epage%3D6882%26doi%3D10.1073%2Fpnas.1302933110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Suntharalingam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abisambra, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinwal, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duerfeldt, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomarev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span> </span><span class="NLM_article-title">Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">40661</span><span class="NLM_x">–</span> <span class="NLM_lpage">40669</span><span class="refDoi"> DOI: 10.1074/jbc.M112.384800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M112.384800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23035116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslantr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=40661-40669&author=A.+Suntharalingamauthor=J.+F.+Abisambraauthor=J.+C.+O%E2%80%99Learyauthor=J.+Korenauthor=B.+Zhangauthor=M.+K.+Joeauthor=L.+J.+Blairauthor=S.+E.+Hillauthor=U.+K.+Jinwalauthor=M.+Cockmanauthor=A.+S.+Duerfeldtauthor=S.+Tomarevauthor=B.+S.+Blaggauthor=R.+L.+Liebermanauthor=C.+A.+Dickey&title=Glucose-regulated+protein+94+triage+of+mutant+myocilin+through+endoplasmic+reticulum-associated+degradation+subverts+a+more+efficient+autophagic+clearance+mechanism&doi=10.1074%2Fjbc.M112.384800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-regulated Protein 94 tiage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism</span></div><div class="casAuthors">Suntharalingam, Amirthaa; Abisambra, Jose F.; O'Leary, John C., III; Koren, John, III; Zhang, Bo; Joe, Myung Kuk; Blair, Laura J.; Hill, Shannon E.; Jinwal, Umesh K.; Cockman, Matthew; Duerfeldt, Adam S.; Tomarev, Stanislav; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">40661-40669</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Clearance of misfolded proteins in the endoplasmic reticulum (ER) is traditionally handled by ER-assocd. degrdn. (ERAD), a process that requires retro-translocation and ubiquitination mediated by a luminal chaperone network.  Here we investigated whether the secreted, glaucoma-assocd. protein myocilin was processed by this pathway.  Myocilin is typically transported through the ER/Golgi network, but inherited mutations in myocilin lead to its misfolding and aggregation within trabecular meshwork cells, and ultimately, ER stress-induced cell death.  Using targeted knockdown strategies, we detd. that glucose-regulated protein 94 (Grp94), the ER equiv. of heat shock protein 90 (Hsp90), specifically recognizes mutant myocilin, triaging it through ERAD.  The addn. of mutant myocilin to the short list of Grp94 clients strengthens the hypothesis that β-strand secondary structure drives client assocn. with Grp94.  Interestingly, the ERAD pathway is incapable of efficiently handling the removal of mutant myocilin, but when Grp94 is depleted, degrdn. of mutant myocilin is shunted away from ERAD toward a more robust clearance pathway for aggregation-prone proteins, the autophagy system.  Thus ERAD inefficiency for distinct aggregation-prone proteins can be subverted by manipulating ER chaperones, leading to more effective clearance by the autophagic/lysosomal pathway.  General Hsp90 inhibitors and a selective Grp94 inhibitor also facilitate clearance of mutant myocilin, suggesting that therapeutic approaches aimed at inhibiting Grp94 could be beneficial for patients suffering from some cases of myocilin glaucoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSe_XBYKAUtrVg90H21EOLACvtfcHk0lidmAwjrP_aqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslantr7I&md5=be4d91d171e7f124716eb2920c9b8080</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.384800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.384800%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DA.%26aulast%3DAbisambra%26aufirst%3DJ.%2BF.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DJ.%2BC.%26aulast%3DKoren%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DJoe%26aufirst%3DM.%2BK.%26aulast%3DBlair%26aufirst%3DL.%2BJ.%26aulast%3DHill%26aufirst%3DS.%2BE.%26aulast%3DJinwal%26aufirst%3DU.%2BK.%26aulast%3DCockman%26aufirst%3DM.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DTomarev%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DGlucose-regulated%2520protein%252094%2520triage%2520of%2520mutant%2520myocilin%2520through%2520endoplasmic%2520reticulum-associated%2520degradation%2520subverts%2520a%2520more%2520efficient%2520autophagic%2520clearance%2520mechanism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D40661%26epage%3D40669%26doi%3D10.1074%2Fjbc.M112.384800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White-Gilbertson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachidi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depinho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6242</span><span class="NLM_x">–</span> <span class="NLM_lpage">6251</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1158%2F1078-0432.CCR-13-2083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=24077352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6242-6251&author=Y.+Huaauthor=S.+White-Gilbertsonauthor=J.+Kellnerauthor=S.+Rachidiauthor=S.+Z.+Usmaniauthor=G.+Chiosisauthor=R.+Depinhoauthor=Z.+Liauthor=B.+Liu&title=Molecular+chaperone+gp96+is+a+novel+therapeutic+target+of+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-13-2083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma</span></div><div class="casAuthors">Hua, Yunpeng; White-Gilbertson, Shai; Kellner, Joshua; Rachidi, Saleh; Usmani, Saad Z.; Chiosis, Gabriela; DePinho, Ronald; Li, Zihai; Liu, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6242-6251</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: gp96 (grp94) is a key downstream chaperone in the endoplasmic reticulum (ER) to mediate unfolded protein response (UPR) and the pathogenesis of multiple myeloma is closely linked to dysregulated UPR.  In this study, we aimed to det. the roles of gp96 in the initiation and progression of multiple myeloma in vivo and in vitro.  Exptl. Design: We generated a mouse model with overexpression of XBP1s and conditional deletion of gp96 in B-cell compartment simultaneously to identify the roles of gp96 in the development of multiple myeloma in vivo.  Using a short hairpin RNA (shRNA) system, we silenced gp96 in multiple human multiple myeloma cells and examd. the effect of gp96 knockdown on multiple myeloma cells by cell proliferation, cell-cycle anal., apoptosis assay, immunohistochem., and human myeloma xenograft model.  The anticancer activity of gp96 selective inhibitor, WS13, was evaluated by apoptosis assay and MTT assay.  Results: Genetic deletion of gp96 in XBP1s-Tg mice attenuates multiple myeloma.  Silencing of gp96 causes severe compromise in human multiple myeloma cell growth through inhibiting Wnt-LRP-survivin pathway.  We also confirmed that knockdown of gp96 decreased human multiple myeloma growth in a murine xenograft model.  The targeted gp96 inhibitor induced apoptosis and blocked multiple myeloma cell growth, but did not induce apoptosis in pre-B leukemic cells.  We have demonstrated that myeloma growth is dependent on gp96 both genetically and pharmacol.  Conclusions: gp96 is essential for multiple myeloma cell proliferation and survival, suggesting that gp96 is a novel therapeutic target for multiple myeloma.  Clin Cancer Res; 19(22); 6242-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-ajwmlaUPrVg90H21EOLACvtfcHk0liUFwl3-IiwJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP&md5=adb618074ee3e9d6ee4795b95c1d906c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2083%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DWhite-Gilbertson%26aufirst%3DS.%26aulast%3DKellner%26aufirst%3DJ.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDepinho%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520chaperone%2520gp96%2520is%2520a%2520novel%2520therapeutic%2520target%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6242%26epage%3D6251%26doi%3D10.1158%2F1078-0432.CCR-13-2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kusuma, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrowsky, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novologues as C-terminal Hsp90 inhibitors with cytoprotective activity against sensory neuron glucotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5797</span><span class="NLM_x">–</span> <span class="NLM_lpage">5812</span><span class="refDoi"> DOI: 10.1021/jm300544c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300544c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1SmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5797-5812&author=B.+R.+Kusumaauthor=L.+Zhangauthor=T.+Sundstromauthor=L.+B.+Petersonauthor=R.+T.+Dobrowskyauthor=B.+S.+Blagg&title=Synthesis+and+evaluation+of+novologues+as+C-terminal+Hsp90+inhibitors+with+cytoprotective+activity+against+sensory+neuron+glucotoxicity&doi=10.1021%2Fjm300544c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Novologues as C-Terminal Hsp90 Inhibitors with Cytoprotective Activity against Sensory Neuron Glucotoxicity</span></div><div class="casAuthors">Kusuma, Bhaskar Reddy; Zhang, Liang; Sundstrom, Teather; Peterson, Laura B.; Dobrowsky, Rick T.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5797-5812</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compd. 2 (KU-32) is a first-generation novologue (a novobiocin-based, C-terminal, heat shock protein 90 (Hsp90) inhibitor) that decreases glucose-induced death of primary sensory neurons and reverses numerous clin. indexes of diabetic peripheral neuropathy in mice.  The current study sought to exploit the C-terminal binding site of Hsp90 to det. whether the optimization of hydrogen bonding and hydrophobic interactions of second-generation novologues could enhance neuroprotective activity.  Using a series of substituted phenylboronic acids to replace the coumarin lactone of 2, we identified that electroneg. atoms placed at the meta-position of the B-ring exhibit improved cytoprotective activity, which is believed to result from favorable interactions with Lys539 in the Hsp90 C-terminal binding pocket.  Consistent with these results, a meta-3-fluorophenyl substituted novologue (13b) exhibited a 14-fold lower ED50 for protection against glucose-induced toxicity of primary sensory neurons compared to 2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS4gyFThKBPLVg90H21EOLACvtfcHk0liUFwl3-IiwJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1SmsL4%253D&md5=2ade8768ae7ba197b3a633babb7d6a3b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm300544c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300544c%26sid%3Dliteratum%253Aachs%26aulast%3DKusuma%26aufirst%3DB.%2BR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSundstrom%26aufirst%3DT.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DDobrowsky%26aufirst%3DR.%2BT.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novologues%2520as%2520C-terminal%2520Hsp90%2520inhibitors%2520with%2520cytoprotective%2520activity%2520against%2520sensory%2520neuron%2520glucotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5797%26epage%3D5812%26doi%3D10.1021%2Fjm300544c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Hall, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Alternative approaches to Hsp90 modulation for the treatment of cancer</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1605</span><span class="refDoi"> DOI: 10.4155/fmc.14.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.4155%2Ffmc.14.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=25367392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1587-1605&author=J.+A.+Hallauthor=L.+K.+Forsbergauthor=B.+S.+Blagg&title=Alternative+approaches+to+Hsp90+modulation+for+the+treatment+of+cancer&doi=10.4155%2Ffmc.14.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative approaches to Hsp90 modulation for the treatment of cancer</span></div><div class="casAuthors">Hall, Jessica A.; Forsberg, Leah K.; Blagg, Brian SJ</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1587-1605</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is responsible for the conformational maturation of newly synthesized polypeptides (client proteins) and the re-maturation of denatured proteins via the Hsp90 chaperone cycle.  Inhibition of the Hsp90 N-terminus has emerged as a clin. relevant strategy for anticancer chemotherapeutics due to the involvement of clients in a variety of oncogenic pathways.  Several immunophilins, co-chaperones and partner proteins are also necessary for Hsp90 chaperoning activity.  Alternative strategies to inhibit Hsp90 function include disruption of the C-terminal dimerization domain and the Hsp90 heteroprotein complex.  C-terminal inhibitors and Hsp90 co-chaperone disruptors prevent cancer cell proliferation similar to N-terminal inhibitors and destabilize client proteins without induction of heat shock proteins.  Herein, current Hsp90 inhibitors, the chaperone cycle, and regulation of this cycle will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbVu5waacb8LVg90H21EOLACvtfcHk0lj_CG2TnBWxCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLvJ&md5=5a0c68b7c9ad23dd261f3f56d1473666</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.89%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DJ.%2BA.%26aulast%3DForsberg%26aufirst%3DL.%2BK.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DAlternative%2520approaches%2520to%2520Hsp90%2520modulation%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1587%26epage%3D1605%26doi%3D10.4155%2Ffmc.14.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Miyata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">The therapeutic target Hsp90 and cancer hallmarks</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.2174/138161213804143725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.2174%2F138161213804143725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22920906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=347-365&author=Y.+Miyataauthor=H.+Nakamotoauthor=L.+Neckers&title=The+therapeutic+target+Hsp90+and+cancer+hallmarks&doi=10.2174%2F138161213804143725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic target Hsp90 and cancer hallmarks</span></div><div class="casAuthors">Miyata, Yoshihiko; Nakamoto, Hitoshi; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-365</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a major mol. chaperone that is expressed abundantly and plays a pivotal role in assisting correct folding and functionality of its client proteins in cells.  The Hsp90 client proteins include a wide variety of signal transducing mols. such as protein kinases and steroid hormone receptors.  Cancer is a complex disease, but most types of human cancer share common hallmarks, including self-sufficiency in growth signals, insensitivity to growth-inhibitory mechanism, evasion of programmed cell death, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis.  A surprisingly large no. of Hsp90-client proteins play crucial roles in establishing cancer cell hallmarks.  We start the review by describing the structure and function of Hsp90 since conformational changes during the ATPase cycle of Hsp90 are closely related to its function.  Many co-chaperones, including Hop, p23, Cdc37, Aha1, and PP5, work together with Hsp90 by modulating the chaperone machinery.  Post-translational modifications of Hsp90 and its co-chaperones are vital for their function.  Many tumor-related Hsp90-client proteins, including signaling kinases, steroid hormone receptors, p53, and telomerase, are described.  Hsp90 and its co-chaperones are required for the function of these tumor-promoting client proteins; therefore, inhibition of Hsp90 by specific inhibitors such as geldanamycin and its derivs. attenuates the tumor progression.  Hsp90 inhibitors can be potential and effective cancer chemotherapeutic drugs with a unique profile and have been examd. in clin. trials.  We describe possible mechanisms why Hsp90 inhibitors show selectivity to cancer cells even though Hsp90 is essential also for normal cells.  Finally, we discuss the "Hsp90-addiction" of cancer cells, and suggest a role for Hsp90 in tumor evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCHug6Q3PILVg90H21EOLACvtfcHk0lj_CG2TnBWxCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D&md5=07f817fc5afc5ef0669aae0cd0dab15d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F138161213804143725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804143725%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DNakamoto%26aufirst%3DH.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DThe%2520therapeutic%2520target%2520Hsp90%2520and%2520cancer%2520hallmarks%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D347%26epage%3D365%26doi%3D10.2174%2F138161213804143725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lj_CG2TnBWxCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gorska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popowska, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sielicka-Dudzin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuban-Jankowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawczuk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knap, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucchieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, M.</span><span> </span><span class="NLM_article-title">Geldanamycin and its derivatives as Hsp90 inhibitors</span> <span class="citation_source-journal">Front. Biosci., Landmark Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2277</span><span class="refDoi"> DOI: 10.2741/4050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.2741%2F4050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22652777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSksb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=2269-2277&author=M.+Gorskaauthor=U.+Popowskaauthor=A.+Sielicka-Dudzinauthor=A.+Kuban-Jankowskaauthor=W.+Sawczukauthor=N.+Knapauthor=G.+Ciceroauthor=F.+Bucchieriauthor=M.+Wozniak&title=Geldanamycin+and+its+derivatives+as+Hsp90+inhibitors&doi=10.2741%2F4050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin and its derivatives as Hsp90 inhibitors</span></div><div class="casAuthors">Gorska, Magdalena; Popowska, Urszula; Sielicka-Dudzin, Alicja; Kuban-Jankowska, Alicja; Sawczuk, Wojciech; Knap, Narcyz; Cicero, Giuseppe; Bucchieri, Fabio; Wozniak, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2269-2277, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The Hsp90 mol., one of the most abundant heat shock proteins in mammalian cells, maintains homeostasis and prevents stress-induced cellular damage.  Hsp90 is expressed under normal conditions at a level of about 1-2 % of total proteins, while its expression increases 2-10 fold in cancer cells.  The two main constitutively expressed isoforms of Hsp90 are known as Hsp90-alpha and Hsp90-beta and their upregulation is assocd. with tumor progression, invasion and formation of metastases, as well as development of drug resistance.  The Hsp90 is a key target for many newly established, potent anticancer agents contg. Hsp90 N-terminal ATP binding inhibitors, such as geldanamycin and its analogs 17AAG and 17DMAG.  The therapeutic usage of geldanamycin has been limited due to its poor water soly. and severe hepatotoxicity.  Therefore, its analogs, including 17AAG, 17DMAG, Tanespimycin and Retaspimycin hydrochloride, with improved pharmacokinetic profiles, have been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_c94d0-i6VbVg90H21EOLACvtfcHk0livmqoi2mDXXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSksb%252FP&md5=fe48ca65ead5d186e6a439770d9ffff7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2741%2F4050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F4050%26sid%3Dliteratum%253Aachs%26aulast%3DGorska%26aufirst%3DM.%26aulast%3DPopowska%26aufirst%3DU.%26aulast%3DSielicka-Dudzin%26aufirst%3DA.%26aulast%3DKuban-Jankowska%26aufirst%3DA.%26aulast%3DSawczuk%26aufirst%3DW.%26aulast%3DKnap%26aufirst%3DN.%26aulast%3DCicero%26aufirst%3DG.%26aulast%3DBucchieri%26aufirst%3DF.%26aulast%3DWozniak%26aufirst%3DM.%26atitle%3DGeldanamycin%2520and%2520its%2520derivatives%2520as%2520Hsp90%2520inhibitors%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2012%26volume%3D17%26spage%3D2269%26epage%3D2277%26doi%3D10.2741%2F4050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Khandelwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Natural product inspired N-terminal Hsp90 inhibitors: from bench to bedside?</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1002/med.21351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1002%2Fmed.21351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=26010985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=92-118&author=A.+Khandelwalauthor=V.+M.+Crowleyauthor=B.+S.+Blagg&title=Natural+product+inspired+N-terminal+Hsp90+inhibitors%3A+from+bench+to+bedside%3F&doi=10.1002%2Fmed.21351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?</span></div><div class="casAuthors">Khandelwal, Anuj; Crowley, Vincent M.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-118</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The 90 kDa heat shock proteins (Hsp90) are responsible for the conformational maturation of nascent polypeptides and the rematuration of denatured proteins.  Proteins dependent upon Hsp90 are assocd. with all six hallmarks of cancer.  Upon Hsp90 inhibition, protein substrates are degraded via the ubiquitin-proteasome pathway.  Consequentially, inhibition of Hsp90 offers a therapeutic opportunity for the treatment of cancer.  Natural product inhibitors of Hsp90 have been identified in vitro, which have served as leads for the development of more efficacious inhibitors and analogs that have entered clin. trials.  This review highlights the development of natural product analogs, as well as the development of clin. important inhibitors that arose from natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqloFmLYY5brbVg90H21EOLACvtfcHk0livmqoi2mDXXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FK&md5=7625868e7c1e904cdd20036003ffb0d4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fmed.21351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21351%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DNatural%2520product%2520inspired%2520N-terminal%2520Hsp90%2520inhibitors%253A%2520from%2520bench%2520to%2520bedside%253F%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D92%26epage%3D118%26doi%3D10.1002%2Fmed.21351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummalapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span> </span><span class="NLM_article-title">Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8718</span><span class="NLM_x">–</span> <span class="NLM_lpage">8728</span><span class="refDoi"> DOI: 10.1021/jm500823a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500823a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8718-8728&author=R.+Bhatauthor=S.+R.+Tummalapalliauthor=D.+P.+Rotella&title=Progress+in+the+discovery+and+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors&doi=10.1021%2Fjm500823a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors</span></div><div class="casAuthors">Bhat, Rohit; Tummalapalli, Sreedhar R.; Rotella, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8718-8728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The discovery and clin. development of heat shock protein 90 (Hsp90) inhibitors continue to progress.  A no. of Hsp90 inhibitors are in clin. trials, and preclin. discoveries of new chemotypes that bind to distinct regions in the protein as well as isoform selective compds. are active areas of research.  This review will highlight progress in the field since 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-SwLv_-B9xLVg90H21EOLACvtfcHk0livmqoi2mDXXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK&md5=132784687bbbcf62cfa8fe04a22577ce</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm500823a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500823a%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DTummalapalli%26aufirst%3DS.%2BR.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DProgress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8718%26epage%3D8728%26doi%3D10.1021%2Fjm500823a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Jhaveri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span><span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.bbamcr.2011.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22062686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+in+cancers&doi=10.1016%2Fj.bbamcr.2011.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span></div><div class="casAuthors">Jhaveri, Komal; Taldone, Tony; Modi, Shanu; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is an ATP dependent mol. chaperone protein which integrates multiple oncogenic pathways.  As such, Hsp90 inhibition is a promising anti-cancer strategy.  Several inhibitors that act on Hsp90 by binding to its N-terminal ATP pocket have entered clin. evaluation.  Robust pre-clin. data suggested anti-tumor activity in multiple cancer types.  Clin., encouraging results have been demonstrated in melanoma, acute myeloid leukemia, castrate refractory prostate cancer, non-small cell lung carcinoma and multiple myeloma.  In breast cancer, proof-of-concept was demonstrated by first generation Hsp90 inhibitors in combination with trastuzumab mainly in human epidermal growth factor receptor 2 (HER2) + metastatic breast cancer.  There are a multitude of second generation Hsp90 inhibitors currently under investigation.  To date, however, there is no FDA approved Hsp90 inhibitor nor standardized assay to ascertain Hsp90 inhibition.  This review summarizes the current status of both first and second generation Hsp90 inhibitors based on their chem. classification and stage of clin. development.  It also discusses the pharmacodynamic assays currently implemented in clinic as well as other novel strategies aimed at enhancing the effectiveness of Hsp90 inhibitors.  Ultimately, these efforts will aid in maximizing the full potential of this class of agents.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDrDTpRQxfYrVg90H21EOLACvtfcHk0lgYgzH_6SIeag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D&md5=03cef7dc96667a4698324f635aacee7a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D742%26epage%3D755%26doi%3D10.1016%2Fj.bbamcr.2011.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Shimamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carretero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgman, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4973</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-2967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1158%2F1078-0432.CCR-11-2967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22806877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=4973-4985&author=T.+Shimamuraauthor=S.+A.+Pereraauthor=K.+P.+Foleyauthor=J.+Sangauthor=S.+J.+Rodigauthor=T.+Inoueauthor=L.+Chenauthor=D.+Liauthor=J.+Carreteroauthor=Y.+C.+Liauthor=P.+Sinhaauthor=C.+D.+Careyauthor=C.+L.+Borgmanauthor=J.+P.+Jimenezauthor=M.+Meyersonauthor=W.+Yingauthor=J.+Barsoumauthor=K.+K.+Wongauthor=G.+I.+Shapiro&title=Ganetespib+%28STA-9090%29%2C+a+nongeldanamycin+HSP90+inhibitor%2C+has+potent+antitumor+activity+in+in+vitro+and+in+vivo+models+of+non-small+cell+lung+cancer&doi=10.1158%2F1078-0432.CCR-11-2967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Shimamura, Takeshi; Perera, Samanthi A.; Foley, Kevin P.; Sang, Jim; Rodig, Scott J.; Inoue, Takayo; Chen, Liang; Li, Danan; Carretero, Julian; Li, Yu-Chen; Sinha, Papiya; Carey, Christopher D.; Borgman, Christa L.; Jimenez, John-Paul; Meyerson, Matthew; Ying, Weiwen; Barsoum, James; Wong, Kwok-Kin; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4973-4985</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We describe the anticancer activity of ganetespib, a novel non-geldanamycin heat shock protein 90 (HSP90) inhibitor, in non-small cell lung cancer (NSCLC) models.  Exptl. Design: The activity of ganetespib was compared with that of the geldanamycin 17-AAG in biochem. assays, cell lines, and xenografts, and evaluated in an ERBB2 YVMA-driven mouse lung adenocarcinoma model.  Results: Ganetespib blocked the ability of HSP90 to bind to biotinylated geldanamycin and disrupted the assocn. of HSP90 with its cochaperone, p23, more potently than 17-AAG.  In genomically defined NSCLC cell lines, ganetespib caused depletion of receptor tyrosine kinases, extinguishing of downstream signaling, inhibition of proliferation and induction of apoptosis with IC50 values ranging 2 to 30 nmol/L, substantially lower than those required for 17-AAG (20-3,500 nmol/L).  Ganetespib was also approx. 20-fold more potent in isogenic Ba/F3 pro-B cells rendered IL-3 independent by expression of EGFR and ERBB2 mutants.  In mice bearing NCI-H1975 (EGFR L858R/T790M) xenografts, ganetespib was rapidly eliminated from plasma and normal tissues but was maintained in tumor with t1/2 58.3 h, supporting once-weekly dosing expts., in which ganetespib produced greater tumor growth inhibition than 17-AAG.  However, after a single dose, reexpression of mutant EGFR occurred by 72 h, correlating with reversal of antiproliferative and proapoptotic effects.  Consecutive day dosing resulted in xenograft regressions, accompanied by more sustained pharmacodynamic effects.  Ganetespib also showed activity against mouse lung adenocarcinomas driven by oncogenic ERBB2 YVMA.  Conclusions: Ganetespib has greater potency than 17-AAG and potential efficacy against several NSCLC subsets, including those harboring EGFR or ERBB2 mutation.  Clin Cancer Res; 18(18); 4973-85. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoOaAHBIqU6bVg90H21EOLACvtfcHk0lgYgzH_6SIeag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lt7zJ&md5=92bb99dd7de0f7d4fc4f1d1a897605ea</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2967%26sid%3Dliteratum%253Aachs%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DPerera%26aufirst%3DS.%2BA.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCarretero%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%2BC.%26aulast%3DSinha%26aufirst%3DP.%26aulast%3DCarey%26aufirst%3DC.%2BD.%26aulast%3DBorgman%26aufirst%3DC.%2BL.%26aulast%3DJimenez%26aufirst%3DJ.%2BP.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DGanetespib%2520%2528STA-9090%2529%252C%2520a%2520nongeldanamycin%2520HSP90%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520activity%2520in%2520in%2520vitro%2520and%2520in%2520vivo%2520models%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D4973%26epage%3D4985%26doi%3D10.1158%2F1078-0432.CCR-11-2967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Garon, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamidi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dering, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamranpour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosmer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avsar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubinett, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D. J.</span><span> </span><span class="NLM_article-title">The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1158%2F1535-7163.MCT-12-0998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23493311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=890-900&author=E.+B.+Garonauthor=R.+S.+Finnauthor=H.+Hamidiauthor=J.+Deringauthor=S.+Pittsauthor=N.+Kamranpourauthor=A.+J.+Desaiauthor=W.+Hosmerauthor=S.+Ideauthor=E.+Avsarauthor=M.+R.+Jensenauthor=C.+Quadtauthor=M.+Liuauthor=S.+M.+Dubinettauthor=D.+J.+Slamon&title=The+HSP90+inhibitor+NVP-AUY922+potently+inhibits+non-small+cell+lung+cancer+growth&doi=10.1158%2F1535-7163.MCT-12-0998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 Inhibitor NVP-AUY922 Potently Inhibits Non-Small Cell Lung Cancer Growth</span></div><div class="casAuthors">Garon, Edward B.; Finn, Richard S.; Hamidi, Habib; Dering, Judy; Pitts, Sharon; Kamranpour, Naeimeh; Desai, Amrita J.; Hosmer, Wylie; Ide, Susan; Avsar, Emin; Jensen, Michael Rugaard; Quadt, Cornelia; Liu, Manway; Dubinett, Steven M.; Slamon, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">890-900</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Heat shock protein 90 (HSP90) is involved in protein folding and functions as a chaperone for numerous client proteins, many of which are important in non-small cell lung cancer (NSCLC) pathogenesis.  We sought to define preclin. effects of the HSP90 inhibitor NVP-AUY922 and identify predictors of response.  We assessed in vitro effects of NVP-AUY922 on proliferation and protein expression in NSCLC cell lines.  We evaluated gene expression changes induced by NVP-AUY922 exposure.  Xenograft models were evaluated for tumor control and biol. effects.  NVP-AUY922 potently inhibited in vitro growth in all 41 NSCLC cell lines evaluated with IC50 < 100 nmol/L.  IC100 (complete inhibition of proliferation) < 40 nmol/L was seen in 36 of 41 lines.  Consistent gene expression changes after NVP-AUY922 exposure involved a wide range of cellular functions, including consistently decreased dihydrofolate reductase after exposure.  NVP-AUY922 slowed growth of A549 (KRAS-mutant) xenografts and achieved tumor stability and decreased EGF receptor (EGFR) protein expression in H1975 xenografts, a model harboring a sensitizing and a resistance mutation for EGFR-tyrosine kinase inhibitors in the EGFR gene.  These data will help inform the evaluation of correlative data from a recently completed phase II NSCLC trial and a planned phase IB trial of NVP-AUY922 in combination with pemetrexed in NSCLCs.  Mol Cancer Ther; 12(6); 890-900. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD4i0xZ06HFrVg90H21EOLACvtfcHk0lgYgzH_6SIeag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOksrs%253D&md5=e330c791147c502855816d4926273315</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0998%26sid%3Dliteratum%253Aachs%26aulast%3DGaron%26aufirst%3DE.%2BB.%26aulast%3DFinn%26aufirst%3DR.%2BS.%26aulast%3DHamidi%26aufirst%3DH.%26aulast%3DDering%26aufirst%3DJ.%26aulast%3DPitts%26aufirst%3DS.%26aulast%3DKamranpour%26aufirst%3DN.%26aulast%3DDesai%26aufirst%3DA.%2BJ.%26aulast%3DHosmer%26aufirst%3DW.%26aulast%3DIde%26aufirst%3DS.%26aulast%3DAvsar%26aufirst%3DE.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DQuadt%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DDubinett%26aufirst%3DS.%2BM.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520HSP90%2520inhibitor%2520NVP-AUY922%2520potently%2520inhibits%2520non-small%2520cell%2520lung%2520cancer%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D890%26epage%3D900%26doi%3D10.1158%2F1535-7163.MCT-12-0998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskew, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vielhauer, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">The hERG channel is dependent upon the Hsp90α isoform for maturation and trafficking</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span><span class="refDoi"> DOI: 10.1021/mp300138n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300138n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVWns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=1841-1846&author=L.+B.+Petersonauthor=J.+D.+Eskewauthor=G.+A.+Vielhauerauthor=B.+S.+Blagg&title=The+hERG+channel+is+dependent+upon+the+Hsp90%CE%B1+isoform+for+maturation+and+trafficking&doi=10.1021%2Fmp300138n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The hERG Channel Is Dependent upon the Hsp90α Isoform for Maturation and Trafficking</span></div><div class="casAuthors">Peterson, Laura B.; Eskew, Jeffrey D.; Vielhauer, George A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1841-1846</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) has emerged as a promising therapeutic target for the treatment of cancer.  Several Hsp90 inhibitors have entered clin. trials.  However, some toxicol. detriments have arisen, such as cardiotoxicity resulting from hERG inhibition following the administration of Hsp90 inhibitors.  We sought to investigate this toxicity as hERG has been previously reported as a client protein that depends upon Hsp90 for its maturation and functional trafficking.  In this study we show that hERG depends upon a single Hsp90 isoform. hERG preferentially co-immunopptd. with Hsp90α, and genetic knockdown of Hsp90α, but not Hsp90β, resulted in a trafficking-defective hERG channel.  This study demonstrates the importance of delineating the isoform dependence of Hsp90 client proteins and provides rationale for the design of isoform-selective Hsp90 inhibitors that avoid detrimental effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5BFhqGrKjIbVg90H21EOLACvtfcHk0lgFRVeEqr0Isw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVWns7k%253D&md5=910dfb5e4a9150f408d5756ab881e492</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fmp300138n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300138n%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DEskew%26aufirst%3DJ.%2BD.%26aulast%3DVielhauer%26aufirst%3DG.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DThe%2520hERG%2520channel%2520is%2520dependent%2520upon%2520the%2520Hsp90%25CE%25B1%2520isoform%2520for%2520maturation%2520and%2520trafficking%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D1841%26epage%3D1846%26doi%3D10.1021%2Fmp300138n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piel, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruford, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, A.</span><span> </span><span class="NLM_article-title">The HSP90 family of genes in the human genome: insights into their divergence and evolution</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.1016/j.ygeno.2005.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.ygeno.2005.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=16269234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12jurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2005&pages=627-637&author=B.+Chenauthor=W.+H.+Pielauthor=L.+Guiauthor=E.+Brufordauthor=A.+Monteiro&title=The+HSP90+family+of+genes+in+the+human+genome%3A+insights+into+their+divergence+and+evolution&doi=10.1016%2Fj.ygeno.2005.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 family of genes in the human genome: Insights into their divergence and evolution</span></div><div class="casAuthors">Chen, Bin; Piel, William H.; Gui, Liming; Bruford, Elspeth; Monteiro, Antonia</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-637</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">HSP90 proteins are important mol. chaperones.  Transcriptome and genome analyses revealed that the human HSP90 family includes 17 genes that fall into four classes.  A standardized nomenclature for each of these genes is presented here.  Classes HSP90AA, HSP90AB, HSP90B, and TRAP contain 7, 6, 3, and 1 genes, resp.  HSP90AA genes mapped onto chromosomes 1, 3, 4, and 11; HSP90AB genes mapped onto 3, 4, 6, 13 and 15; HSP90B genes mapped onto 1, 12, and 15; and the TRAP1 gene mapped onto 16.  Six genes, HSP90AA1, HSP90AA2, HSP90N, HSP90AB1, HSP90B1 and TRAP1, were recognized as functional, and the remaining 11 genes were considered putative pseudogenes.  Amino acid polymorphic variants were detected for genes HSP90AA1, HSP90AA2, HSP90AB1, HSP90B1, and TRAP1.  The structures of these genes and the functional motifs and polymorphic variants of their proteins were documented and the features and functions of their proteins were discussed.  Phylogenetic analyses based on both nucleotide and protein data demonstrated that HSP90(AA + AB + B) formed a monophyletic clade, whereas TRAP is a relatively distant paralogue of this clade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWj0BC1lItPLVg90H21EOLACvtfcHk0lhNOlq-MyViCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12jurvN&md5=ce235856d3bc4abf368fecdb5de9ba46</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ygeno.2005.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygeno.2005.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPiel%26aufirst%3DW.%2BH.%26aulast%3DGui%26aufirst%3DL.%26aulast%3DBruford%26aufirst%3DE.%26aulast%3DMonteiro%26aufirst%3DA.%26atitle%3DThe%2520HSP90%2520family%2520of%2520genes%2520in%2520the%2520human%2520genome%253A%2520insights%2520into%2520their%2520divergence%2520and%2520evolution%26jtitle%3DGenomics%26date%3D2005%26volume%3D86%26spage%3D627%26epage%3D637%26doi%3D10.1016%2Fj.ygeno.2005.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6803</span><span class="NLM_x">–</span> <span class="NLM_lpage">6818</span><span class="refDoi"> DOI: 10.1021/jm400619b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400619b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6803-6818&author=T.+Taldoneauthor=P.+D.+Patelauthor=M.+Patelauthor=H.+J.+Patelauthor=C.+E.+Evansauthor=A.+Rodinaauthor=S.+Ochianaauthor=S.+K.+Shahauthor=M.+Uddinauthor=D.+Gewirthauthor=G.+Chiosis&title=Experimental+and+structural+testing+module+to+analyze+paralogue-specificity+and+affinity+in+the+Hsp90+inhibitors+series&doi=10.1021%2Fjm400619b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series</span></div><div class="casAuthors">Taldone, Tony; Patel, Pallav D.; Patel, Maulik; Patel, Hardik J.; Evans, Christopher E.; Rodina, Anna; Ochiana, Stefan; Shah, Smit K.; Uddin, Mohammad; Gewirth, Daniel; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6803-6818</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We here describe the first reported comprehensive anal. of Hsp90 paralogue affinity and selectivity in the clin. Hsp90 inhibitor chemotypes.  This has been possible through the development of a versatile exptl. assay based on a new FP-probe that we both describe here.  The assay can test rapidly and accurately the binding affinity of all major Hsp90 chemotypes and has a testing range that spans low nanomolar to millimolar binding affinities.  We couple this assay with a computational anal. that allows for rationalization of paralogue selectivity and defines not only the major binding modes that relay pan-paralogue binding or, conversely, paralogue selectivity, but also identifies mol. characteristics that impart such features.  The methods developed here provide a blueprint for parsing out the contribution of the four Hsp90 paralogues to the perceived biol. activity with the current Hsp90 chemotypes and set the ground for the development of paralogue selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgOst3-n58BrVg90H21EOLACvtfcHk0lhNOlq-MyViCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWltbvM&md5=bda49f7f2f61553e344b100d5d6949dd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm400619b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400619b%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DEvans%26aufirst%3DC.%2BE.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DOchiana%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DUddin%26aufirst%3DM.%26aulast%3DGewirth%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DExperimental%2520and%2520structural%2520testing%2520module%2520to%2520analyze%2520paralogue-specificity%2520and%2520affinity%2520in%2520the%2520Hsp90%2520inhibitors%2520series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6803%26epage%3D6818%26doi%3D10.1021%2Fjm400619b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Song, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donner, D. B.</span><span> </span><span class="NLM_article-title">Identification of a protein with homology to Hsp90 that binds the type 1 tumor necrosis factor receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">3574</span><span class="NLM_x">–</span> <span class="NLM_lpage">3581</span><span class="refDoi"> DOI: 10.1074/jbc.270.8.3574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.270.8.3574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=7876093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADyaK2MXjvVyrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=3574-3581&author=H.+Y.+Songauthor=J.+D.+Dunbarauthor=Y.+X.+Zhangauthor=D.+Guoauthor=D.+B.+Donner&title=Identification+of+a+protein+with+homology+to+Hsp90+that+binds+the+type+1+tumor+necrosis+factor+receptor&doi=10.1074%2Fjbc.270.8.3574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor</span></div><div class="casAuthors">Song, Ho Yeong; Dunbar, James D.; Zhang, Yuan Xin; Guo, Danqun; Donner, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3574-81</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The yeast-based two hybrid has been used to identify a novel protein that binds to the intracellular domain of the type 1 receptor for tumor necrosis factor (TNFR-1IC).  The TNF receptor-assocd. protein, TRAP-1, shows strong homol. to members of the 90-kDa family of heat shock proteins.  After in vitro transcription/translation and 35S labeling, TRAP-1 was pptd. using a fusion protein consisting of glutathione S-transferase and TNFR-1IC, showing that the two proteins directly interact.  The ability of deletion mutants of TNFR-1 to interact with TRAP-1 was tested using the two hybrid system.  This showed that the amino acid sequences that mediate binding are diffusely distributed outside of the domain in the C terminus of TNFR-1IC that signals cytotoxicity.  The 2.4-kilobase TRAP-1 mRNA was variably expressed in skeletal muscle, liver, heart, brain, kidney, pancreas, lung, and placenta.  TRAP-1 mRNA was also detected in each of eight different transformed cell lines.  Identification of TRAP-1 may be an important step toward defining how TNFR-1, which does not contain protein kinase activity, transmits its message to signal transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMKs-XwrfD0rVg90H21EOLACvtfcHk0lhNOlq-MyViCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvVyrsro%253D&md5=7cf51fbc1c210b58ea195dd150b62533</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.8.3574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.8.3574%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%2BY.%26aulast%3DDunbar%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%2BX.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DDonner%26aufirst%3DD.%2BB.%26atitle%3DIdentification%2520of%2520a%2520protein%2520with%2520homology%2520to%2520Hsp90%2520that%2520binds%2520the%2520type%25201%2520tumor%2520necrosis%2520factor%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D3574%26epage%3D3581%26doi%3D10.1074%2Fjbc.270.8.3574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lee, A. S.</span><span> </span><span class="NLM_article-title">Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1038/nrc3701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1038%2Fnrc3701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=24658275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslCqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=263-276&author=A.+S.+Lee&title=Glucose-regulated+proteins+in+cancer%3A+molecular+mechanisms+and+therapeutic+potential&doi=10.1038%2Fnrc3701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential</span></div><div class="casAuthors">Lee, Amy S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">263-276</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The glucose-regulated proteins (GRPs) are stress-inducible chaperones that mostly reside in the endoplasmic reticulum or the mitochondria.  Recent advances show that the GRPs have functions that are distinct from those of the related heat shock proteins, and they can be actively translocated to other cellular locations and assume novel functions that control signalling, proliferation, invasion, apoptosis, inflammation and immunity.  Mouse models further identified their specific roles in development, tumorigenesis, metastasis and angiogenesis.  This Review describes their discovery and regulation, as well as their biol. functions in cancer.  Promising agents that use or target the GRPs are being developed, and their efficacy as anticancer therapeutics is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozBF42yfN9I7Vg90H21EOLACvtfcHk0lgtGwn6rBCV3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslCqs7c%253D&md5=8a8539550b16c4ac0630114261b1302e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc3701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3701%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DGlucose-regulated%2520proteins%2520in%2520cancer%253A%2520molecular%2520mechanisms%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D263%26epage%3D276%26doi%3D10.1038%2Fnrc3701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Stothert, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suntharalingam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span> </span><span class="NLM_article-title">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6470</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span><span class="refDoi"> DOI: 10.1093/hmg/ddu367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1093%2Fhmg%2Fddu367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=25027323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=6470-6480&author=A.+R.+Stothertauthor=A.+Suntharalingamauthor=D.+J.+Huardauthor=S.+N.+Fontaineauthor=V.+M.+Crowleyauthor=S.+Mishraauthor=B.+S.+Blaggauthor=R.+L.+Liebermanauthor=C.+A.+Dickey&title=Exploiting+the+interaction+between+Grp94+and+aggregated+myocilin+to+treat+glaucoma&doi=10.1093%2Fhmg%2Fddu367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span></div><div class="casAuthors">Stothert, Andrew R.; Suntharalingam, Amirthaa; Huard, Dustin J. E.; Fontaine, Sarah N.; Crowley, Vincent M.; Mishra, Sanket; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6470-6480</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Gain-of-function mutations in the olfactomedin domain of the MYOC gene facilitate the toxic accumulation of amyloid-contg. myocilin aggregates, hastening the onset of the prevalent ocular disorder primary open-angle glaucoma.  Aggregation of wild-type myocilin has been reported in other glaucoma subtypes, suggesting broader relevance of misfolded myocilin across the disease spectrum, but the absence of myocilin does not cause disease.  Thus, strategies aimed at eliminating myocilin could be therapeutically relevant for glaucoma.  Here, a novel and selective Grp94 inhibitor reduced the levels of several mutant myocilin proteins as well as wild-type myocilin when forced to misfold in cells.  This inhibitor rescued mutant myocilin toxicity in primary human trabecular meshwork cells.  Mechanistically, in vitro kinetics studies demonstrate that Grp94 recognizes on-pathway aggregates of the myocilin olfactomedin domain (myoc-OLF), accelerates rates of aggregation and co-ppts. with myoc-OLF.  These results indicate that aberrant myocilin quaternary structure drives Grp94 recognition, rather than peptide motifs exposed by unfolded protein.  Inhibition of Grp94 ameliorates the effects of Grp94-accelerated myoc-OLF aggregation, and Grp94 remains in soln.  In cells, when wild-type myocilin is driven to misfold and aggregate, it becomes a client of Grp94 and sensitive to Grp94 inhibition.  Taken together, the interaction of Grp94 with myocilin aggregates can be manipulated by cellular environment and genetics; this process can be exploited with Grp94 inhibitors to promote the clearance of toxic forms of myocilin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQYeK777kKLVg90H21EOLACvtfcHk0lgtGwn6rBCV3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D&md5=cbabbce383403838a4cbc3ffe24bdce8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu367%26sid%3Dliteratum%253Aachs%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DSuntharalingam%26aufirst%3DA.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%26aulast%3DFontaine%26aufirst%3DS.%2BN.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DExploiting%2520the%2520interaction%2520between%2520Grp94%2520and%2520aggregated%2520myocilin%2520to%2520treat%2520glaucoma%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D6470%26epage%3D6480%26doi%3D10.1093%2Fhmg%2Fddu367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Soldano, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jivan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">48330</span><span class="NLM_x">–</span> <span class="NLM_lpage">48338</span><span class="refDoi"> DOI: 10.1074/jbc.M308661200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M308661200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=12970348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Gjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=48330-48338&author=K.+L.+Soldanoauthor=A.+Jivanauthor=C.+V.+Nicchittaauthor=D.+T.+Gewirth&title=Structure+of+the+N-terminal+domain+of+GRP94.+Basis+for+ligand+specificity+and+regulation&doi=10.1074%2Fjbc.M308661200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the N-terminal Domain of GRP94: Basis for Ligand Specificity and Regulation</span></div><div class="casAuthors">Soldano, Karen L.; Jivan, Arif; Nicchitta, Christopher V.; Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">48330-48338</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">GRP94, the endoplasmic reticulum (ER) paralog of the chaperone Hsp90, plays an essential role in the structural maturation or secretion of a subset of proteins destined for transport to the cell surface, such as the Toll-like receptors 2 and 4, and IgG, resp.  GRP94 differs from cytoplasmic Hsp90 by exhibiting very weak ATP binding and hydrolysis activity.  GRP94 also binds selectively to a series of substituted adenosine analogs.  The high resoln. crystal structures at 1.75-2.1 Å of the N-terminal and adjacent charged domains of GRP94 in complex with N-ethylcarboxamidoadenosine (NECA), radicicol, and 2-chlorodideoxyadenosine reveals a structural mechanism for ligand discrimination among hsp90 family members.  The structures also identify a putative subdomain that may act as a ligand-responsive switch.  The residues of the charged region fold into a disordered loop whose termini are ordered and continue the twisted beta sheet that forms the structural core of the N-domain.  This continuation of the beta sheet past the charged domain suggests a structural basis for the assocn. of the N-terminal and middle domains of the full-length chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1SkIPU21-TLVg90H21EOLACvtfcHk0lgtGwn6rBCV3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Gjt78%253D&md5=0d83c7ac820dbdab6faf940dd1052ad0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M308661200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M308661200%26sid%3Dliteratum%253Aachs%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DJivan%26aufirst%3DA.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520of%2520the%2520N-terminal%2520domain%2520of%2520GRP94.%2520Basis%2520for%2520ligand%2520specificity%2520and%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D48330%26epage%3D48338%26doi%3D10.1074%2Fjbc.M308661200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Marzec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span> </span><span class="NLM_article-title">GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span><span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.bbamcr.2011.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22079671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=774-787&author=M.+Marzecauthor=D.+Elettoauthor=Y.+Argon&title=GRP94%3A+An+HSP90-like+protein+specialized+for+protein+folding+and+quality+control+in+the+endoplasmic+reticulum&doi=10.1016%2Fj.bbamcr.2011.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span></div><div class="casAuthors">Marzec, Michal; Eletto, Davide; Argon, Yair</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">774-787</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glucose-regulated protein 94 is the HSP90-like protein in the lumen of the endoplasmic reticulum and therefore it chaperones secreted and membrane proteins.  It has essential functions in development and physiol. of multicellular organisms, at least in part because of this unique clientele.  GRP94 shares many biochem. features with other HSP90 proteins, in particular its domain structure and ATPase activity, but also displays distinct activities, such as calcium binding, necessitated by the conditions in the endoplasmic reticulum.  GRP94's mode of action varies from the general HSP90 theme in the conformational changes induced by nucleotide binding, and in its interactions with co-chaperones, which are very different from known cytosolic co-chaperones.  GRP94 is more selective than many of the ER chaperones and the basis for this selectivity remains obscure.  Recent development of mol. tools and functional assays has expanded the spectrum of clients that rely on GRP94 activity, but it is still not clear how the chaperone binds them, or what aspect of folding it impacts.  These mechanistic questions and the regulation of GRP94 activity by other proteins and by post-translational modification differences pose new questions and present future research avenues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnr8jU7cub5LVg90H21EOLACvtfcHk0linycTffH05WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7g%253D&md5=421b27e4a82e34398366793c11147b99</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DMarzec%26aufirst%3DM.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DGRP94%253A%2520An%2520HSP90-like%2520protein%2520specialized%2520for%2520protein%2520folding%2520and%2520quality%2520control%2520in%2520the%2520endoplasmic%2520reticulum%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D774%26epage%3D787%26doi%3D10.1016%2Fj.bbamcr.2011.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Stothert, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span> </span><span class="NLM_article-title">Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1016/j.exer.2015.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.exer.2015.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=26302411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSitbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2016&pages=38-45&author=A.+R.+Stothertauthor=S.+N.+Fontaineauthor=J.+J.+Sabbaghauthor=C.+A.+Dickey&title=Targeting+the+ER-autophagy+system+in+the+trabecular+meshwork+to+treat+glaucoma&doi=10.1016%2Fj.exer.2015.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma</span></div><div class="casAuthors">Stothert, Andrew R.; Fontaine, Sarah N.; Sabbagh, Jonathan J.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38-45</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A major drainage network involved in aq. humor dynamics is the conventional outflow pathway, which is gated by the trabecular meshwork (TM).  The TM acts as a mol. sieve, providing resistance to aq. outflow, which is responsible for regulating intraocular pressure (IOP).  If the TM is damaged, aq. outflow is impaired, IOP increases and glaucoma can manifest.  Mutations in the MYOC gene cause hereditary primary open-angle glaucoma (POAG) by promoting the abnormal amyloidosis of the myocilin protein in the endoplasmic reticulum (ER), leading to ER stress-induced TM cell death.  Myocilin accumulation is obsd. in approx. 70-80% of all glaucoma cases suggesting that environmental or other genetic factors may also promote myocilin toxicity.  For example, simply preventing myocilin glycosylation is sufficient to promote its abnormal accretion.  These myocilin amyloids are unique as there are no other known pathogenic proteins that accumulate within the ER of TM cells and cause toxicity.  Moreover, this pathogenic accumulation only kills TM cells, despite expression of this protein in other cell types, suggesting that another modifier exclusive to the TM participates in the proteotoxicity of myocilin.  ER autophagy (reticulophagy) is one of the pathways essential for myocilin clearance that can be impacted dramatically by aging and other environmental factors such as nutrition.  This review will discuss the link between myocilin and autophagy, evaluating the role of this degrdn. pathway in glaucoma as well as its potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ_Ml3J4Yt5LVg90H21EOLACvtfcHk0linycTffH05WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSitbbO&md5=c51dc569be7d4b06624daf5f8abe8b30</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2015.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2015.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DFontaine%26aufirst%3DS.%2BN.%26aulast%3DSabbagh%26aufirst%3DJ.%2BJ.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DTargeting%2520the%2520ER-autophagy%2520system%2520in%2520the%2520trabecular%2520meshwork%2520to%2520treat%2520glaucoma%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2016%26volume%3D144%26spage%3D38%26epage%3D45%26doi%3D10.1016%2Fj.exer.2015.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Weekes, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antrobus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simecek, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehner, P. J.</span><span> </span><span class="NLM_article-title">Proteomic plasma membrane profiling reveals an essential role for gp96 in the cell surface expression of LDLR family members, including the LDL receptor and LRP6</span> <span class="citation_source-journal">J. Proteome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">–</span> <span class="NLM_lpage">1484</span><span class="refDoi"> DOI: 10.1021/pr201135e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr201135e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1475-1484&author=M.+P.+Weekesauthor=R.+Antrobusauthor=S.+Talbotauthor=S.+Horauthor=N.+Simecekauthor=D.+L.+Smithauthor=S.+Bloorauthor=F.+Randowauthor=P.+J.+Lehner&title=Proteomic+plasma+membrane+profiling+reveals+an+essential+role+for+gp96+in+the+cell+surface+expression+of+LDLR+family+members%2C+including+the+LDL+receptor+and+LRP6&doi=10.1021%2Fpr201135e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic Plasma Membrane Profiling Reveals an Essential Role for gp96 in the Cell Surface Expression of LDLR Family Members, Including the LDL Receptor and LRP6</span></div><div class="casAuthors">Weekes, Michael P.; Antrobus, Robin; Talbot, Suzanne; Hor, Simon; Simecek, Nikol; Smith, Duncan L.; Bloor, Stuart; Randow, Felix; Lehner, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1475-1484</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The endoplasmic reticulum chaperone gp96 is required for the cell surface expression of a narrow range of proteins, including toll-like receptors (TLRs) and integrins.  To identify a more comprehensive repertoire of proteins whose cell surface expression is dependent on gp96, the authors developed plasma membrane profiling (PMP), a technique that combines SILAC labeling with selective cell surface aminooxy-biotinylation.  This approach allowed the authors to compare the relative abundance of plasma membrane (PM) proteins on gp96-deficient vs. gp96-reconstituted murine pre-B cells.  Anal. of unfractionated tryptic peptides initially identified 113 PM proteins, which extended to 706 PM proteins using peptide prefractionation.  The authors confirmed a requirement for gp96 in the cell surface expression of certain TLRs and integrins and found a marked decrease in cell surface expression of four members of the extended LDL receptor family (LDLR, LRP6, Sorl1 and LRP8) in the absence of gp96.  Other novel gp96 client proteins included CD180/Ly86, important in the B-cell response to lipopolysaccharide.  The authors highlight common structural motifs in these client proteins that may be recognized by gp96, including the beta-propeller and leucine-rich repeat.  This study therefore identifies the extended LDL receptor family as an important new family of proteins whose cell surface expression is regulated by gp96.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyQkiMCW-Z07Vg90H21EOLACvtfcHk0linycTffH05WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGls7Y%253D&md5=8aa4227b76be5b35db6a0b73a9f16bf7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fpr201135e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr201135e%26sid%3Dliteratum%253Aachs%26aulast%3DWeekes%26aufirst%3DM.%2BP.%26aulast%3DAntrobus%26aufirst%3DR.%26aulast%3DTalbot%26aufirst%3DS.%26aulast%3DHor%26aufirst%3DS.%26aulast%3DSimecek%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DBloor%26aufirst%3DS.%26aulast%3DRandow%26aufirst%3DF.%26aulast%3DLehner%26aufirst%3DP.%2BJ.%26atitle%3DProteomic%2520plasma%2520membrane%2520profiling%2520reveals%2520an%2520essential%2520role%2520for%2520gp96%2520in%2520the%2520cell%2520surface%2520expression%2520of%2520LDLR%2520family%2520members%252C%2520including%2520the%2520LDL%2520receptor%2520and%2520LRP6%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2012%26volume%3D11%26spage%3D1475%26epage%3D1484%26doi%3D10.1021%2Fpr201135e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidler, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Que, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1038/nchembio.1335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D.+Patelauthor=P.+Yanauthor=P.+M.+Seidlerauthor=H.+J.+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S.+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A.+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+Hsp90+inhibitors+define+tumor-specific+regulation+of+HER2&doi=10.1038%2Fnchembio.1335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0ljiL3afmB6BVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520Hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520HER2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684%26doi%3D10.1038%2Fnchembio.1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tramentozzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolaender, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrestha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3922</span><span class="NLM_x">–</span> <span class="NLM_lpage">3943</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3922-3943&author=H.+J.+Patelauthor=P.+D.+Patelauthor=S.+O.+Ochianaauthor=P.+Yanauthor=W.+Sunauthor=M.+R.+Patelauthor=S.+K.+Shahauthor=E.+Tramentozziauthor=J.+Brooksauthor=A.+Bolaenderauthor=L.+Shresthaauthor=R.+Stephaniauthor=P.+Finottiauthor=C.+Leiferauthor=Z.+Liauthor=D.+T.+Gewirthauthor=T.+Taldoneauthor=G.+Chiosis&title=Structure-activity+relationship+in+a+purine-scaffold+compound+series+with+selectivity+for+the+endoplasmic+reticulum+Hsp90+paralog+Grp94&doi=10.1021%2Facs.jmedchem.5b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94</span></div><div class="casAuthors">Patel, Hardik J.; Patel, Pallav D.; Ochiana, Stefan O.; Yan, Pengrong; Sun, Weilin; Patel, Maulik R.; Shah, Smit K.; Tramentozzi, Elisa; Brooks, James; Bolaender, Alexander; Shrestha, Liza; Stephani, Ralph; Finotti, Paola; Leifer, Cynthia; Li, Zihai; Gewirth, Daniel T.; Taldone, Tony; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3922-3943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Grp94 is involved in the regulation of a restricted no. of proteins and represents a potential target in a host of diseases, including cancer, septic shock, autoimmune diseases, chronic inflammatory conditions, diabetes, coronary thrombosis, and stroke.  The authors have recently identified a novel allosteric pocket located in the Grp94 N-terminal binding site that can be used to design ligands with a 2-log selectivity over the other Hsp90 paralogs.  Here the authors perform extensive SAR investigations in this ligand series and rationalize the affinity and paralog selectivity of choice derivs. by mol. modeling.  The authors then use this to design I, a deriv. with good potency for Grp94 (IC50 = 0.22 μM) and selectivity over other paralogs (>100- and 33-fold for Hsp90α/β and Trap-1, resp.).  The paralog selectivity and target-mediated activity of I was confirmed in cells through several functional readouts.  Compd. I was also inert when tested against a large panel of kinases.  The authors show that I has biol. activity in several cellular models of inflammation and cancer and also present here for the first time the in vivo profile of a Grp94 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-3SSMDJ2Ti7Vg90H21EOLACvtfcHk0ljiL3afmB6BVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWnsbg%253D&md5=4c341cedaf3aa4d08afa43cbca301717</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00197%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DTramentozzi%26aufirst%3DE.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DBolaender%26aufirst%3DA.%26aulast%3DShrestha%26aufirst%3DL.%26aulast%3DStephani%26aufirst%3DR.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DLeifer%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DStructure-activity%2520relationship%2520in%2520a%2520purine-scaffold%2520compound%2520series%2520with%2520selectivity%2520for%2520the%2520endoplasmic%2520reticulum%2520Hsp90%2520paralog%2520Grp94%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3922%26epage%3D3943%26doi%3D10.1021%2Facs.jmedchem.5b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Duerfeldt, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinogle, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9804</span><span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0ljcaKBiGTdVnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Muth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandelwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Development of radamide analogs as Grp94 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4083</span><span class="NLM_x">–</span> <span class="NLM_lpage">4098</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.05.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.bmc.2014.05.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=25027801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFGru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4083-4098&author=A.+Muthauthor=V.+Crowleyauthor=A.+Khandelwalauthor=S.+Mishraauthor=J.+Zhaoauthor=J.+Hallauthor=B.+S.+Blagg&title=Development+of+radamide+analogs+as+Grp94+inhibitors&doi=10.1016%2Fj.bmc.2014.05.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radamide analogs as Grp94 inhibitors</span></div><div class="casAuthors">Muth, Aaron; Crowley, Vincent; Khandelwal, Anuj; Mishra, Sanket; Zhao, Jinbo; Hall, Jessica; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4083-4098</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hsp90 isoform-selective inhibition is highly desired as it can potentially avoid the toxic side-effects of pan-inhibition.  The current study developed selective inhibitors of one such isoform, Grp94, predicated on the chimeric and pan-Hsp90 inhibitor, radamide (RDA).  Replacement of the quinone moiety of RDA with a Ph ring (2) was found to be better suited for Grp94 inhibition as it can fully interact with a unique hydrophobic pocket present in Grp94.  An extensive SAR for this scaffold showed that substitutions at the 2- and 4-positions (8 and 27, resp.) manifested excellent Grp94 affinity and selectivity.  Introduction of heteroatoms into the ring also proved beneficial, with a 2-pyridine deriv. (38) exhibiting the highest Grp94 affinity (Kd = 820 nM).  Subsequent cell-based assays showed that these Grp94 inhibitors inhibit migration of the metastatic breast cancer cell line, MDA-MB-231, as well as exhibit an anti-proliferative affect against the multiple myeloma cell line, RPMI 8226.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxdbHibsHh3rVg90H21EOLACvtfcHk0ljcaKBiGTdVnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFGru7bK&md5=6025c533f1c107eb5c54a559c679c8d2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.05.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.05.075%26sid%3Dliteratum%253Aachs%26aulast%3DMuth%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520radamide%2520analogs%2520as%2520Grp94%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4083%26epage%3D4098%26doi%3D10.1016%2Fj.bmc.2014.05.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Rosser, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span> </span><span class="NLM_article-title">Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">22798</span><span class="NLM_x">–</span> <span class="NLM_lpage">22805</span><span class="refDoi"> DOI: 10.1074/jbc.M001477200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M001477200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22798-22805&author=M.+F.+Rosserauthor=C.+V.+Nicchitta&title=Ligand+interactions+in+the+adenosine+nucleotide-binding+domain+of+the+Hsp90+chaperone%2C+GRP94.+I.+Evidence+for+allosteric+regulation+of+ligand+binding&doi=10.1074%2Fjbc.M001477200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001477200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001477200%26sid%3Dliteratum%253Aachs%26aulast%3DRosser%26aufirst%3DM.%2BF.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26atitle%3DLigand%2520interactions%2520in%2520the%2520adenosine%2520nucleotide-binding%2520domain%2520of%2520the%2520Hsp90%2520chaperone%252C%2520GRP94.%2520I.%2520Evidence%2520for%2520allosteric%2520regulation%2520of%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22798%26epage%3D22805%26doi%3D10.1074%2Fjbc.M001477200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldano, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">46162</span><span class="NLM_x">–</span> <span class="NLM_lpage">46171</span><span class="refDoi"> DOI: 10.1074/jbc.M405253200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M405253200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46162-46171&author=R.+M.+Immorminoauthor=D.+E.+Dollinsauthor=P.+L.+Shafferauthor=K.+L.+Soldanoauthor=M.+A.+Walkerauthor=D.+T.+Gewirth&title=Ligand-induced+conformational+shift+in+the+N-terminal+domain+of+GRP94%2C+an+Hsp90+chaperone&doi=10.1074%2Fjbc.M405253200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M405253200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M405253200%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DP.%2BL.%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DWalker%26aufirst%3DM.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DLigand-induced%2520conformational%2520shift%2520in%2520the%2520N-terminal%2520domain%2520of%2520GRP94%252C%2520an%2520Hsp90%2520chaperone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46162%26epage%3D46171%26doi%3D10.1074%2Fjbc.M405253200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wassenberg, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span> </span><span class="NLM_article-title">Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. II. Ligand-mediated activation of GRP94 molecular chaperone and peptide binding activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">22806</span><span class="NLM_x">–</span> <span class="NLM_lpage">22814</span><span class="refDoi"> DOI: 10.1074/jbc.M001476200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M001476200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22806-22814&author=J.+J.+Wassenbergauthor=R.+C.+Reedauthor=C.+V.+Nicchitta&title=Ligand+interactions+in+the+adenosine+nucleotide-binding+domain+of+the+Hsp90+chaperone%2C+GRP94.+II.+Ligand-mediated+activation+of+GRP94+molecular+chaperone+and+peptide+binding+activity&doi=10.1074%2Fjbc.M001476200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001476200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001476200%26sid%3Dliteratum%253Aachs%26aulast%3DWassenberg%26aufirst%3DJ.%2BJ.%26aulast%3DReed%26aufirst%3DR.%2BC.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26atitle%3DLigand%2520interactions%2520in%2520the%2520adenosine%2520nucleotide-binding%2520domain%2520of%2520the%2520Hsp90%2520chaperone%252C%2520GRP94.%2520II.%2520Ligand-mediated%2520activation%2520of%2520GRP94%2520molecular%2520chaperone%2520and%2520peptide%2520binding%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22806%26epage%3D22814%26doi%3D10.1074%2Fjbc.M001476200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, L. E.,  IV</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.03.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.jmb.2009.03.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=1033-1042&author=R.+M.+Immorminoauthor=L.+E.+Metzgerauthor=P.+N.+Reardonauthor=D.+E.+Dollinsauthor=B.+S.+Blaggauthor=D.+T.+Gewirth&title=Different+poses+for+ligand+and+chaperone+in+inhibitor-bound+Hsp90+and+GRP94%3A+implications+for+paralog-specific+drug+design&doi=10.1016%2Fj.jmb.2009.03.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.03.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.03.071%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DMetzger%26aufirst%3DL.%2BE.%26aulast%3DReardon%26aufirst%3DP.%2BN.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DDifferent%2520poses%2520for%2520ligand%2520and%2520chaperone%2520in%2520inhibitor-bound%2520Hsp90%2520and%2520GRP94%253A%2520implications%2520for%2520paralog-specific%2520drug%2520design%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D1033%26epage%3D1042%26doi%3D10.1016%2Fj.jmb.2009.03.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Park, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morieux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salome, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotten, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reamtong, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, H.</span><span> </span><span class="NLM_article-title">Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6897</span><span class="NLM_x">–</span> <span class="NLM_lpage">6911</span><span class="refDoi"> DOI: 10.1021/jm9012054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9012054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6897-6911&author=K.+D.+Parkauthor=P.+Morieuxauthor=C.+Salomeauthor=S.+W.+Cottenauthor=O.+Reamtongauthor=C.+Eyersauthor=S.+J.+Gaskellauthor=J.+P.+Stablesauthor=R.+Liuauthor=H.+Kohn&title=Lacosamide+isothiocyanate-based+agents%3A+novel+agents+to+target+and+identify+lacosamide+receptors&doi=10.1021%2Fjm9012054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm9012054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012054%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BD.%26aulast%3DMorieux%26aufirst%3DP.%26aulast%3DSalome%26aufirst%3DC.%26aulast%3DCotten%26aufirst%3DS.%2BW.%26aulast%3DReamtong%26aufirst%3DO.%26aulast%3DEyers%26aufirst%3DC.%26aulast%3DGaskell%26aufirst%3DS.%2BJ.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DKohn%26aufirst%3DH.%26atitle%3DLacosamide%2520isothiocyanate-based%2520agents%253A%2520novel%2520agents%2520to%2520target%2520and%2520identify%2520lacosamide%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6897%26epage%3D6911%26doi%3D10.1021%2Fjm9012054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Clevenger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4459</span><span class="NLM_x">–</span> <span class="NLM_lpage">4462</span><span class="refDoi"> DOI: 10.1021/ol048266o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol048266o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4459-4462&author=R.+C.+Clevengerauthor=B.+S.+Blagg&title=Design%2C+synthesis%2C+and+evaluation+of+a+radicicol+and+geldanamycin+chimera%2C+radamide&doi=10.1021%2Fol048266o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol048266o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol048266o%26sid%3Dliteratum%253Aachs%26aulast%3DClevenger%26aufirst%3DR.%2BC.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520radicicol%2520and%2520geldanamycin%2520chimera%252C%2520radamide%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4459%26epage%3D4462%26doi%3D10.1021%2Fol048266o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hadden, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">4697</span><span class="NLM_x">–</span> <span class="NLM_lpage">4704</span><span class="refDoi"> DOI: 10.1021/jo900278g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo900278g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=4697-4704&author=M.+K.+Haddenauthor=B.+S.+Blagg&title=Synthesis+and+evaluation+of+radamide+analogues%2C+a+chimera+of+radicicol+and+geldanamycin&doi=10.1021%2Fjo900278g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin</span></div><div class="casAuthors">Hadden, M. Kyle; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4697-4704</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previously, we reported the Hsp90 inhibitory activity of radamide, an open chain amide chimera of geldanamycin and radicicol.  Attempts to further expand upon structure-activity relationships for this class of Hsp90 inhibitors led to the prepn. of a series of radamide analogs focused on differing tether lengths and quinone mimics.  In addn., the cup-shaped conformation adopted by the two natural products when bound to the Hsp90 N-terminal ATP binding pocket suggests that conformationally biased compds. may demonstrate improved binding and inhibition.  The prepn. and evaluation of radamide analogs with cis/trans α,β-unsatd. amides yielded compds. that exhibit improved antiproliferative activity.  In addn., several analogs demonstrated the ability to induce degrdn. of Hsp90-dependent oncogenic signaling proteins in vitro, a hallmark of Hsp90 N-terminal inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolUb0gnS13ebVg90H21EOLACvtfcHk0lhEJSic0U1CTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtLo%253D&md5=ab0a5d5a5822af962943b761fa2c14ab</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo900278g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900278g%26sid%3Dliteratum%253Aachs%26aulast%3DHadden%26aufirst%3DM.%2BK.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520radamide%2520analogues%252C%2520a%2520chimera%2520of%2520radicicol%2520and%2520geldanamycin%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D4697%26epage%3D4704%26doi%3D10.1021%2Fjo900278g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Luo, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carman, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Structural basis of integrin regulation and signaling</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span><span class="refDoi"> DOI: 10.1146/annurev.immunol.25.022106.141618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1146%2Fannurev.immunol.25.022106.141618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=17201681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlansrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=619-647&author=B.+H.+Luoauthor=C.+V.+Carmanauthor=T.+A.+Springer&title=Structural+basis+of+integrin+regulation+and+signaling&doi=10.1146%2Fannurev.immunol.25.022106.141618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of integrin regulation and signaling</span></div><div class="casAuthors">Luo, Bing-Hao; Carman, Christopher V.; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">619-647</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Integrins are cell adhesion mols. that mediate cell-cell, cell-extracellular matrix, and cell-pathogen interactions.  They play crit. roles for the immune system in leukocyte trafficking and migration, immunol. synapse formation, costimulation, and phagocytosis.  Integrin adhesiveness can be dynamically regulated through a process termed inside-out signaling.  In addn., ligand binding transduces signals from the extracellular domain to the cytoplasm in the classical outside-in direction.  Recent structural, biochem., and biophys. studies have greatly advanced our understanding of the mechanisms of integrin bidirectional signaling across the plasma membrane.  Large-scale reorientations of the ectodomain of up to 200 Å couple to conformational change in ligand-binding sites and are linked to changes in α and β subunit transmembrane domain assocn.  In this review, we focus on integrin structure as it relates to affinity modulation, ligand binding, outside-in signaling, and cell surface distribution dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZNENOA_pMEbVg90H21EOLACvtfcHk0li4Q6qEYBc1eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlansrc%253D&md5=f6e4ae57d35b2826223e6aeb28e42b6d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.25.022106.141618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.25.022106.141618%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DB.%2BH.%26aulast%3DCarman%26aufirst%3DC.%2BV.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DStructural%2520basis%2520of%2520integrin%2520regulation%2520and%2520signaling%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D25%26spage%3D619%26epage%3D647%26doi%3D10.1146%2Fannurev.immunol.25.022106.141618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Naci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoudjit, F.</span><span> </span><span class="NLM_article-title">α2β1 integrin in cancer development and chemoresistance</span> <span class="citation_source-journal">Semin. Cancer Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1016/j.semcancer.2015.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.semcancer.2015.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=26297892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyjtLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=145-153&author=D.+Naciauthor=K.+Vuoriauthor=F.+Aoudjit&title=%CE%B12%CE%B21+integrin+in+cancer+development+and+chemoresistance&doi=10.1016%2Fj.semcancer.2015.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">α2β1 integrin in cancer development and chemoresistance</span></div><div class="casAuthors">Naci, Dalila; Vuori, Kristiina; Aoudjit, Fawzi</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-153</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Extracellular matrix, via its receptors the integrins, has emerged as a crucial factor in cancer development.  The α2β1 integrin is a major collagen receptor that is widely expressed and known to promote cell migration and control tissue homeostasis.  Growing evidence suggests that it can be a key pathway in cancer.  Recent studies have shown that α2β1 integrin is a regulator of cancer metastasis either by promoting or inhibiting the dissemination process of cancer cells.  The α2β1 integrin signaling can also enhance tumor angiogenesis.  Emerging evidence supports a role for α2β1 integrin in cancer chemoresistance esp. in hematol. malignancies originating from the T cell lineage.  In addn., α2β1 integrin has been assocd. with cancer stem cells.  In this review, we will discuss the complex role of α2β1 integrin in these processes.  Collagen is a major matrix protein of the tumor microenvironment and thus, understanding how α2β1 integrin regulates cancer pathogenesis is likely to lead to new therapeutic approaches and agents for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfc4wrw4MlKLVg90H21EOLACvtfcHk0li4Q6qEYBc1eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyjtLrO&md5=fc9e5a82ccdf89141e62d8fa562b35a2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2015.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2015.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DNaci%26aufirst%3DD.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DAoudjit%26aufirst%3DF.%26atitle%3D%25CE%25B12%25CE%25B21%2520integrin%2520in%2520cancer%2520development%2520and%2520chemoresistance%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2015%26volume%3D35%26spage%3D145%26epage%3D153%26doi%3D10.1016%2Fj.semcancer.2015.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">The molecular chaperone gp96/GRP94 interacts with Toll-like receptors and integrins via its C-terminal hydrophobic domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">6735</span><span class="NLM_x">–</span> <span class="NLM_lpage">6742</span><span class="refDoi"> DOI: 10.1074/jbc.M111.309526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M111.309526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22223641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xisl2ksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=6735-6742&author=S.+Wuauthor=F.+Hongauthor=D.+Gewirthauthor=B.+Guoauthor=B.+Liuauthor=Z.+Li&title=The+molecular+chaperone+gp96%2FGRP94+interacts+with+Toll-like+receptors+and+integrins+via+its+C-terminal+hydrophobic+domain&doi=10.1074%2Fjbc.M111.309526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Chaperone gp96/GRP94 Interacts with Toll-like Receptors and Integrins via Its C-terminal Hydrophobic Domain</span></div><div class="casAuthors">Wu, Shuang; Hong, Feng; Gewirth, Daniel; Guo, Beichu; Liu, Bei; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6735-6742</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The structural basis for mol. chaperones to discern misfolded proteins has long been an enigma.  As the endoplasmic reticulum paralogue of the cytosolic HSP90, gp96 (GRP94, HSP90b1) is an essential mol. chaperone for Toll-like receptors (TLRs) and integrins.  However, little is known about its client-binding domain (CBD).  Herein, we provide genetic and biochem. evidence to definitively demonstrate that a C-terminal loop structure, formed by residues 652-678, is the crit. region of CBD for both TLRs and integrins.  Deletion of this region affects neither the intrinsic ATPase activity nor the overall conformation of gp96.  However, without it, the chaperoning function of gp96 collapses.  We also find a crit. Met pair (Met658-Met662) for the folding of integrins but not TLRs.  Moreover, we find that the TLR binding to gp96 is also dependent on the C-terminal dimerization domain but not the N-terminal ATP-binding pocket of gp96.  Our study has unveiled surprisingly the exquisite specificity of gp96 in substrate binding and suggests a manipulation of its CBD as an alternative strategy for targeted therapy of a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbUZKYPoen27Vg90H21EOLACvtfcHk0li4Q6qEYBc1eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xisl2ksr0%253D&md5=1e09f7597b9d41e87eeac61da356d690</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.309526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.309526%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DGewirth%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DThe%2520molecular%2520chaperone%2520gp96%252FGRP94%2520interacts%2520with%2520Toll-like%2520receptors%2520and%2520integrins%2520via%2520its%2520C-terminal%2520hydrophobic%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D6735%26epage%3D6742%26doi%3D10.1074%2Fjbc.M111.309526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Haidari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caivano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganjehei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortazavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodside, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willerson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. A.</span><span> </span><span class="NLM_article-title">Integrin α2β1 mediates tyrosine phosphorylation of vascular endothelial cadherin induced by invasive breast cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">32981</span><span class="NLM_x">–</span> <span class="NLM_lpage">32992</span><span class="refDoi"> DOI: 10.1074/jbc.M112.395905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M112.395905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=32981-32992&author=M.+Haidariauthor=W.+Zhangauthor=A.+Caivanoauthor=Z.+Chenauthor=L.+Ganjeheiauthor=A.+Mortazaviauthor=C.+Stroudauthor=D.+G.+Woodsideauthor=J.+T.+Willersonauthor=R.+A.+Dixon&title=Integrin+%CE%B12%CE%B21+mediates+tyrosine+phosphorylation+of+vascular+endothelial+cadherin+induced+by+invasive+breast+cancer+cells&doi=10.1074%2Fjbc.M112.395905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.395905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.395905%26sid%3Dliteratum%253Aachs%26aulast%3DHaidari%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DCaivano%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGanjehei%26aufirst%3DL.%26aulast%3DMortazavi%26aufirst%3DA.%26aulast%3DStroud%26aufirst%3DC.%26aulast%3DWoodside%26aufirst%3DD.%2BG.%26aulast%3DWillerson%26aufirst%3DJ.%2BT.%26aulast%3DDixon%26aufirst%3DR.%2BA.%26atitle%3DIntegrin%2520%25CE%25B12%25CE%25B21%2520mediates%2520tyrosine%2520phosphorylation%2520of%2520vascular%2520endothelial%2520cadherin%2520induced%2520by%2520invasive%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D32981%26epage%3D32992%26doi%3D10.1074%2Fjbc.M112.395905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Dejeans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glorieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sid, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delvenne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buc Calderon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrax, J.</span><span> </span><span class="NLM_article-title">Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.freeradbiomed.2011.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22245095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=993-1002&author=N.+Dejeansauthor=C.+Glorieuxauthor=S.+Gueninauthor=R.+Beckauthor=B.+Sidauthor=R.+Rousseauauthor=B.+Bisigauthor=P.+Delvenneauthor=P.+Buc+Calderonauthor=J.+Verrax&title=Overexpression+of+GRP94+in+breast+cancer+cells+resistant+to+oxidative+stress+promotes+high+levels+of+cancer+cell+proliferation+and+migration%3A+implications+for+tumor+recurrence&doi=10.1016%2Fj.freeradbiomed.2011.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: Implications for tumor recurrence</span></div><div class="casAuthors">Dejeans, Nicolas; Glorieux, Christophe; Guenin, Samuel; Beck, Raphael; Sid, Brice; Rousseau, Rejane; Bisig, Bettina; Delvenne, Philippe; Buc Calderon, Pedro; Verrax, Julien</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-1002</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting the altered redox status of cancer cells is emerging as an interesting approach to potentiate chemotherapy.  However, to maximize the effectiveness of this strategy and define the correct chemotherapeutic assocns., it is important to understand the biol. consequences of chronically exposing cancer cells to reactive oxygen species (ROS).  Using an H2O2-generating system, we selected a ROS-resistant MCF-7 breast cancer cell line, namely Resox cells.  By exploring different survival pathways that are usually induced during oxidative stress, we identified a constitutive overexpression of the endoplasmic reticulum chaperone, GRP94, in these cells, whereas levels of its cytoplasmic homolog HSP90, or GRP78, were not modified.  This overexpression was not mediated by constitutive unfolded protein response (UPR) activation.  The increase in GRP94 is tightly linked to an increase in cell proliferation and migration capacities, as shown by GRP94-silencing expts.  Interestingly, we also obsd. that GRP94 silencing inhibits migration and proliferation of the highly aggressive MDA-MB-231 cells.  By immunohistochem., we showed that GRP94 expression was higher in recurrent human breast cancers than in their paired primary neoplasias.  Similar to the situation in the Resox cells, this increase was not assocd. with an increase in UPR activation in recurrent tumors.  In conclusion, this study suggests that GRP94 overexpression may be a hallmark of aggressiveness and recurrence in breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvjqFOXM39gbVg90H21EOLACvtfcHk0li2UJptleLXkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSitbs%253D&md5=7125eef26433c15ec7b357151ecc5d20</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DDejeans%26aufirst%3DN.%26aulast%3DGlorieux%26aufirst%3DC.%26aulast%3DGuenin%26aufirst%3DS.%26aulast%3DBeck%26aufirst%3DR.%26aulast%3DSid%26aufirst%3DB.%26aulast%3DRousseau%26aufirst%3DR.%26aulast%3DBisig%26aufirst%3DB.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DBuc%2BCalderon%26aufirst%3DP.%26aulast%3DVerrax%26aufirst%3DJ.%26atitle%3DOverexpression%2520of%2520GRP94%2520in%2520breast%2520cancer%2520cells%2520resistant%2520to%2520oxidative%2520stress%2520promotes%2520high%2520levels%2520of%2520cancer%2520cell%2520proliferation%2520and%2520migration%253A%2520implications%2520for%2520tumor%2520recurrence%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D993%26epage%3D1002%26doi%3D10.1016%2Fj.freeradbiomed.2011.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinogle, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeva, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrowsky, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Endoplasmic reticulum resident heat shock protein 90 (Hsp90) isoform glucose-regulated protein 94 (Grp94) regulates cell polarity and cancer cell migration by affecting intracellular transport</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1074/jbc.M115.688374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M115.688374" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ghoshauthor=H.+E.+Shinogleauthor=N.+A.+Galevaauthor=R.+T.+Dobrowskyauthor=B.+S.+Blagg&title=Endoplasmic+reticulum+resident+heat+shock+protein+90+%28Hsp90%29+isoform+glucose-regulated+protein+94+%28Grp94%29+regulates+cell+polarity+and+cancer+cell+migration+by+affecting+intracellular+transport&doi=10.1074%2Fjbc.M115.688374"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.688374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.688374%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DGaleva%26aufirst%3DN.%2BA.%26aulast%3DDobrowsky%26aufirst%3DR.%2BT.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DEndoplasmic%2520reticulum%2520resident%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520isoform%2520glucose-regulated%2520protein%252094%2520%2528Grp94%2529%2520regulates%2520cell%2520polarity%2520and%2520cancer%2520cell%2520migration%2520by%2520affecting%2520intracellular%2520transport%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26doi%3D10.1074%2Fjbc.M115.688374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Tamm, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunger, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchshofer, R.</span><span> </span><span class="NLM_article-title">Intraocular pressure and the mechanisms involved in resistance of the aqueous humor flow in the trabecular meshwork outflow pathways</span> <span class="citation_source-journal">Prog. Mol. Biol. Transl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1016/bs.pmbts.2015.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fbs.pmbts.2015.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=26310162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A280%3ADC%252BC287ms1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2015&pages=301-314&author=E.+R.+Tammauthor=B.+M.+Braungerauthor=R.+Fuchshofer&title=Intraocular+pressure+and+the+mechanisms+involved+in+resistance+of+the+aqueous+humor+flow+in+the+trabecular+meshwork+outflow+pathways&doi=10.1016%2Fbs.pmbts.2015.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Intraocular Pressure and the Mechanisms Involved in Resistance of the Aqueous Humor Flow in the Trabecular Meshwork Outflow Pathways</span></div><div class="casAuthors">Tamm Ernst R; Braunger Barbara M; Fuchshofer Rudolf</div><div class="citationInfo"><span class="NLM_cas:title">Progress in molecular biology and translational science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">301-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Intraocular pressure (IOP), the critical risk factor for glaucoma, is generated and maintained by the aqueous humor circulation system.  Aqueous humor is secreted from the epithelial layers of the ciliary body and exits the eye through the trabecular meshwork or the uveoscleral outflow pathways.  IOP builds up in response to a resistance to aqueous humor flow in the trabecular outflow pathways.  The trabecular outflow resistance is localized in the inner wall region, which comprises the juxtacanalicular connective tissue (JCT) and the inner wall endothelium of Schlemm's canal (SC).  Outflow resistance in this region is lowered through the relaxation of contractile myofibroblast-like cells in trabecular meshwork and the adjacent scleral spur, or the contraction of the ciliary muscle.  In primary open-angle glaucoma, the most frequent form of glaucoma, outflow resistance of the inner wall region is typically higher than normal.  There is evidence that the increase in resistance is related to characteristic biological changes in the resident cells of the JCT, which more and more acquire the structural and functional characteristics of contractile myofibroblasts.  The changes involve an augmentation of their actin cytoskeleton and of their surrounding fibrillary extracellular matrix, which connects to JCT cells via integrins.  This scenario leads to an overall stiffening of the inner wall region, and is modulated by transforming growth factor-β/connective tissue growth factor signaling.  Essentially comparable changes appear to occur in SC endothelial cells.  Stiffening of JCT and SC cells is very likely a critical causative factor for the increase in trabecular outflow resistance in POAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIRhOrbxe3cu3MPKNEWB5RfW6udTcc2ea15mUZFSq7tLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ms1ymtQ%253D%253D&md5=a484733a8c3c3164f6c8cd39653c9255</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fbs.pmbts.2015.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.pmbts.2015.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DE.%2BR.%26aulast%3DBraunger%26aufirst%3DB.%2BM.%26aulast%3DFuchshofer%26aufirst%3DR.%26atitle%3DIntraocular%2520pressure%2520and%2520the%2520mechanisms%2520involved%2520in%2520resistance%2520of%2520the%2520aqueous%2520humor%2520flow%2520in%2520the%2520trabecular%2520meshwork%2520outflow%2520pathways%26jtitle%3DProg.%2520Mol.%2520Biol.%2520Transl.%2520Sci.%26date%3D2015%26volume%3D134%26spage%3D301%26epage%3D314%26doi%3D10.1016%2Fbs.pmbts.2015.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Donegan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span> </span><span class="NLM_article-title">Discovery of molecular therapeutics for glaucoma: challenges, successes, and promising directions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=788-809&author=R.+K.+Doneganauthor=R.+L.+Lieberman&title=Discovery+of+molecular+therapeutics+for+glaucoma%3A+challenges%2C+successes%2C+and+promising+directions&doi=10.1021%2Facs.jmedchem.5b00828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions</span></div><div class="casAuthors">Donegan, Rebecca K.; Lieberman, Raquel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">788-809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glaucoma, a heterogeneous ocular disorder affecting ∼60 million people worldwide, is characterized by painless neurodegeneration of retinal ganglion cells (RGCs), resulting in irreversible vision loss.  Available therapies, which decrease the common causal risk factor of elevated intraocular pressure, delay, but cannot prevent, RGC death and blindness.  Notably, it is changes in the anterior segment of the eye, particularly in the drainage of aq. humor fluid, which are believed to bring about changes in pressure.  Thus, it is primarily this region whose properties are manipulated in current and emerging therapies for glaucoma.  Here, we focus on the challenges assocd. with developing treatments, review the available exptl. methods to evaluate the therapeutic potential of new drugs, describe the development and evaluation of emerging Rho-kinase inhibitors and adenosine receptor ligands that offer the potential to improve aq. humor outflow and protect RGCs simultaneously, and present new targets and approaches on the horizon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1zW4SfFzeH7Vg90H21EOLACvtfcHk0lgpBt2du6qeWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7rE&md5=fb3c7936206db063ba3b99b767f38504</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00828%26sid%3Dliteratum%253Aachs%26aulast%3DDonegan%26aufirst%3DR.%2BK.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520of%2520molecular%2520therapeutics%2520for%2520glaucoma%253A%2520challenges%252C%2520successes%252C%2520and%2520promising%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D788%26epage%3D809%26doi%3D10.1021%2Facs.jmedchem.5b00828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Hill, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donegan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span> </span><span class="NLM_article-title">The glaucoma-associated olfactomedin domain of myocilin forms polymorphic fibrils that are constrained by partial unfolding and peptide sequence</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1016/j.jmb.2013.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.jmb.2013.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=24333014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWntb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2014&pages=921-935&author=S.+E.+Hillauthor=R.+K.+Doneganauthor=R.+L.+Lieberman&title=The+glaucoma-associated+olfactomedin+domain+of+myocilin+forms+polymorphic+fibrils+that+are+constrained+by+partial+unfolding+and+peptide+sequence&doi=10.1016%2Fj.jmb.2013.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The Glaucoma-Associated Olfactomedin Domain of Myocilin Forms Polymorphic Fibrils That Are Constrained by Partial Unfolding and Peptide Sequence</span></div><div class="casAuthors">Hill, Shannon E.; Donegan, Rebecca K.; Lieberman, Raquel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-935</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The glaucoma-assocd. olfactomedin domain of myocilin (myoc-OLF) is a recent addn. to the growing list of disease-assocd. amyloidogenic proteins.  Inherited, disease-causing myocilin variants aggregate intracellularly instead of being secreted to the trabecular meshwork (TM), which is a scenario toxic to trabecular meshwork cells and leads to early onset of ocular hypertension, the major risk factor for glaucoma.  Here we systematically structurally and biophys. dissected myoc-OLF to better understand its amyloidogenesis.  Under mildly destabilizing conditions, wild-type myoc-OLF adopts non-native structures that readily fibrillize when incubated at a temp. just below the transition for tertiary unfolding.  With buffers at physiol. pH, two main endpoint fibril morphologies are obsd.: (a) straight fibrils common to many amyloids and (b) unique micron-length, ∼300 nm or larger diam., species that lasso oligomers, which also exhibit classical spectroscopic amyloid signatures.  Three disease-causing variants investigated herein exhibit non-native tertiary structures under physiol. conditions, leading to a variety of growth rates and a fibril morphologies.  In particular, the well-documented D380A variant, which lacks calcium, forms large circular fibrils.  Two amyloid-forming peptide stretches have been identified, one for each of the main fibril morphologies obsd.  Our study places myoc-OLF within the larger landscape of the amylome and provides insight into the diversity of myoc-OLF aggregation that plays a role in glaucoma pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqatLM_cpzTfrVg90H21EOLACvtfcHk0lgpBt2du6qeWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWntb%252FO&md5=046a26d965d57fd7f94759c2678f8c76</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2013.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2013.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DS.%2BE.%26aulast%3DDonegan%26aufirst%3DR.%2BK.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26atitle%3DThe%2520glaucoma-associated%2520olfactomedin%2520domain%2520of%2520myocilin%2520forms%2520polymorphic%2520fibrils%2520that%2520are%2520constrained%2520by%2520partial%2520unfolding%2520and%2520peptide%2520sequence%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D426%26spage%3D921%26epage%3D935%26doi%3D10.1016%2Fj.jmb.2013.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span><span class="refDoi"> DOI: 10.1038/nature01913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors&doi=10.1038%2Fnature01913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0lgAFTPGso2EEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410%26doi%3D10.1038%2Fnature01913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structures of GRP94-nucleotide complexes reveal mechanistic differences between the Hsp90 chaperones</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.molcel.2007.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.molcel.2007.08.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=41-56&author=D.+E.+Dollinsauthor=J.+J.+Warrenauthor=R.+M.+Immorminoauthor=D.+T.+Gewirth&title=Structures+of+GRP94-nucleotide+complexes+reveal+mechanistic+differences+between+the+Hsp90+chaperones&doi=10.1016%2Fj.molcel.2007.08.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DWarren%26aufirst%3DJ.%2BJ.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructures%2520of%2520GRP94-nucleotide%2520complexes%2520reveal%2520mechanistic%2520differences%2520between%2520the%2520Hsp90%2520chaperones%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D28%26spage%3D41%26epage%3D56%26doi%3D10.1016%2Fj.molcel.2007.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Tropea, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waugh, D. S.</span><span> </span><span class="NLM_article-title">Expression and purification of soluble His(6)-tagged TEV protease</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1007/978-1-59745-196-3_19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1007%2F978-1-59745-196-3_19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=18988033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2009&pages=297-307&author=J.+E.+Tropeaauthor=S.+Cherryauthor=D.+S.+Waugh&title=Expression+and+purification+of+soluble+His%286%29-tagged+TEV+protease&doi=10.1007%2F978-1-59745-196-3_19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and purification of soluble His6-tagged TEV protease</span></div><div class="casAuthors">Tropea, Joseph E.; Cherry, Scott; Waugh, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">498</span>
        (<span class="NLM_cas:issue">High Throughput Protein Expression and Purification</span>),
    <span class="NLM_cas:pages">297-307</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">This chapter describes a simple method for overproducing a sol. form of the tobacco etch virus (TEV) protease in Escherichia coli and purifying it to homogeneity so that it may be used as a reagent for removing affinity tags from recombinant proteins by site-specific endoproteolysis.  The protease is initially produced as a fusion on the C-terminus of E.coli maltose binding protein (MBP), which causes it to accumulate in a sol. and active form rather than in inclusion bodies.  The fusion protein subsequently cleaves itself in vivo to remove the MBP moiety, yielding a sol. TEV protease catalytic domain with an N-terminal polyhistidine tag.  The His-tagged TEV protease can be purified in two steps using immobilized metal affinity chromatog. (IMAC) followed by gel filtration.  An S219V mutation in the protease reduces its rate of autolysis by approx. 100-fold and also gives rise to an enzyme with greater catalytic efficiency than the wild-type protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNe7Jl6qta0LVg90H21EOLACvtfcHk0lgAFTPGso2EEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFyqsbs%253D&md5=8031a280366500e8c1b20ba4e50d793b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2F978-1-59745-196-3_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-59745-196-3_19%26sid%3Dliteratum%253Aachs%26aulast%3DTropea%26aufirst%3DJ.%2BE.%26aulast%3DCherry%26aufirst%3DS.%26aulast%3DWaugh%26aufirst%3DD.%2BS.%26atitle%3DExpression%2520and%2520purification%2520of%2520soluble%2520His%25286%2529-tagged%2520TEV%2520protease%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2009%26volume%3D498%26spage%3D297%26epage%3D307%26doi%3D10.1007%2F978-1-59745-196-3_19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Xds</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Xds&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgAFTPGso2EEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXds%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lijCZfRuNL6ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lijCZfRuNL6ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Schuttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M.</span><span> </span><span class="NLM_article-title">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span><span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Schuttelkopfauthor=D.+M.+van+Aalten&title=PRODRG%3A+a+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuttelkopf Alexander W; van Aalten Daan M F</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1355-63</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The small-molecule topology generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and molecular topologies suitable for X-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compounds from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the standard libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallographic R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdNRIcoht5aXy-c-E1v-fmfW6udTcc2eZGBI-Rg1i5nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D&md5=1adce6cd2cacdace513a69efa33c4e93</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DPRODRG%253A%2520a%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Dilip K. Tosh, Christopher M. Brackett, Young-Hwan Jung, Zhan-Guo Gao, Monimoy Banerjee, Brian S. J. Blagg, <span class="NLM_string-name hlFld-ContribAuthor">Kenneth A. Jacobson</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Evaluation of 5′-(N-Ethylcarboxamido)adenosine Analogues as Grp94-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 373-379. <a href="https://doi.org/10.1021/acsmedchemlett.0c00509" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00509%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBiological%252BEvaluation%252Bof%252B5%2525E2%252580%2525B2-%252528N-Ethylcarboxamido%252529adenosine%252BAnalogues%252Bas%252BGrp94-Selective%252BInhibitors%26aulast%3DTosh%26aufirst%3DDilip%2BK.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D18092020%26date%3D19022021%26date%3D01032021%26volume%3D12%26issue%3D3%26spage%3D373%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Sanket J. Mishra, Weiya Liu, Kristin Beebe, Monimoy Banerjee, Caitlin N. Kent, Vitumbiko Munthali, John Koren, III, John A Taylor, III, Leonard M. Neckers, Jeffrey Holzbeierlein, <span class="NLM_string-name hlFld-ContribAuthor">Brian S. J. Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1545-1557. <a href="https://doi.org/10.1021/acs.jmedchem.0c01700" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01700%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDevelopment%252Bof%252BHsp90%2525CE%2525B2-Selective%252BInhibitors%252Bto%252BOvercome%252BDetriments%252BAssociated%252Bwith%252Bpan-Hsp90%252BInhibition%26aulast%3DMishra%26aufirst%3DSanket%2BJ.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28092020%26date%3D11012021%26volume%3D64%26issue%3D3%26spage%3D1545%26epage%3D1557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul T. Marcyk, Emmanuelle V. LeBlanc, Douglas A. Kuntz, Alice Xue, Francisco Ortiz, Richard Trilles, Stephen Bengtson, Tristan M. G. Kenney, David S. Huang, Nicole Robbins, Noelle S. Williams, Damian J. Krysan, Gilbert G. Privé, Luke Whitesell, Leah E. Cowen, <span class="NLM_string-name hlFld-ContribAuthor">Lauren E. Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors: Optimization of Whole-Cell Anticryptococcal Activity and Insights into the Structural Origins of Cryptococcal Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (2)
                                     , 1139-1169. <a href="https://doi.org/10.1021/acs.jmedchem.0c01777" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01777</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01777%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFungal-Selective%252BResorcylate%252BAminopyrazole%252BHsp90%252BInhibitors%25253A%252BOptimization%252Bof%252BWhole-Cell%252BAnticryptococcal%252BActivity%252Band%252BInsights%252Binto%252Bthe%252BStructural%252BOrigins%252Bof%252BCryptococcal%252BSelectivity%26aulast%3DMarcyk%26aufirst%3DPaul%2BT.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D20102020%26date%3D14012021%26volume%3D64%26issue%3D2%26spage%3D1139%26epage%3D1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David S. Huang, Emmanuelle V. LeBlanc, Tanvi Shekhar-Guturja, Nicole Robbins, Damian J. Krysan, Juan Pizarro, Luke Whitesell, Leah E. Cowen, <span class="NLM_string-name hlFld-ContribAuthor">Lauren E. Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2139-2180. <a href="https://doi.org/10.1021/acs.jmedchem.9b00826" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00826%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BFungal-Selective%252BResorcylate%252BAminopyrazole%252BHsp90%252BInhibitors%26aulast%3DHuang%26aufirst%3DDavid%2BS.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D20052019%26date%3D26092019%26date%3D12092019%26volume%3D63%26issue%3D5%26spage%3D2139%26epage%3D2180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Deborah A. Smithen, Leo M. H. Leung, Mairi Challinor, Rae Lawrence, HaoRan Tang, Dan Niculescu-Duvaz, Simon P. Pearce, Robert Mcleary, Filipa Lopes, Mohammed Aljarah, Michael Brown, Louise Johnson, Graeme Thomson, Richard Marais, <span class="NLM_string-name hlFld-ContribAuthor">Caroline Springer</span>. </span><span class="cited-content_cbyCitation_article-title">2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2308-2324. <a href="https://doi.org/10.1021/acs.jmedchem.9b01112" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01112%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D2-Aminomethylene-5-sulfonylthiazole%252BInhibitors%252Bof%252BLysyl%252BOxidase%252B%252528LOX%252529%252Band%252BLOXL2%252BShow%252BSignificant%252BEfficacy%252Bin%252BDelaying%252BTumor%252BGrowth%26aulast%3DSmithen%26aufirst%3DDeborah%2BA.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D11072019%26date%3D04092019%26date%3D20082019%26volume%3D63%26issue%3D5%26spage%3D2308%26epage%3D2324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fen Jiang, An-ping Guo, Jia-chen Xu, Qi-Dong You, <span class="NLM_string-name hlFld-ContribAuthor">Xiao-Li Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9513-9533. <a href="https://doi.org/10.1021/acs.jmedchem.8b00800" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00800</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00800%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BGrp94%252BSelective%252BInhibitor%252Bwith%252BAnti-Inflammatory%252BEfficacy%252Bin%252Ba%252BMouse%252BModel%252Bof%252BUlcerative%252BColitis%26aulast%3DJiang%26aufirst%3DFen%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19052018%26date%3D26102018%26date%3D15102018%26volume%3D61%26issue%3D21%26spage%3D9513%26epage%3D9533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stephen
D. Kozuch, Christopher N. Cultrara, Adah E. Beck, Claudia J. Heller, Sunil Shah, Mayurbhai R. Patel, Jenny Zilberberg, <span class="NLM_string-name hlFld-ContribAuthor">David Sabatino</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced Cancer Theranostics with Self-Assembled, Multilabeled siRNAs. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (10)
                                     , 12975-12984. <a href="https://doi.org/10.1021/acsomega.8b01999" title="DOI URL">https://doi.org/10.1021/acsomega.8b01999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b01999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b01999%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DEnhanced%252BCancer%252BTheranostics%252Bwith%252BSelf-Assembled%25252C%252BMultilabeled%252BsiRNAs%26aulast%3DKozuch%26aufirst%3DStephen%2BD.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11082018%26date%3D26092018%26volume%3D3%26issue%3D10%26spage%3D12975%26epage%3D12984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dustin
J. E. Huard, Vincent M. Crowley, Yuhong Du, Ricardo A. Cordova, Zheying Sun, Moya O. Tomlin, Chad A. Dickey, John Koren, III, Laura Blair, Haian Fu, Brian S. J. Blagg, <span class="NLM_string-name hlFld-ContribAuthor">Raquel L. Lieberman</span>. </span><span class="cited-content_cbyCitation_article-title">Trifunctional High-Throughput Screen Identifies Promising Scaffold To Inhibit Grp94 and Treat Myocilin-Associated Glaucoma. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (4)
                                     , 933-941. <a href="https://doi.org/10.1021/acschembio.7b01083" title="DOI URL">https://doi.org/10.1021/acschembio.7b01083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b01083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b01083%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DTrifunctional%252BHigh-Throughput%252BScreen%252BIdentifies%252BPromising%252BScaffold%252BTo%252BInhibit%252BGrp94%252Band%252BTreat%252BMyocilin-Associated%252BGlaucoma%26aulast%3DHuard%26aufirst%3DDustin%2BJ.%2BE.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D19122017%26date%3D05022018%26date%3D20022018%26date%3D05022018%26volume%3D13%26issue%3D4%26spage%3D933%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nanette
L. S. Que, Vincent M. Crowley, Adam S. Duerfeldt, Jinbo Zhao, Caitlin N. Kent, Brian S. J. Blagg, <span class="NLM_string-name hlFld-ContribAuthor">Daniel T. Gewirth</span>. </span><span class="cited-content_cbyCitation_article-title">Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (7)
                                     , 2793-2805. <a href="https://doi.org/10.1021/acs.jmedchem.7b01608" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01608</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01608%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%252BBased%252BDesign%252Bof%252Ba%252BGrp94-Selective%252BInhibitor%25253A%252BExploiting%252Ba%252BKey%252BResidue%252Bin%252BGrp94%252BTo%252BOptimize%252BParalog-Selective%252BBinding%26aulast%3DQue%26aufirst%3DNanette%2BL.%2BS.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D31102017%26date%3D20032018%26date%3D12032018%26volume%3D61%26issue%3D7%26spage%3D2793%26epage%3D2805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuj  Khandelwal</span>, <span class="hlFld-ContribAuthor ">Vincent M.  Crowley</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Resorcinol-Based Grp94-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1013-1018. <a href="https://doi.org/10.1021/acsmedchemlett.7b00193" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00193%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DResorcinol-Based%252BGrp94-Selective%252BInhibitors%26aulast%3DKhandelwal%26aufirst%3DAnuj%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08052017%26date%3D01092017%26date%3D07092017%26date%3D12102017%26date%3D01092017%26volume%3D8%26issue%3D10%26spage%3D1013%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanket J.  Mishra</span>, <span class="hlFld-ContribAuthor ">Suman  Ghosh</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Stothert</span>, <span class="hlFld-ContribAuthor ">Chad A.  Dickey</span>, and <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>  . </span><span class="cited-content_cbyCitation_article-title">Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (1)
                                     , 244-253. <a href="https://doi.org/10.1021/acschembio.6b00747" title="DOI URL">https://doi.org/10.1021/acschembio.6b00747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00747%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DTransformation%252Bof%252Bthe%252BNon-Selective%252BAminocyclohexanol-Based%252BHsp90%252BInhibitor%252Binto%252Ba%252BGrp94-Seletive%252BScaffold%26aulast%3DMishra%26aufirst%3DSanket%2BJ.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25082016%26date%3D10112016%26date%3D13122016%26date%3D20012017%26volume%3D12%26issue%3D1%26spage%3D244%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Hui-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Hui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Min  Jia</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, and <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10498-10519. <a href="https://doi.org/10.1021/acs.jmedchem.6b00912" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00912%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BTetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidines%252Bas%252BPotent%252BInhibitors%252Bof%252BChaperone%252BHeat%252BShock%252BProtein%252B90%26aulast%3DJiang%26aufirst%3DFen%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D22112016%26date%3D08122016%26date%3D09112016%26volume%3D59%26issue%3D23%26spage%3D10498%26epage%3D10519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shicheng  Xu</span>, <span class="hlFld-ContribAuthor ">Anping  Guo</span>, <span class="hlFld-ContribAuthor ">Nan-nan  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Dai</span>, <span class="hlFld-ContribAuthor ">Huan-aoyu  Yang</span>, <span class="hlFld-ContribAuthor ">Wenqin  Xie</span>, <span class="hlFld-ContribAuthor ">Mengjie  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of Grp94 selective inhibitors based on Phe199 induced fit mechanism and their anti-inflammatory effects. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113604. <a href="https://doi.org/10.1016/j.ejmech.2021.113604" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113604%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252BGrp94%252Bselective%252Binhibitors%252Bbased%252Bon%252BPhe199%252Binduced%252Bfit%252Bmechanism%252Band%252Btheir%252Banti-inflammatory%252Beffects%26aulast%3DXu%26aufirst%3DShicheng%26date%3D2021%26volume%3D223%26spage%3D113604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian S.J.  Blagg</span>, <span class="hlFld-ContribAuthor ">Matthew Kyle  Hadden</span>, <span class="hlFld-ContribAuthor ">Reid S.  Tarpley</span>. </span><span class="cited-content_cbyCitation_article-title">Hsp90 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-88. <a href="https://doi.org/10.1002/0471266949.bmc212.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc212.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc212.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc212.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DHsp90%252BInhibitors%26aulast%3DBlagg%26aufirst%3DBrian%2BS.J.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D88%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofeng  Duan</span>, <span class="hlFld-ContribAuthor ">Stephen  Iwanowycz</span>, <span class="hlFld-ContribAuthor ">Soo  Ngoi</span>, <span class="hlFld-ContribAuthor ">Megan  Hill</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Bei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2021,</strong> <em>11 </em><a href="https://doi.org/10.3389/fonc.2021.629846" title="DOI URL">https://doi.org/10.3389/fonc.2021.629846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2021.629846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2021.629846%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DMolecular%252BChaperone%252BGRP94%25252FGP96%252Bin%252BCancers%25253A%252BOncogenesis%252Band%252BTherapeutic%252BTarget%26aulast%3DDuan%26aufirst%3DXiaofeng%26date%3D2021%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji Woong  Kim</span>, <span class="hlFld-ContribAuthor ">Yea Bin  Cho</span>, <span class="hlFld-ContribAuthor ">Sukmook  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (3)
                                     , 670. <a href="https://doi.org/10.3390/cells10030670" title="DOI URL">https://doi.org/10.3390/cells10030670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10030670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10030670%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DCell%252BSurface%252BGRP94%252Bas%252Ba%252BNovel%252BEmerging%252BTherapeutic%252BTarget%252Bfor%252BMonoclonal%252BAntibody%252BCancer%252BTherapy%26aulast%3DKim%26aufirst%3DJi%2BWoong%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D3%26spage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhidong  Xu</span>, <span class="hlFld-ContribAuthor ">Limeng  Jia</span>, <span class="hlFld-ContribAuthor ">Wenqing  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Song</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [11C]TPN171 as a new potential PET heart imaging agent. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2020,</strong> <em>162 </em>, 109190. <a href="https://doi.org/10.1016/j.apradiso.2020.109190" title="DOI URL">https://doi.org/10.1016/j.apradiso.2020.109190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2020.109190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2020.109190%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DRadiosynthesis%252Bof%252Ba%252Bcarbon-11%252Blabeled%252BPDE5%252Binhibitor%252B%25255B11C%25255DTPN171%252Bas%252Ba%252Bnew%252Bpotential%252BPET%252Bheart%252Bimaging%252Bagent%26aulast%3DXu%26aufirst%3DZhidong%26date%3D2020%26volume%3D162%26spage%3D109190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jackee  Sanchez</span>, <span class="hlFld-ContribAuthor ">Trever R.  Carter</span>, <span class="hlFld-ContribAuthor ">Mark S.  Cohen</span>, <span class="hlFld-ContribAuthor ">Brian S.J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Old and New Approaches to Target the Hsp90 Chaperone. </span><span class="cited-content_cbyCitation_journal-name">Current Cancer Drug Targets</span><span> <strong>2020,</strong> <em>20 </em>
                                    (4)
                                     , 253-270. <a href="https://doi.org/10.2174/1568009619666191202101330" title="DOI URL">https://doi.org/10.2174/1568009619666191202101330</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568009619666191202101330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568009619666191202101330%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Cancer%2520Drug%2520Targets%26atitle%3DOld%252Band%252BNew%252BApproaches%252Bto%252BTarget%252Bthe%252BHsp90%252BChaperone%26aulast%3DSanchez%26aufirst%3DJackee%26date%3D2020%26volume%3D20%26issue%3D4%26spage%3D253%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dustin J. E.  Huard</span>, <span class="hlFld-ContribAuthor ">Alex P.  Jonke</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Torres</span>, <span class="hlFld-ContribAuthor ">Raquel L.  Lieberman</span>. </span><span class="cited-content_cbyCitation_article-title">Different Grp94 components interact transiently with the myocilin olfactomedin domain in vitro to enhance or retard its amyloid aggregation. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-48751-8" title="DOI URL">https://doi.org/10.1038/s41598-019-48751-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-48751-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-48751-8%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDifferent%252BGrp94%252Bcomponents%252Binteract%252Btransiently%252Bwith%252Bthe%252Bmyocilin%252Bolfactomedin%252Bdomain%252Bin%252Bvitro%252Bto%252Benhance%252Bor%252Bretard%252Bits%252Bamyloid%252Baggregation%26aulast%3DHuard%26aufirst%3DDustin%2BJ.%2BE.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John D.  Huck</span>, <span class="hlFld-ContribAuthor ">Nanette L.S.  Que</span>, <span class="hlFld-ContribAuthor ">Robert M.  Immormino</span>, <span class="hlFld-ContribAuthor ">Liza  Shrestha</span>, <span class="hlFld-ContribAuthor ">Tony  Taldone</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>, <span class="hlFld-ContribAuthor ">Daniel T.  Gewirth</span>. </span><span class="cited-content_cbyCitation_article-title">NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (44)
                                     , 16010-16019. <a href="https://doi.org/10.1074/jbc.RA119.009960" title="DOI URL">https://doi.org/10.1074/jbc.RA119.009960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA119.009960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA119.009960%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DNECA%252Bderivatives%252Bexploit%252Bthe%252Bparalog-specific%252Bproperties%252Bof%252Bthe%252Bsite%252B3%252Bside%252Bpocket%252Bof%252BGrp94%25252C%252Bthe%252Bendoplasmic%252Breticulum%252BHsp90%26aulast%3DHuck%26aufirst%3DJohn%2BD.%26date%3D2019%26volume%3D294%26issue%3D44%26spage%3D16010%26epage%3D16019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qun  Wei</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Le  Su</span>, <span class="hlFld-ContribAuthor ">Xuan  Zhao</span>, <span class="hlFld-ContribAuthor ">BaoXiang  Zhao</span>, <span class="hlFld-ContribAuthor ">JunYing  Miao</span>, <span class="hlFld-ContribAuthor ">ZhaoMin  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Low-concentration HCP1 inhibits apoptosis in vascular endothelial cells. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2019,</strong> <em>511 </em>
                                    (1)
                                     , 92-98. <a href="https://doi.org/10.1016/j.bbrc.2019.02.003" title="DOI URL">https://doi.org/10.1016/j.bbrc.2019.02.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2019.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2019.02.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DLow-concentration%252BHCP1%252Binhibits%252Bapoptosis%252Bin%252Bvascular%252Bendothelial%252Bcells%26aulast%3DWei%26aufirst%3DQun%26date%3D2019%26volume%3D511%26issue%3D1%26spage%3D92%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuj  Khandelwal</span>, <span class="hlFld-ContribAuthor ">Caitlin N.  Kent</span>, <span class="hlFld-ContribAuthor ">Maurie  Balch</span>, <span class="hlFld-ContribAuthor ">Shuxia  Peng</span>, <span class="hlFld-ContribAuthor ">Sanket J.  Mishra</span>, <span class="hlFld-ContribAuthor ">Junpeng  Deng</span>, <span class="hlFld-ContribAuthor ">Victor W.  Day</span>, <span class="hlFld-ContribAuthor ">Weiya  Liu</span>, <span class="hlFld-ContribAuthor ">Chitra  Subramanian</span>, <span class="hlFld-ContribAuthor ">Mark  Cohen</span>, <span class="hlFld-ContribAuthor ">Jeffery M.  Holzbeierlein</span>, <span class="hlFld-ContribAuthor ">Robert  Matts</span>, <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-02013-1" title="DOI URL">https://doi.org/10.1038/s41467-017-02013-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-02013-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-02013-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStructure-guided%252Bdesign%252Bof%252Ban%252BHsp90%2525CE%2525B2%252BN-terminal%252Bisoform-selective%252Binhibitor%26aulast%3DKhandelwal%26aufirst%3DAnuj%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongwei  Wang</span>, <span class="hlFld-ContribAuthor ">Mingzhe  Li</span>, <span class="hlFld-ContribAuthor ">Zhenzhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Haifeng  Xue</span>, <span class="hlFld-ContribAuthor ">Xing  Chen</span>, <span class="hlFld-ContribAuthor ">Yong  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Physiological function of myocilin and its role in the pathogenesis of glaucoma in the trabecular meshwork (Review). </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Medicine</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/ijmm.2018.3992" title="DOI URL">https://doi.org/10.3892/ijmm.2018.3992</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/ijmm.2018.3992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fijmm.2018.3992%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Medicine%26atitle%3DPhysiological%252Bfunction%252Bof%252Bmyocilin%252Band%252Bits%252Brole%252Bin%252Bthe%252Bpathogenesis%252Bof%252Bglaucoma%252Bin%252Bthe%252Btrabecular%252Bmeshwork%252B%252528Review%252529%26aulast%3DWang%26aufirst%3DHongwei%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fisayo  Olotu</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Adeniji</span>, <span class="hlFld-ContribAuthor ">Clement  Agoni</span>, <span class="hlFld-ContribAuthor ">Imane  Bjij</span>, <span class="hlFld-ContribAuthor ">Shama  Khan</span>, <span class="hlFld-ContribAuthor ">Ahmed  Elrashedy</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">An update on the discovery and development of selective heat shock protein inhibitors as anti-cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2018,</strong> <em>13 </em>
                                    (10)
                                     , 903-918. <a href="https://doi.org/10.1080/17460441.2018.1516035" title="DOI URL">https://doi.org/10.1080/17460441.2018.1516035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2018.1516035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2018.1516035%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DAn%252Bupdate%252Bon%252Bthe%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bselective%252Bheat%252Bshock%252Bprotein%252Binhibitors%252Bas%252Banti-cancer%252Btherapy%26aulast%3DOlotu%26aufirst%3DFisayo%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D10%26spage%3D903%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Moses</span>, <span class="hlFld-ContribAuthor ">Abbey D.  Zuehlke</span>, <span class="hlFld-ContribAuthor ">Len  Neckers</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Chaperone Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 21-40. <a href="https://doi.org/10.1007/978-3-319-69042-1_2" title="DOI URL">https://doi.org/10.1007/978-3-319-69042-1_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-69042-1_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-69042-1_2%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BChaperone%252BInhibitors%26aulast%3DMoses%26aufirst%3DMichael%2BA.%26date%3D2018%26date%3D2018%26spage%3D21%26epage%3D40%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHeat%252BShock%252BProteins%252Bin%252Bthe%252BImmune%252BSystem%26aulast%3DBinder%26aufirst%3DRobert%2BJ.%26date%3D2018%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katherine M.  Byrd</span>, <span class="hlFld-ContribAuthor ">Caitlin N.  Kent</span>, <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Stilbene Analogues as Hsp90 C-Terminal Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (24)
                                     , 2022-2029. <a href="https://doi.org/10.1002/cmdc.201700630" title="DOI URL">https://doi.org/10.1002/cmdc.201700630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700630%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BStilbene%252BAnalogues%252Bas%252BHsp90%252BC-Terminal%252BInhibitors%26aulast%3DByrd%26aufirst%3DKatherine%2BM.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D24%26spage%3D2022%26epage%3D2029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lorenz  Weidenauer</span>, <span class="hlFld-ContribAuthor ">Tai  Wang</span>, <span class="hlFld-ContribAuthor ">Suhasini  Joshi</span>, <span class="hlFld-ContribAuthor ">Gabriela  Chiosis</span>, <span class="hlFld-ContribAuthor ">Manfredo R.  Quadroni</span>. </span><span class="cited-content_cbyCitation_article-title">Proteomic interrogation of HSP90 and insights for medical research. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Proteomics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (12)
                                     , 1105-1117. <a href="https://doi.org/10.1080/14789450.2017.1389649" title="DOI URL">https://doi.org/10.1080/14789450.2017.1389649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14789450.2017.1389649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14789450.2017.1389649%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Proteomics%26atitle%3DProteomic%252Binterrogation%252Bof%252BHSP90%252Band%252Binsights%252Bfor%252Bmedical%252Bresearch%26aulast%3DWeidenauer%26aufirst%3DLorenz%26date%3D2017%26date%3D2017%26volume%3D14%26issue%3D12%26spage%3D1105%26epage%3D1117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew R.  Stothert</span>, <span class="hlFld-ContribAuthor ">Amirthaa  Suntharalingam</span>, <span class="hlFld-ContribAuthor ">Xiaolan  Tang</span>, <span class="hlFld-ContribAuthor ">Vincent M.  Crowley</span>, <span class="hlFld-ContribAuthor ">Sanket J.  Mishra</span>, <span class="hlFld-ContribAuthor ">Jack M.  Webster</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Nordhues</span>, <span class="hlFld-ContribAuthor ">Dustin J. E.  Huard</span>, <span class="hlFld-ContribAuthor ">Christopher L.  Passaglia</span>, <span class="hlFld-ContribAuthor ">Raquel L.  Lieberman</span>, <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>, <span class="hlFld-ContribAuthor ">Laura J.  Blair</span>, <span class="hlFld-ContribAuthor ">John  Koren</span>, <span class="hlFld-ContribAuthor ">Chad A.  Dickey</span>. </span><span class="cited-content_cbyCitation_article-title">Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-18344-4" title="DOI URL">https://doi.org/10.1038/s41598-017-18344-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-18344-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-18344-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DIsoform-selective%252BHsp90%252Binhibition%252Brescues%252Bmodel%252Bof%252Bhereditary%252Bopen-angle%252Bglaucoma%26aulast%3DStothert%26aufirst%3DAndrew%2BR.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. O.  Sinenko</span>, <span class="hlFld-ContribAuthor ">S. R.  Slivchuk</span>, <span class="hlFld-ContribAuthor ">O. P.  Mityukhin</span>, <span class="hlFld-ContribAuthor ">V. S.  Brovarets</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of New 1,3-Thiazolecarbaldehydes. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2017,</strong> <em>87 </em>
                                    (12)
                                     , 2766-2775. <a href="https://doi.org/10.1134/S1070363217120039" title="DOI URL">https://doi.org/10.1134/S1070363217120039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363217120039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363217120039%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DSynthesis%252Bof%252BNew%252B1%25252C3-Thiazolecarbaldehydes%26aulast%3DSinenko%26aufirst%3DV.%2BO.%26date%3D2017%26date%3D2018%26volume%3D87%26issue%3D12%26spage%3D2766%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincent M.  Crowley</span>, <span class="hlFld-ContribAuthor ">Dustin J. E.  Huard</span>, <span class="hlFld-ContribAuthor ">Raquel L.  Lieberman</span>, <span class="hlFld-ContribAuthor ">Brian S. J.  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2017,</strong> <em>23 </em>
                                    (62)
                                     , 15775-15782. <a href="https://doi.org/10.1002/chem.201703398" title="DOI URL">https://doi.org/10.1002/chem.201703398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201703398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201703398%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DSecond%252BGeneration%252BGrp94-Selective%252BInhibitors%252BProvide%252BOpportunities%252Bfor%252Bthe%252BInhibition%252Bof%252BMetastatic%252BCancer%26aulast%3DCrowley%26aufirst%3DVincent%2BM.%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D62%26spage%3D15775%26epage%3D15782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinqin  Song</span>, <span class="hlFld-ContribAuthor ">Hailong  Zhou</span>, <span class="hlFld-ContribAuthor ">Qian  Han</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Diao</span>. </span><span class="cited-content_cbyCitation_article-title">Toxic responses of Perna viridis hepatopancreas exposed to DDT, benzo(a)pyrene and their mixture uncovered by iTRAQ-based proteomics and NMR-based metabolomics. </span><span class="cited-content_cbyCitation_journal-name">Aquatic Toxicology</span><span> <strong>2017,</strong> <em>192 </em>, 48-57. <a href="https://doi.org/10.1016/j.aquatox.2017.09.010" title="DOI URL">https://doi.org/10.1016/j.aquatox.2017.09.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.aquatox.2017.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.aquatox.2017.09.010%26sid%3Dliteratum%253Aachs%26jtitle%3DAquatic%2520Toxicology%26atitle%3DToxic%252Bresponses%252Bof%252BPerna%252Bviridis%252Bhepatopancreas%252Bexposed%252Bto%252BDDT%25252C%252Bbenzo%252528a%252529pyrene%252Band%252Btheir%252Bmixture%252Buncovered%252Bby%252BiTRAQ-based%252Bproteomics%252Band%252BNMR-based%252Bmetabolomics%26aulast%3DSong%26aufirst%3DQinqin%26date%3D2017%26volume%3D192%26spage%3D48%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arin N.  Graner</span>, <span class="hlFld-ContribAuthor ">Justin E.  Hellwinkel</span>, <span class="hlFld-ContribAuthor ">Alex M.  Lencioni</span>, <span class="hlFld-ContribAuthor ">Helen J.  Madsen</span>, <span class="hlFld-ContribAuthor ">Tessa A.  Harland</span>, <span class="hlFld-ContribAuthor ">Paul  Marchando</span>, <span class="hlFld-ContribAuthor ">Ger J.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Mary  Wang</span>, <span class="hlFld-ContribAuthor ">Laura M.  Russell</span>, <span class="hlFld-ContribAuthor ">Lynne T.  Bemis</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Anchordoquy</span>, <span class="hlFld-ContribAuthor ">Michael W.  Graner</span>. </span><span class="cited-content_cbyCitation_article-title">HSP90 inhibitors in the context of heat shock and the unfolded protein response: effects on a primary canine pulmonary adenocarcinoma cell line*. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Hyperthermia</span><span> <strong>2017,</strong> <em>33 </em>
                                    (3)
                                     , 303-317. <a href="https://doi.org/10.1080/02656736.2016.1256503" title="DOI URL">https://doi.org/10.1080/02656736.2016.1256503</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/02656736.2016.1256503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F02656736.2016.1256503%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Hyperthermia%26atitle%3DHSP90%252Binhibitors%252Bin%252Bthe%252Bcontext%252Bof%252Bheat%252Bshock%252Band%252Bthe%252Bunfolded%252Bprotein%252Bresponse%25253A%252Beffects%252Bon%252Ba%252Bprimary%252Bcanine%252Bpulmonary%252Badenocarcinoma%252Bcell%252Bline%252A%26aulast%3DGraner%26aufirst%3DArin%2BN.%26date%3D2017%26date%3D2016%26volume%3D33%26issue%3D3%26spage%3D303%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madeline Y.  Wong</span>, <span class="hlFld-ContribAuthor ">Andrew S.  DiChiara</span>, <span class="hlFld-ContribAuthor ">Patreece H.  Suen</span>, <span class="hlFld-ContribAuthor ">Kenny  Chen</span>, <span class="hlFld-ContribAuthor ">Ngoc-Duc  Doan</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Shoulders</span>. </span><span class="cited-content_cbyCitation_article-title">Adapting Secretory Proteostasis and Function Through the Unfolded Protein Response. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-25. <a href="https://doi.org/10.1007/82_2017_56" title="DOI URL">https://doi.org/10.1007/82_2017_56</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/82_2017_56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F82_2017_56%26sid%3Dliteratum%253Aachs%26atitle%3DAdapting%252BSecretory%252BProteostasis%252Band%252BFunction%252BThrough%252Bthe%252BUnfolded%252BProtein%252BResponse%26aulast%3DWong%26aufirst%3DMadeline%2BY.%26date%3D2017%26date%3D2017%26spage%3D1%26epage%3D25%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCoordinating%252BOrganismal%252BPhysiology%252BThrough%252Bthe%252BUnfolded%252BProtein%252BResponse%26aulast%3DWiseman%26aufirst%3DR.%2BLuke%26date%3D2018%26volume%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Purine-based Grp94-selective inhibitors (<b>1</b>, <b>2</b>, and <b>3</b>). Resorcinol-based <i>pan</i>-Hsp90 (<b>4</b>) and Grp94-selective (<b>5</b>) inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structures of RDA with Hsp90 isoforms. cGrp94 (A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD">2GFD</a>) highlights the hydrophobic and π-rich nature of the unique secondary binding pocket of Grp94. Only <i>cis</i>-RDA shown for clarity. yHsp82 (B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS">2FXS</a>) highlights the hydrogen bonding network present and restricted access to the aromatic residues. Residues are numbered as in their respective proteins. BnIm docked in to Gpr94 (C) highlighting substitution positions on the aryl side chain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) LiAlH<sub>4</sub>, THF, 0–25 °C, 12 h; (b) DBU, DPPA, toluene, 0–25 °C, 12 h; (c) PPh<sub>3</sub>, THF:H<sub>2</sub>O (10:1), 25 °C, 12 h.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Tertiary structure of RDA bound to Grp94 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD">2GFD</a>) showing the open conformation of the N-terminal domain of Grp94. (B) Tertiary structure of <b>3</b> bound to Grp94 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F">3O2F</a>) showing the conformational shift (blue, green, and orange helices) of the N-terminal domain induced by the inhibitor binding to Grp94 revealing the extended binding pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Amines from Aromatic Aldehydes<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, Ac<sub>2</sub>O, 0 °C, 1 h; (b) 50% H<sub>2</sub>SO<sub>4</sub> (aq), 110 °C, 5 min; (c) conc HCl, 40 °C, 12 h; (d) NH<sub>2</sub>OH·HCl, NaOAc, MeOH, 25 °C, 8 h; (e) LiAlH<sub>4</sub>, THF, 0–25 °C, 12 h; (f) potassium vinyltrifluoroborate, Pd(dppf)Cl<sub>2</sub>, <sup><i>i</i></sup>Pr<sub>2</sub>EtN, toluene, 110 °C, 14 h; (g) H<sub>2</sub>, 10% Pd/C, EtOH, 25 °C, 6 h.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) SO<sub>2</sub>Cl<sub>2</sub>, 15 °C, AcOH:Et<sub>2</sub>O (9:1), 1 h; (b) NBS, AIBN, CCl<sub>4</sub>, 80 °C, 4 h; (c) NaN<sub>3</sub>, MeOH:H<sub>2</sub>O (10:1), 25 °C, 12 h; (d) PPh<sub>3</sub>, THF:H<sub>2</sub>O (10:1), 25 °C, 12 h; (e) LiOH, THF:MeOH:H<sub>2</sub>O (9:1:1), 25 °C, 10 h; (f) LDA, MeI, THF, −40 °C, 3 h; (g) LiAlH<sub>4</sub>, THF, 0–25 °C, 12 h; (h) DBU, DPPA, toluene, 25 °C, 12 h; (i) <i>n</i>-BuLi, CO<sub>2</sub>(g), THF, −78 °C, 2 h.</p></p></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of the minimized structures of BnIm (cyan) and <b>46</b> (green) highlighting the overlapping 4- and 5-positions, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of <b>48</b> bound to Grp94. (a) Surface representation of ATP-binding pocket with <b>48</b> as ball and stick. Arrow points to a well-ordered loop at the mouth of the active site. (b) Cartoon representation of the structure as in (a) highlighting H-bonding interactions (≤3.5 Å) and loop configuration. (c) Zoomed view of <b>48</b> in active site with H-bonding interactions as in (b). (d) Final 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density contoured at 1 σ (gray mesh) superimposed with initial <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> density contoured at 3 σ (green) after molecular replacement (see <a class="ref internalNav" href="#sec7" aria-label="Experimental Section">Experimental Section</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Wound-healing scratch assay results after 24 h treatment with BnIm, <b>40</b>, <b>48</b>, or vehicle. Antiproliferative activity given is relative to vehicle control (<i>n</i> = 4). ND = not determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Western blot analysis of MDA-MB-231 cells treated with Grp94-selective inhibitors, geldanamycin (GDA, a <i>pan</i>-Hsp90 inhibitor), or vehicle control (DMSO, 0.25% final concentration). Ratio of Integrin α2 (B), Akt (C), and Hsp70 (D) normalized to actin for each compound concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Western blot analysis of HEK cells overexpressing the I477N myocilin mutant and treated with 1 μM of indicated Grp94-selective inhibitors illustrating (A) myocilin degradation and (B) lack of AKT degradation and Hsp70 induction. Ratio of myocilin (C), AKT (D), and Hsp70 (E) normalized to actin for each compound. Vehicle = DMSO and 17-AAG = 17-(allylamino)-17-demethoxygeldanamycin (<i>pan</i>-Hsp90 N-terminal inhibitor).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/medium/jm-2016-00085y_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0010.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Summary of structure–activity relationships for the BnIm series of Grp94-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.6b00085/20160414/images/large/jm-2016-00085y_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00085&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i117">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33853" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33853" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Structure, function and regulation of the Hsp90 machinery</span> <span class="citation_source-journal">Biomed. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span><span class="refDoi"> DOI: 10.4103/2319-4170.113230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.4103%2F2319-4170.113230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23806880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A280%3ADC%252BC3sjmtlelsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=106-117&author=J.+Liauthor=J.+Buchner&title=Structure%2C+function+and+regulation+of+the+Hsp90+machinery&doi=10.4103%2F2319-4170.113230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, function and regulation of the hsp90 machinery</span></div><div class="casAuthors">Li Jing; Buchner Johannes</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">106-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is an ATP-dependent molecular chaperone which is essential in eukaryotes.  It is required for the activation and stabilization of a wide variety of client proteins and many of them are involved in important cellular pathways.  Since Hsp90 affects numerous physiological processes such as signal transduction, intracellular transport, and protein degradation, it became an interesting target for cancer therapy.  Structurally, Hsp90 is a flexible dimeric protein composed of three different domains which adopt structurally distinct conformations.  ATP binding triggers directionality in these conformational changes and leads to a more compact state.  To achieve its function, Hsp90 works together with a large group of cofactors, termed co-chaperones.  Co-chaperones form defined binary or ternary complexes with Hsp90, which facilitate the maturation of client proteins.  In addition, posttranslational modifications of Hsp90, such as phosphorylation and acetylation, provide another level of regulation.  They influence the conformational cycle, co-chaperone interaction, and inter-domain communications.  In this review, we discuss the recent progress made in understanding the Hsp90 machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGO1vbg1ywaVm8bhe6roZYfW6udTcc2eY-RfHX_FjHtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjmtlelsg%253D%253D&md5=239f9f8865489ee74f5f8163ea1007ce</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4103%2F2319-4170.113230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2319-4170.113230%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DStructure%252C%2520function%2520and%2520regulation%2520of%2520the%2520Hsp90%2520machinery%26jtitle%3DBiomed.%2520J.%26date%3D2013%26volume%3D36%26spage%3D106%26epage%3D117%26doi%3D10.4103%2F2319-4170.113230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Centenera, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tilley, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, L. M.</span><span> </span><span class="NLM_article-title">Hsp90: still a viable target in prostate cancer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">1835</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span><span class="refDoi"> DOI: 10.1016/j.bbcan.2012.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.bbcan.2012.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23287571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVegsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1835&publication_year=2013&pages=211-218&author=M.+M.+Centeneraauthor=A.+K.+Fitzpatrickauthor=W.+D.+Tilleyauthor=L.+M.+Butler&title=Hsp90%3A+still+a+viable+target+in+prostate+cancer&doi=10.1016%2Fj.bbcan.2012.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90: Still a viable target in prostate cancer</span></div><div class="casAuthors">Centenera, Margaret M.; Fitzpatrick, Alyssa K.; Tilley, Wayne D.; Butler, Lisa M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1835</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-218</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is a mol. chaperone that regulates the maturation, activation and stability of crit. signaling proteins that drive the development and progression of prostate cancer, including the androgen receptor.  Despite robust preclin. data demonstrating anti-tumor activity of first-generation Hsp90 inhibitors in prostate cancer, poor clin. responses initially cast doubt over the clin. utility of this class of agent.  Recent advances in compd. design and development, use of novel preclin. models and further biol. insights into Hsp90 structure and function have now stimulated a resurgence in enthusiasm for these drugs as a therapeutic option.  This review highlights how the development of new-generation Hsp90 inhibitors with improved phys. and pharmacol. properties is unfolding, and discusses the potential contexts for their use either as single agents or in combination, for men with metastatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAD5tSTFibe7Vg90H21EOLACvtfcHk0li0XH_arJRvDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVegsr4%253D&md5=4cde3dedb6e6450dd3c4b44663953a72</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2012.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2012.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCentenera%26aufirst%3DM.%2BM.%26aulast%3DFitzpatrick%26aufirst%3DA.%2BK.%26aulast%3DTilley%26aufirst%3DW.%2BD.%26aulast%3DButler%26aufirst%3DL.%2BM.%26atitle%3DHsp90%253A%2520still%2520a%2520viable%2520target%2520in%2520prostate%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2013%26volume%3D1835%26spage%3D211%26epage%3D218%26doi%3D10.1016%2Fj.bbcan.2012.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">Essential roles of Grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">6877</span><span class="NLM_x">–</span> <span class="NLM_lpage">6882</span><span class="refDoi"> DOI: 10.1073/pnas.1302933110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1073%2Fpnas.1302933110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23572575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=6877-6882&author=B.+Liuauthor=M.+Staronauthor=F.+Hongauthor=B.+X.+Wuauthor=S.+Sunauthor=C.+Moralesauthor=C.+E.+Crossonauthor=S.+Tomlinsonauthor=I.+Kimauthor=D.+Wuauthor=Z.+Li&title=Essential+roles+of+Grp94+in+gut+homeostasis+via+chaperoning+canonical+Wnt+pathway&doi=10.1073%2Fpnas.1302933110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway</span></div><div class="casAuthors">Liu, Bei; Staron, Matthew; Hong, Feng; Wu, Bill X.; Sun, Shaoli; Morales, Crystal; Crosson, Craig E.; Tomlinson, Stephen; Kim, Ingyu; Wu, Dianqing; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6877-6882</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Increasing evidence points to a role for the protein quality control in the endoplasmic reticulum (ER) in maintaining intestinal homeostasis.  However, the specific role for general ER chaperones in this process remains unknown.  Herein, we report that a major ER heat shock protein grp94 interacts with MesD, a crit. chaperone for the Wnt coreceptor low-d. lipoprotein receptor-related protein 6 (LRP6).  Without grp94, LRP6 fails to export from the ER to the cell surface, resulting in a profound loss of canonical Wnt signaling.  The significance of this finding is demonstrated in vivo in that grp94 loss causes a rapid and profound compromise in intestinal homeostasis with gut-intrinsic defect in the proliferation of intestinal crypts, compromise of nuclear β-catenin translocation, loss of crypt-villus structure, and impaired barrier function.  Taken together, our work has uncovered the role of grp94 in chaperoning LRP6-MesD in coordinating intestinal homeostasis, placing canonical Wnt-signaling pathway under the direct regulation of the general protein quality control machinery in the ER.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7emg80iB5gLVg90H21EOLACvtfcHk0lijyAP6EXWNXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Ghtrs%253D&md5=221593fe9162fee07b700367633663e1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1302933110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1302933110%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DStaron%26aufirst%3DM.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DB.%2BX.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DMorales%26aufirst%3DC.%26aulast%3DCrosson%26aufirst%3DC.%2BE.%26aulast%3DTomlinson%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DEssential%2520roles%2520of%2520Grp94%2520in%2520gut%2520homeostasis%2520via%2520chaperoning%2520canonical%2520Wnt%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D6877%26epage%3D6882%26doi%3D10.1073%2Fpnas.1302933110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Suntharalingam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abisambra, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joe, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinwal, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duerfeldt, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomarev, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span> </span><span class="NLM_article-title">Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">40661</span><span class="NLM_x">–</span> <span class="NLM_lpage">40669</span><span class="refDoi"> DOI: 10.1074/jbc.M112.384800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M112.384800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23035116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslantr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=40661-40669&author=A.+Suntharalingamauthor=J.+F.+Abisambraauthor=J.+C.+O%E2%80%99Learyauthor=J.+Korenauthor=B.+Zhangauthor=M.+K.+Joeauthor=L.+J.+Blairauthor=S.+E.+Hillauthor=U.+K.+Jinwalauthor=M.+Cockmanauthor=A.+S.+Duerfeldtauthor=S.+Tomarevauthor=B.+S.+Blaggauthor=R.+L.+Liebermanauthor=C.+A.+Dickey&title=Glucose-regulated+protein+94+triage+of+mutant+myocilin+through+endoplasmic+reticulum-associated+degradation+subverts+a+more+efficient+autophagic+clearance+mechanism&doi=10.1074%2Fjbc.M112.384800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-regulated Protein 94 tiage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism</span></div><div class="casAuthors">Suntharalingam, Amirthaa; Abisambra, Jose F.; O'Leary, John C., III; Koren, John, III; Zhang, Bo; Joe, Myung Kuk; Blair, Laura J.; Hill, Shannon E.; Jinwal, Umesh K.; Cockman, Matthew; Duerfeldt, Adam S.; Tomarev, Stanislav; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">40661-40669</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Clearance of misfolded proteins in the endoplasmic reticulum (ER) is traditionally handled by ER-assocd. degrdn. (ERAD), a process that requires retro-translocation and ubiquitination mediated by a luminal chaperone network.  Here we investigated whether the secreted, glaucoma-assocd. protein myocilin was processed by this pathway.  Myocilin is typically transported through the ER/Golgi network, but inherited mutations in myocilin lead to its misfolding and aggregation within trabecular meshwork cells, and ultimately, ER stress-induced cell death.  Using targeted knockdown strategies, we detd. that glucose-regulated protein 94 (Grp94), the ER equiv. of heat shock protein 90 (Hsp90), specifically recognizes mutant myocilin, triaging it through ERAD.  The addn. of mutant myocilin to the short list of Grp94 clients strengthens the hypothesis that β-strand secondary structure drives client assocn. with Grp94.  Interestingly, the ERAD pathway is incapable of efficiently handling the removal of mutant myocilin, but when Grp94 is depleted, degrdn. of mutant myocilin is shunted away from ERAD toward a more robust clearance pathway for aggregation-prone proteins, the autophagy system.  Thus ERAD inefficiency for distinct aggregation-prone proteins can be subverted by manipulating ER chaperones, leading to more effective clearance by the autophagic/lysosomal pathway.  General Hsp90 inhibitors and a selective Grp94 inhibitor also facilitate clearance of mutant myocilin, suggesting that therapeutic approaches aimed at inhibiting Grp94 could be beneficial for patients suffering from some cases of myocilin glaucoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSe_XBYKAUtrVg90H21EOLACvtfcHk0lizc7vkxflgvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslantr7I&md5=be4d91d171e7f124716eb2920c9b8080</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.384800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.384800%26sid%3Dliteratum%253Aachs%26aulast%3DSuntharalingam%26aufirst%3DA.%26aulast%3DAbisambra%26aufirst%3DJ.%2BF.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DJ.%2BC.%26aulast%3DKoren%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DJoe%26aufirst%3DM.%2BK.%26aulast%3DBlair%26aufirst%3DL.%2BJ.%26aulast%3DHill%26aufirst%3DS.%2BE.%26aulast%3DJinwal%26aufirst%3DU.%2BK.%26aulast%3DCockman%26aufirst%3DM.%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DTomarev%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DGlucose-regulated%2520protein%252094%2520triage%2520of%2520mutant%2520myocilin%2520through%2520endoplasmic%2520reticulum-associated%2520degradation%2520subverts%2520a%2520more%2520efficient%2520autophagic%2520clearance%2520mechanism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D40661%26epage%3D40669%26doi%3D10.1074%2Fjbc.M112.384800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hua, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White-Gilbertson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kellner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rachidi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usmani, S. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depinho, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span> </span><span class="NLM_article-title">Molecular chaperone gp96 is a novel therapeutic target of multiple myeloma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6242</span><span class="NLM_x">–</span> <span class="NLM_lpage">6251</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-2083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1158%2F1078-0432.CCR-13-2083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=24077352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6242-6251&author=Y.+Huaauthor=S.+White-Gilbertsonauthor=J.+Kellnerauthor=S.+Rachidiauthor=S.+Z.+Usmaniauthor=G.+Chiosisauthor=R.+Depinhoauthor=Z.+Liauthor=B.+Liu&title=Molecular+chaperone+gp96+is+a+novel+therapeutic+target+of+multiple+myeloma&doi=10.1158%2F1078-0432.CCR-13-2083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Chaperone gp96 Is a Novel Therapeutic Target of Multiple Myeloma</span></div><div class="casAuthors">Hua, Yunpeng; White-Gilbertson, Shai; Kellner, Joshua; Rachidi, Saleh; Usmani, Saad Z.; Chiosis, Gabriela; DePinho, Ronald; Li, Zihai; Liu, Bei</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6242-6251</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: gp96 (grp94) is a key downstream chaperone in the endoplasmic reticulum (ER) to mediate unfolded protein response (UPR) and the pathogenesis of multiple myeloma is closely linked to dysregulated UPR.  In this study, we aimed to det. the roles of gp96 in the initiation and progression of multiple myeloma in vivo and in vitro.  Exptl. Design: We generated a mouse model with overexpression of XBP1s and conditional deletion of gp96 in B-cell compartment simultaneously to identify the roles of gp96 in the development of multiple myeloma in vivo.  Using a short hairpin RNA (shRNA) system, we silenced gp96 in multiple human multiple myeloma cells and examd. the effect of gp96 knockdown on multiple myeloma cells by cell proliferation, cell-cycle anal., apoptosis assay, immunohistochem., and human myeloma xenograft model.  The anticancer activity of gp96 selective inhibitor, WS13, was evaluated by apoptosis assay and MTT assay.  Results: Genetic deletion of gp96 in XBP1s-Tg mice attenuates multiple myeloma.  Silencing of gp96 causes severe compromise in human multiple myeloma cell growth through inhibiting Wnt-LRP-survivin pathway.  We also confirmed that knockdown of gp96 decreased human multiple myeloma growth in a murine xenograft model.  The targeted gp96 inhibitor induced apoptosis and blocked multiple myeloma cell growth, but did not induce apoptosis in pre-B leukemic cells.  We have demonstrated that myeloma growth is dependent on gp96 both genetically and pharmacol.  Conclusions: gp96 is essential for multiple myeloma cell proliferation and survival, suggesting that gp96 is a novel therapeutic target for multiple myeloma.  Clin Cancer Res; 19(22); 6242-51. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-ajwmlaUPrVg90H21EOLACvtfcHk0lizc7vkxflgvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslyku7jP&md5=adb618074ee3e9d6ee4795b95c1d906c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-2083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-2083%26sid%3Dliteratum%253Aachs%26aulast%3DHua%26aufirst%3DY.%26aulast%3DWhite-Gilbertson%26aufirst%3DS.%26aulast%3DKellner%26aufirst%3DJ.%26aulast%3DRachidi%26aufirst%3DS.%26aulast%3DUsmani%26aufirst%3DS.%2BZ.%26aulast%3DChiosis%26aufirst%3DG.%26aulast%3DDepinho%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DB.%26atitle%3DMolecular%2520chaperone%2520gp96%2520is%2520a%2520novel%2520therapeutic%2520target%2520of%2520multiple%2520myeloma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6242%26epage%3D6251%26doi%3D10.1158%2F1078-0432.CCR-13-2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kusuma, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrowsky, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novologues as C-terminal Hsp90 inhibitors with cytoprotective activity against sensory neuron glucotoxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5797</span><span class="NLM_x">–</span> <span class="NLM_lpage">5812</span><span class="refDoi"> DOI: 10.1021/jm300544c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300544c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1SmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5797-5812&author=B.+R.+Kusumaauthor=L.+Zhangauthor=T.+Sundstromauthor=L.+B.+Petersonauthor=R.+T.+Dobrowskyauthor=B.+S.+Blagg&title=Synthesis+and+evaluation+of+novologues+as+C-terminal+Hsp90+inhibitors+with+cytoprotective+activity+against+sensory+neuron+glucotoxicity&doi=10.1021%2Fjm300544c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Novologues as C-Terminal Hsp90 Inhibitors with Cytoprotective Activity against Sensory Neuron Glucotoxicity</span></div><div class="casAuthors">Kusuma, Bhaskar Reddy; Zhang, Liang; Sundstrom, Teather; Peterson, Laura B.; Dobrowsky, Rick T.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5797-5812</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compd. 2 (KU-32) is a first-generation novologue (a novobiocin-based, C-terminal, heat shock protein 90 (Hsp90) inhibitor) that decreases glucose-induced death of primary sensory neurons and reverses numerous clin. indexes of diabetic peripheral neuropathy in mice.  The current study sought to exploit the C-terminal binding site of Hsp90 to det. whether the optimization of hydrogen bonding and hydrophobic interactions of second-generation novologues could enhance neuroprotective activity.  Using a series of substituted phenylboronic acids to replace the coumarin lactone of 2, we identified that electroneg. atoms placed at the meta-position of the B-ring exhibit improved cytoprotective activity, which is believed to result from favorable interactions with Lys539 in the Hsp90 C-terminal binding pocket.  Consistent with these results, a meta-3-fluorophenyl substituted novologue (13b) exhibited a 14-fold lower ED50 for protection against glucose-induced toxicity of primary sensory neurons compared to 2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS4gyFThKBPLVg90H21EOLACvtfcHk0lhA_I1BDFleJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1SmsL4%253D&md5=2ade8768ae7ba197b3a633babb7d6a3b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm300544c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300544c%26sid%3Dliteratum%253Aachs%26aulast%3DKusuma%26aufirst%3DB.%2BR.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSundstrom%26aufirst%3DT.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DDobrowsky%26aufirst%3DR.%2BT.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novologues%2520as%2520C-terminal%2520Hsp90%2520inhibitors%2520with%2520cytoprotective%2520activity%2520against%2520sensory%2520neuron%2520glucotoxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5797%26epage%3D5812%26doi%3D10.1021%2Fjm300544c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Hall, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsberg, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Alternative approaches to Hsp90 modulation for the treatment of cancer</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1605</span><span class="refDoi"> DOI: 10.4155/fmc.14.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.4155%2Ffmc.14.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=25367392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1587-1605&author=J.+A.+Hallauthor=L.+K.+Forsbergauthor=B.+S.+Blagg&title=Alternative+approaches+to+Hsp90+modulation+for+the+treatment+of+cancer&doi=10.4155%2Ffmc.14.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative approaches to Hsp90 modulation for the treatment of cancer</span></div><div class="casAuthors">Hall, Jessica A.; Forsberg, Leah K.; Blagg, Brian SJ</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1587-1605</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is responsible for the conformational maturation of newly synthesized polypeptides (client proteins) and the re-maturation of denatured proteins via the Hsp90 chaperone cycle.  Inhibition of the Hsp90 N-terminus has emerged as a clin. relevant strategy for anticancer chemotherapeutics due to the involvement of clients in a variety of oncogenic pathways.  Several immunophilins, co-chaperones and partner proteins are also necessary for Hsp90 chaperoning activity.  Alternative strategies to inhibit Hsp90 function include disruption of the C-terminal dimerization domain and the Hsp90 heteroprotein complex.  C-terminal inhibitors and Hsp90 co-chaperone disruptors prevent cancer cell proliferation similar to N-terminal inhibitors and destabilize client proteins without induction of heat shock proteins.  Herein, current Hsp90 inhibitors, the chaperone cycle, and regulation of this cycle will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbVu5waacb8LVg90H21EOLACvtfcHk0lhA_I1BDFleJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLvJ&md5=5a0c68b7c9ad23dd261f3f56d1473666</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.89%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DJ.%2BA.%26aulast%3DForsberg%26aufirst%3DL.%2BK.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DAlternative%2520approaches%2520to%2520Hsp90%2520modulation%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1587%26epage%3D1605%26doi%3D10.4155%2Ffmc.14.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Miyata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">The therapeutic target Hsp90 and cancer hallmarks</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span><span class="refDoi"> DOI: 10.2174/138161213804143725</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.2174%2F138161213804143725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22920906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=347-365&author=Y.+Miyataauthor=H.+Nakamotoauthor=L.+Neckers&title=The+therapeutic+target+Hsp90+and+cancer+hallmarks&doi=10.2174%2F138161213804143725"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic target Hsp90 and cancer hallmarks</span></div><div class="casAuthors">Miyata, Yoshihiko; Nakamoto, Hitoshi; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-365</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is a major mol. chaperone that is expressed abundantly and plays a pivotal role in assisting correct folding and functionality of its client proteins in cells.  The Hsp90 client proteins include a wide variety of signal transducing mols. such as protein kinases and steroid hormone receptors.  Cancer is a complex disease, but most types of human cancer share common hallmarks, including self-sufficiency in growth signals, insensitivity to growth-inhibitory mechanism, evasion of programmed cell death, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis.  A surprisingly large no. of Hsp90-client proteins play crucial roles in establishing cancer cell hallmarks.  We start the review by describing the structure and function of Hsp90 since conformational changes during the ATPase cycle of Hsp90 are closely related to its function.  Many co-chaperones, including Hop, p23, Cdc37, Aha1, and PP5, work together with Hsp90 by modulating the chaperone machinery.  Post-translational modifications of Hsp90 and its co-chaperones are vital for their function.  Many tumor-related Hsp90-client proteins, including signaling kinases, steroid hormone receptors, p53, and telomerase, are described.  Hsp90 and its co-chaperones are required for the function of these tumor-promoting client proteins; therefore, inhibition of Hsp90 by specific inhibitors such as geldanamycin and its derivs. attenuates the tumor progression.  Hsp90 inhibitors can be potential and effective cancer chemotherapeutic drugs with a unique profile and have been examd. in clin. trials.  We describe possible mechanisms why Hsp90 inhibitors show selectivity to cancer cells even though Hsp90 is essential also for normal cells.  Finally, we discuss the "Hsp90-addiction" of cancer cells, and suggest a role for Hsp90 in tumor evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBCHug6Q3PILVg90H21EOLACvtfcHk0lhA_I1BDFleJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqsL8%253D&md5=07f817fc5afc5ef0669aae0cd0dab15d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F138161213804143725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804143725%26sid%3Dliteratum%253Aachs%26aulast%3DMiyata%26aufirst%3DY.%26aulast%3DNakamoto%26aufirst%3DH.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DThe%2520therapeutic%2520target%2520Hsp90%2520and%2520cancer%2520hallmarks%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D347%26epage%3D365%26doi%3D10.2174%2F138161213804143725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lhA_I1BDFleJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gorska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popowska, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sielicka-Dudzin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuban-Jankowska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawczuk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knap, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicero, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bucchieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, M.</span><span> </span><span class="NLM_article-title">Geldanamycin and its derivatives as Hsp90 inhibitors</span> <span class="citation_source-journal">Front. Biosci., Landmark Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2277</span><span class="refDoi"> DOI: 10.2741/4050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.2741%2F4050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22652777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSksb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=2269-2277&author=M.+Gorskaauthor=U.+Popowskaauthor=A.+Sielicka-Dudzinauthor=A.+Kuban-Jankowskaauthor=W.+Sawczukauthor=N.+Knapauthor=G.+Ciceroauthor=F.+Bucchieriauthor=M.+Wozniak&title=Geldanamycin+and+its+derivatives+as+Hsp90+inhibitors&doi=10.2741%2F4050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Geldanamycin and its derivatives as Hsp90 inhibitors</span></div><div class="casAuthors">Gorska, Magdalena; Popowska, Urszula; Sielicka-Dudzin, Alicja; Kuban-Jankowska, Alicja; Sawczuk, Wojciech; Knap, Narcyz; Cicero, Giuseppe; Bucchieri, Fabio; Wozniak, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience, Landmark Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2269-2277, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The Hsp90 mol., one of the most abundant heat shock proteins in mammalian cells, maintains homeostasis and prevents stress-induced cellular damage.  Hsp90 is expressed under normal conditions at a level of about 1-2 % of total proteins, while its expression increases 2-10 fold in cancer cells.  The two main constitutively expressed isoforms of Hsp90 are known as Hsp90-alpha and Hsp90-beta and their upregulation is assocd. with tumor progression, invasion and formation of metastases, as well as development of drug resistance.  The Hsp90 is a key target for many newly established, potent anticancer agents contg. Hsp90 N-terminal ATP binding inhibitors, such as geldanamycin and its analogs 17AAG and 17DMAG.  The therapeutic usage of geldanamycin has been limited due to its poor water soly. and severe hepatotoxicity.  Therefore, its analogs, including 17AAG, 17DMAG, Tanespimycin and Retaspimycin hydrochloride, with improved pharmacokinetic profiles, have been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_c94d0-i6VbVg90H21EOLACvtfcHk0lhU2RkeQCeYMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSksb%252FP&md5=fe48ca65ead5d186e6a439770d9ffff7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2741%2F4050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F4050%26sid%3Dliteratum%253Aachs%26aulast%3DGorska%26aufirst%3DM.%26aulast%3DPopowska%26aufirst%3DU.%26aulast%3DSielicka-Dudzin%26aufirst%3DA.%26aulast%3DKuban-Jankowska%26aufirst%3DA.%26aulast%3DSawczuk%26aufirst%3DW.%26aulast%3DKnap%26aufirst%3DN.%26aulast%3DCicero%26aufirst%3DG.%26aulast%3DBucchieri%26aufirst%3DF.%26aulast%3DWozniak%26aufirst%3DM.%26atitle%3DGeldanamycin%2520and%2520its%2520derivatives%2520as%2520Hsp90%2520inhibitors%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2012%26volume%3D17%26spage%3D2269%26epage%3D2277%26doi%3D10.2741%2F4050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Khandelwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Natural product inspired N-terminal Hsp90 inhibitors: from bench to bedside?</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1002/med.21351</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1002%2Fmed.21351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=26010985" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=92-118&author=A.+Khandelwalauthor=V.+M.+Crowleyauthor=B.+S.+Blagg&title=Natural+product+inspired+N-terminal+Hsp90+inhibitors%3A+from+bench+to+bedside%3F&doi=10.1002%2Fmed.21351"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?</span></div><div class="casAuthors">Khandelwal, Anuj; Crowley, Vincent M.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">92-118</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The 90 kDa heat shock proteins (Hsp90) are responsible for the conformational maturation of nascent polypeptides and the rematuration of denatured proteins.  Proteins dependent upon Hsp90 are assocd. with all six hallmarks of cancer.  Upon Hsp90 inhibition, protein substrates are degraded via the ubiquitin-proteasome pathway.  Consequentially, inhibition of Hsp90 offers a therapeutic opportunity for the treatment of cancer.  Natural product inhibitors of Hsp90 have been identified in vitro, which have served as leads for the development of more efficacious inhibitors and analogs that have entered clin. trials.  This review highlights the development of natural product analogs, as well as the development of clin. important inhibitors that arose from natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqloFmLYY5brbVg90H21EOLACvtfcHk0lhU2RkeQCeYMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVagsb%252FK&md5=7625868e7c1e904cdd20036003ffb0d4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fmed.21351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21351%26sid%3Dliteratum%253Aachs%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DNatural%2520product%2520inspired%2520N-terminal%2520Hsp90%2520inhibitors%253A%2520from%2520bench%2520to%2520bedside%253F%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2016%26volume%3D36%26spage%3D92%26epage%3D118%26doi%3D10.1002%2Fmed.21351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummalapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotella, D. P.</span><span> </span><span class="NLM_article-title">Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8718</span><span class="NLM_x">–</span> <span class="NLM_lpage">8728</span><span class="refDoi"> DOI: 10.1021/jm500823a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500823a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8718-8728&author=R.+Bhatauthor=S.+R.+Tummalapalliauthor=D.+P.+Rotella&title=Progress+in+the+discovery+and+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors&doi=10.1021%2Fjm500823a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors</span></div><div class="casAuthors">Bhat, Rohit; Tummalapalli, Sreedhar R.; Rotella, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8718-8728</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The discovery and clin. development of heat shock protein 90 (Hsp90) inhibitors continue to progress.  A no. of Hsp90 inhibitors are in clin. trials, and preclin. discoveries of new chemotypes that bind to distinct regions in the protein as well as isoform selective compds. are active areas of research.  This review will highlight progress in the field since 2010.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-SwLv_-B9xLVg90H21EOLACvtfcHk0lhU2RkeQCeYMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSnsrfK&md5=132784687bbbcf62cfa8fe04a22577ce</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm500823a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500823a%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DTummalapalli%26aufirst%3DS.%2BR.%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DProgress%2520in%2520the%2520discovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8718%26epage%3D8728%26doi%3D10.1021%2Fjm500823a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Jhaveri, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span><span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.bbamcr.2011.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22062686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=742-755&author=K.+Jhaveriauthor=T.+Taldoneauthor=S.+Modiauthor=G.+Chiosis&title=Advances+in+the+clinical+development+of+heat+shock+protein+90+%28Hsp90%29+inhibitors+in+cancers&doi=10.1016%2Fj.bbamcr.2011.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers</span></div><div class="casAuthors">Jhaveri, Komal; Taldone, Tony; Modi, Shanu; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">742-755</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is an ATP dependent mol. chaperone protein which integrates multiple oncogenic pathways.  As such, Hsp90 inhibition is a promising anti-cancer strategy.  Several inhibitors that act on Hsp90 by binding to its N-terminal ATP pocket have entered clin. evaluation.  Robust pre-clin. data suggested anti-tumor activity in multiple cancer types.  Clin., encouraging results have been demonstrated in melanoma, acute myeloid leukemia, castrate refractory prostate cancer, non-small cell lung carcinoma and multiple myeloma.  In breast cancer, proof-of-concept was demonstrated by first generation Hsp90 inhibitors in combination with trastuzumab mainly in human epidermal growth factor receptor 2 (HER2) + metastatic breast cancer.  There are a multitude of second generation Hsp90 inhibitors currently under investigation.  To date, however, there is no FDA approved Hsp90 inhibitor nor standardized assay to ascertain Hsp90 inhibition.  This review summarizes the current status of both first and second generation Hsp90 inhibitors based on their chem. classification and stage of clin. development.  It also discusses the pharmacodynamic assays currently implemented in clinic as well as other novel strategies aimed at enhancing the effectiveness of Hsp90 inhibitors.  Ultimately, these efforts will aid in maximizing the full potential of this class of agents.  This article is part of a Special Issue entitled: Heat Shock Protein 90 (HSP90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDrDTpRQxfYrVg90H21EOLACvtfcHk0ljPXBk_PNc3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFShsbY%253D&md5=03cef7dc96667a4698324f635aacee7a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DJhaveri%26aufirst%3DK.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DModi%26aufirst%3DS.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DAdvances%2520in%2520the%2520clinical%2520development%2520of%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520in%2520cancers%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D742%26epage%3D755%26doi%3D10.1016%2Fj.bbamcr.2011.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Shimamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carretero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgman, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4973</span><span class="NLM_x">–</span> <span class="NLM_lpage">4985</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-11-2967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1158%2F1078-0432.CCR-11-2967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22806877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=4973-4985&author=T.+Shimamuraauthor=S.+A.+Pereraauthor=K.+P.+Foleyauthor=J.+Sangauthor=S.+J.+Rodigauthor=T.+Inoueauthor=L.+Chenauthor=D.+Liauthor=J.+Carreteroauthor=Y.+C.+Liauthor=P.+Sinhaauthor=C.+D.+Careyauthor=C.+L.+Borgmanauthor=J.+P.+Jimenezauthor=M.+Meyersonauthor=W.+Yingauthor=J.+Barsoumauthor=K.+K.+Wongauthor=G.+I.+Shapiro&title=Ganetespib+%28STA-9090%29%2C+a+nongeldanamycin+HSP90+inhibitor%2C+has+potent+antitumor+activity+in+in+vitro+and+in+vivo+models+of+non-small+cell+lung+cancer&doi=10.1158%2F1078-0432.CCR-11-2967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Shimamura, Takeshi; Perera, Samanthi A.; Foley, Kevin P.; Sang, Jim; Rodig, Scott J.; Inoue, Takayo; Chen, Liang; Li, Danan; Carretero, Julian; Li, Yu-Chen; Sinha, Papiya; Carey, Christopher D.; Borgman, Christa L.; Jimenez, John-Paul; Meyerson, Matthew; Ying, Weiwen; Barsoum, James; Wong, Kwok-Kin; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4973-4985</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We describe the anticancer activity of ganetespib, a novel non-geldanamycin heat shock protein 90 (HSP90) inhibitor, in non-small cell lung cancer (NSCLC) models.  Exptl. Design: The activity of ganetespib was compared with that of the geldanamycin 17-AAG in biochem. assays, cell lines, and xenografts, and evaluated in an ERBB2 YVMA-driven mouse lung adenocarcinoma model.  Results: Ganetespib blocked the ability of HSP90 to bind to biotinylated geldanamycin and disrupted the assocn. of HSP90 with its cochaperone, p23, more potently than 17-AAG.  In genomically defined NSCLC cell lines, ganetespib caused depletion of receptor tyrosine kinases, extinguishing of downstream signaling, inhibition of proliferation and induction of apoptosis with IC50 values ranging 2 to 30 nmol/L, substantially lower than those required for 17-AAG (20-3,500 nmol/L).  Ganetespib was also approx. 20-fold more potent in isogenic Ba/F3 pro-B cells rendered IL-3 independent by expression of EGFR and ERBB2 mutants.  In mice bearing NCI-H1975 (EGFR L858R/T790M) xenografts, ganetespib was rapidly eliminated from plasma and normal tissues but was maintained in tumor with t1/2 58.3 h, supporting once-weekly dosing expts., in which ganetespib produced greater tumor growth inhibition than 17-AAG.  However, after a single dose, reexpression of mutant EGFR occurred by 72 h, correlating with reversal of antiproliferative and proapoptotic effects.  Consecutive day dosing resulted in xenograft regressions, accompanied by more sustained pharmacodynamic effects.  Ganetespib also showed activity against mouse lung adenocarcinomas driven by oncogenic ERBB2 YVMA.  Conclusions: Ganetespib has greater potency than 17-AAG and potential efficacy against several NSCLC subsets, including those harboring EGFR or ERBB2 mutation.  Clin Cancer Res; 18(18); 4973-85. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoOaAHBIqU6bVg90H21EOLACvtfcHk0ljPXBk_PNc3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lt7zJ&md5=92bb99dd7de0f7d4fc4f1d1a897605ea</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2967%26sid%3Dliteratum%253Aachs%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DPerera%26aufirst%3DS.%2BA.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCarretero%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%2BC.%26aulast%3DSinha%26aufirst%3DP.%26aulast%3DCarey%26aufirst%3DC.%2BD.%26aulast%3DBorgman%26aufirst%3DC.%2BL.%26aulast%3DJimenez%26aufirst%3DJ.%2BP.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DGanetespib%2520%2528STA-9090%2529%252C%2520a%2520nongeldanamycin%2520HSP90%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520activity%2520in%2520in%2520vitro%2520and%2520in%2520vivo%2520models%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D4973%26epage%3D4985%26doi%3D10.1158%2F1078-0432.CCR-11-2967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Garon, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamidi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dering, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamranpour, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosmer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avsar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubinett, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slamon, D. J.</span><span> </span><span class="NLM_article-title">The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">900</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1158%2F1535-7163.MCT-12-0998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23493311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVOksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=890-900&author=E.+B.+Garonauthor=R.+S.+Finnauthor=H.+Hamidiauthor=J.+Deringauthor=S.+Pittsauthor=N.+Kamranpourauthor=A.+J.+Desaiauthor=W.+Hosmerauthor=S.+Ideauthor=E.+Avsarauthor=M.+R.+Jensenauthor=C.+Quadtauthor=M.+Liuauthor=S.+M.+Dubinettauthor=D.+J.+Slamon&title=The+HSP90+inhibitor+NVP-AUY922+potently+inhibits+non-small+cell+lung+cancer+growth&doi=10.1158%2F1535-7163.MCT-12-0998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 Inhibitor NVP-AUY922 Potently Inhibits Non-Small Cell Lung Cancer Growth</span></div><div class="casAuthors">Garon, Edward B.; Finn, Richard S.; Hamidi, Habib; Dering, Judy; Pitts, Sharon; Kamranpour, Naeimeh; Desai, Amrita J.; Hosmer, Wylie; Ide, Susan; Avsar, Emin; Jensen, Michael Rugaard; Quadt, Cornelia; Liu, Manway; Dubinett, Steven M.; Slamon, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">890-900</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Heat shock protein 90 (HSP90) is involved in protein folding and functions as a chaperone for numerous client proteins, many of which are important in non-small cell lung cancer (NSCLC) pathogenesis.  We sought to define preclin. effects of the HSP90 inhibitor NVP-AUY922 and identify predictors of response.  We assessed in vitro effects of NVP-AUY922 on proliferation and protein expression in NSCLC cell lines.  We evaluated gene expression changes induced by NVP-AUY922 exposure.  Xenograft models were evaluated for tumor control and biol. effects.  NVP-AUY922 potently inhibited in vitro growth in all 41 NSCLC cell lines evaluated with IC50 < 100 nmol/L.  IC100 (complete inhibition of proliferation) < 40 nmol/L was seen in 36 of 41 lines.  Consistent gene expression changes after NVP-AUY922 exposure involved a wide range of cellular functions, including consistently decreased dihydrofolate reductase after exposure.  NVP-AUY922 slowed growth of A549 (KRAS-mutant) xenografts and achieved tumor stability and decreased EGF receptor (EGFR) protein expression in H1975 xenografts, a model harboring a sensitizing and a resistance mutation for EGFR-tyrosine kinase inhibitors in the EGFR gene.  These data will help inform the evaluation of correlative data from a recently completed phase II NSCLC trial and a planned phase IB trial of NVP-AUY922 in combination with pemetrexed in NSCLCs.  Mol Cancer Ther; 12(6); 890-900. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD4i0xZ06HFrVg90H21EOLACvtfcHk0ljPXBk_PNc3Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVOksrs%253D&md5=e330c791147c502855816d4926273315</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0998%26sid%3Dliteratum%253Aachs%26aulast%3DGaron%26aufirst%3DE.%2BB.%26aulast%3DFinn%26aufirst%3DR.%2BS.%26aulast%3DHamidi%26aufirst%3DH.%26aulast%3DDering%26aufirst%3DJ.%26aulast%3DPitts%26aufirst%3DS.%26aulast%3DKamranpour%26aufirst%3DN.%26aulast%3DDesai%26aufirst%3DA.%2BJ.%26aulast%3DHosmer%26aufirst%3DW.%26aulast%3DIde%26aufirst%3DS.%26aulast%3DAvsar%26aufirst%3DE.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DQuadt%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DDubinett%26aufirst%3DS.%2BM.%26aulast%3DSlamon%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520HSP90%2520inhibitor%2520NVP-AUY922%2520potently%2520inhibits%2520non-small%2520cell%2520lung%2520cancer%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D890%26epage%3D900%26doi%3D10.1158%2F1535-7163.MCT-12-0998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskew, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vielhauer, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">The hERG channel is dependent upon the Hsp90α isoform for maturation and trafficking</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span><span class="refDoi"> DOI: 10.1021/mp300138n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300138n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsVWns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=1841-1846&author=L.+B.+Petersonauthor=J.+D.+Eskewauthor=G.+A.+Vielhauerauthor=B.+S.+Blagg&title=The+hERG+channel+is+dependent+upon+the+Hsp90%CE%B1+isoform+for+maturation+and+trafficking&doi=10.1021%2Fmp300138n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The hERG Channel Is Dependent upon the Hsp90α Isoform for Maturation and Trafficking</span></div><div class="casAuthors">Peterson, Laura B.; Eskew, Jeffrey D.; Vielhauer, George A.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1841-1846</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) has emerged as a promising therapeutic target for the treatment of cancer.  Several Hsp90 inhibitors have entered clin. trials.  However, some toxicol. detriments have arisen, such as cardiotoxicity resulting from hERG inhibition following the administration of Hsp90 inhibitors.  We sought to investigate this toxicity as hERG has been previously reported as a client protein that depends upon Hsp90 for its maturation and functional trafficking.  In this study we show that hERG depends upon a single Hsp90 isoform. hERG preferentially co-immunopptd. with Hsp90α, and genetic knockdown of Hsp90α, but not Hsp90β, resulted in a trafficking-defective hERG channel.  This study demonstrates the importance of delineating the isoform dependence of Hsp90 client proteins and provides rationale for the design of isoform-selective Hsp90 inhibitors that avoid detrimental effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5BFhqGrKjIbVg90H21EOLACvtfcHk0ljAjQE0xBg63Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsVWns7k%253D&md5=910dfb5e4a9150f408d5756ab881e492</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fmp300138n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300138n%26sid%3Dliteratum%253Aachs%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DEskew%26aufirst%3DJ.%2BD.%26aulast%3DVielhauer%26aufirst%3DG.%2BA.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DThe%2520hERG%2520channel%2520is%2520dependent%2520upon%2520the%2520Hsp90%25CE%25B1%2520isoform%2520for%2520maturation%2520and%2520trafficking%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D1841%26epage%3D1846%26doi%3D10.1021%2Fmp300138n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piel, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruford, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, A.</span><span> </span><span class="NLM_article-title">The HSP90 family of genes in the human genome: insights into their divergence and evolution</span> <span class="citation_source-journal">Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span><span class="refDoi"> DOI: 10.1016/j.ygeno.2005.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.ygeno.2005.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=16269234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12jurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2005&pages=627-637&author=B.+Chenauthor=W.+H.+Pielauthor=L.+Guiauthor=E.+Brufordauthor=A.+Monteiro&title=The+HSP90+family+of+genes+in+the+human+genome%3A+insights+into+their+divergence+and+evolution&doi=10.1016%2Fj.ygeno.2005.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The HSP90 family of genes in the human genome: Insights into their divergence and evolution</span></div><div class="casAuthors">Chen, Bin; Piel, William H.; Gui, Liming; Bruford, Elspeth; Monteiro, Antonia</div><div class="citationInfo"><span class="NLM_cas:title">Genomics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">627-637</span>CODEN:
                <span class="NLM_cas:coden">GNMCEP</span>;
        ISSN:<span class="NLM_cas:issn">0888-7543</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">HSP90 proteins are important mol. chaperones.  Transcriptome and genome analyses revealed that the human HSP90 family includes 17 genes that fall into four classes.  A standardized nomenclature for each of these genes is presented here.  Classes HSP90AA, HSP90AB, HSP90B, and TRAP contain 7, 6, 3, and 1 genes, resp.  HSP90AA genes mapped onto chromosomes 1, 3, 4, and 11; HSP90AB genes mapped onto 3, 4, 6, 13 and 15; HSP90B genes mapped onto 1, 12, and 15; and the TRAP1 gene mapped onto 16.  Six genes, HSP90AA1, HSP90AA2, HSP90N, HSP90AB1, HSP90B1 and TRAP1, were recognized as functional, and the remaining 11 genes were considered putative pseudogenes.  Amino acid polymorphic variants were detected for genes HSP90AA1, HSP90AA2, HSP90AB1, HSP90B1, and TRAP1.  The structures of these genes and the functional motifs and polymorphic variants of their proteins were documented and the features and functions of their proteins were discussed.  Phylogenetic analyses based on both nucleotide and protein data demonstrated that HSP90(AA + AB + B) formed a monophyletic clade, whereas TRAP is a relatively distant paralogue of this clade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWj0BC1lItPLVg90H21EOLACvtfcHk0ljAjQE0xBg63Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12jurvN&md5=ce235856d3bc4abf368fecdb5de9ba46</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ygeno.2005.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ygeno.2005.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPiel%26aufirst%3DW.%2BH.%26aulast%3DGui%26aufirst%3DL.%26aulast%3DBruford%26aufirst%3DE.%26aulast%3DMonteiro%26aufirst%3DA.%26atitle%3DThe%2520HSP90%2520family%2520of%2520genes%2520in%2520the%2520human%2520genome%253A%2520insights%2520into%2520their%2520divergence%2520and%2520evolution%26jtitle%3DGenomics%26date%3D2005%26volume%3D86%26spage%3D627%26epage%3D637%26doi%3D10.1016%2Fj.ygeno.2005.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uddin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6803</span><span class="NLM_x">–</span> <span class="NLM_lpage">6818</span><span class="refDoi"> DOI: 10.1021/jm400619b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400619b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlWltbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6803-6818&author=T.+Taldoneauthor=P.+D.+Patelauthor=M.+Patelauthor=H.+J.+Patelauthor=C.+E.+Evansauthor=A.+Rodinaauthor=S.+Ochianaauthor=S.+K.+Shahauthor=M.+Uddinauthor=D.+Gewirthauthor=G.+Chiosis&title=Experimental+and+structural+testing+module+to+analyze+paralogue-specificity+and+affinity+in+the+Hsp90+inhibitors+series&doi=10.1021%2Fjm400619b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and Structural Testing Module to Analyze Paralogue-Specificity and Affinity in the Hsp90 Inhibitors Series</span></div><div class="casAuthors">Taldone, Tony; Patel, Pallav D.; Patel, Maulik; Patel, Hardik J.; Evans, Christopher E.; Rodina, Anna; Ochiana, Stefan; Shah, Smit K.; Uddin, Mohammad; Gewirth, Daniel; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6803-6818</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We here describe the first reported comprehensive anal. of Hsp90 paralogue affinity and selectivity in the clin. Hsp90 inhibitor chemotypes.  This has been possible through the development of a versatile exptl. assay based on a new FP-probe that we both describe here.  The assay can test rapidly and accurately the binding affinity of all major Hsp90 chemotypes and has a testing range that spans low nanomolar to millimolar binding affinities.  We couple this assay with a computational anal. that allows for rationalization of paralogue selectivity and defines not only the major binding modes that relay pan-paralogue binding or, conversely, paralogue selectivity, but also identifies mol. characteristics that impart such features.  The methods developed here provide a blueprint for parsing out the contribution of the four Hsp90 paralogues to the perceived biol. activity with the current Hsp90 chemotypes and set the ground for the development of paralogue selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgOst3-n58BrVg90H21EOLACvtfcHk0ljAjQE0xBg63Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlWltbvM&md5=bda49f7f2f61553e344b100d5d6949dd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm400619b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400619b%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DEvans%26aufirst%3DC.%2BE.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DOchiana%26aufirst%3DS.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DUddin%26aufirst%3DM.%26aulast%3DGewirth%26aufirst%3DD.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DExperimental%2520and%2520structural%2520testing%2520module%2520to%2520analyze%2520paralogue-specificity%2520and%2520affinity%2520in%2520the%2520Hsp90%2520inhibitors%2520series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6803%26epage%3D6818%26doi%3D10.1021%2Fjm400619b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Song, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbar, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donner, D. B.</span><span> </span><span class="NLM_article-title">Identification of a protein with homology to Hsp90 that binds the type 1 tumor necrosis factor receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">3574</span><span class="NLM_x">–</span> <span class="NLM_lpage">3581</span><span class="refDoi"> DOI: 10.1074/jbc.270.8.3574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.270.8.3574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=7876093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADyaK2MXjvVyrsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=3574-3581&author=H.+Y.+Songauthor=J.+D.+Dunbarauthor=Y.+X.+Zhangauthor=D.+Guoauthor=D.+B.+Donner&title=Identification+of+a+protein+with+homology+to+Hsp90+that+binds+the+type+1+tumor+necrosis+factor+receptor&doi=10.1074%2Fjbc.270.8.3574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor</span></div><div class="casAuthors">Song, Ho Yeong; Dunbar, James D.; Zhang, Yuan Xin; Guo, Danqun; Donner, David B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">270</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3574-81</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The yeast-based two hybrid has been used to identify a novel protein that binds to the intracellular domain of the type 1 receptor for tumor necrosis factor (TNFR-1IC).  The TNF receptor-assocd. protein, TRAP-1, shows strong homol. to members of the 90-kDa family of heat shock proteins.  After in vitro transcription/translation and 35S labeling, TRAP-1 was pptd. using a fusion protein consisting of glutathione S-transferase and TNFR-1IC, showing that the two proteins directly interact.  The ability of deletion mutants of TNFR-1 to interact with TRAP-1 was tested using the two hybrid system.  This showed that the amino acid sequences that mediate binding are diffusely distributed outside of the domain in the C terminus of TNFR-1IC that signals cytotoxicity.  The 2.4-kilobase TRAP-1 mRNA was variably expressed in skeletal muscle, liver, heart, brain, kidney, pancreas, lung, and placenta.  TRAP-1 mRNA was also detected in each of eight different transformed cell lines.  Identification of TRAP-1 may be an important step toward defining how TNFR-1, which does not contain protein kinase activity, transmits its message to signal transduction pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMKs-XwrfD0rVg90H21EOLACvtfcHk0lip8tQam5s46g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvVyrsro%253D&md5=7cf51fbc1c210b58ea195dd150b62533</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.8.3574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.8.3574%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%2BY.%26aulast%3DDunbar%26aufirst%3DJ.%2BD.%26aulast%3DZhang%26aufirst%3DY.%2BX.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DDonner%26aufirst%3DD.%2BB.%26atitle%3DIdentification%2520of%2520a%2520protein%2520with%2520homology%2520to%2520Hsp90%2520that%2520binds%2520the%2520type%25201%2520tumor%2520necrosis%2520factor%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D3574%26epage%3D3581%26doi%3D10.1074%2Fjbc.270.8.3574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lee, A. S.</span><span> </span><span class="NLM_article-title">Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span><span class="refDoi"> DOI: 10.1038/nrc3701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1038%2Fnrc3701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=24658275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslCqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=263-276&author=A.+S.+Lee&title=Glucose-regulated+proteins+in+cancer%3A+molecular+mechanisms+and+therapeutic+potential&doi=10.1038%2Fnrc3701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential</span></div><div class="casAuthors">Lee, Amy S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">263-276</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The glucose-regulated proteins (GRPs) are stress-inducible chaperones that mostly reside in the endoplasmic reticulum or the mitochondria.  Recent advances show that the GRPs have functions that are distinct from those of the related heat shock proteins, and they can be actively translocated to other cellular locations and assume novel functions that control signalling, proliferation, invasion, apoptosis, inflammation and immunity.  Mouse models further identified their specific roles in development, tumorigenesis, metastasis and angiogenesis.  This Review describes their discovery and regulation, as well as their biol. functions in cancer.  Promising agents that use or target the GRPs are being developed, and their efficacy as anticancer therapeutics is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozBF42yfN9I7Vg90H21EOLACvtfcHk0lip8tQam5s46g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslCqs7c%253D&md5=8a8539550b16c4ac0630114261b1302e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc3701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3701%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DA.%2BS.%26atitle%3DGlucose-regulated%2520proteins%2520in%2520cancer%253A%2520molecular%2520mechanisms%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D263%26epage%3D276%26doi%3D10.1038%2Fnrc3701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Stothert, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suntharalingam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span> </span><span class="NLM_article-title">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">6470</span><span class="NLM_x">–</span> <span class="NLM_lpage">6480</span><span class="refDoi"> DOI: 10.1093/hmg/ddu367</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1093%2Fhmg%2Fddu367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=25027323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=6470-6480&author=A.+R.+Stothertauthor=A.+Suntharalingamauthor=D.+J.+Huardauthor=S.+N.+Fontaineauthor=V.+M.+Crowleyauthor=S.+Mishraauthor=B.+S.+Blaggauthor=R.+L.+Liebermanauthor=C.+A.+Dickey&title=Exploiting+the+interaction+between+Grp94+and+aggregated+myocilin+to+treat+glaucoma&doi=10.1093%2Fhmg%2Fddu367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the interaction between Grp94 and aggregated myocilin to treat glaucoma</span></div><div class="casAuthors">Stothert, Andrew R.; Suntharalingam, Amirthaa; Huard, Dustin J. E.; Fontaine, Sarah N.; Crowley, Vincent M.; Mishra, Sanket; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6470-6480</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Gain-of-function mutations in the olfactomedin domain of the MYOC gene facilitate the toxic accumulation of amyloid-contg. myocilin aggregates, hastening the onset of the prevalent ocular disorder primary open-angle glaucoma.  Aggregation of wild-type myocilin has been reported in other glaucoma subtypes, suggesting broader relevance of misfolded myocilin across the disease spectrum, but the absence of myocilin does not cause disease.  Thus, strategies aimed at eliminating myocilin could be therapeutically relevant for glaucoma.  Here, a novel and selective Grp94 inhibitor reduced the levels of several mutant myocilin proteins as well as wild-type myocilin when forced to misfold in cells.  This inhibitor rescued mutant myocilin toxicity in primary human trabecular meshwork cells.  Mechanistically, in vitro kinetics studies demonstrate that Grp94 recognizes on-pathway aggregates of the myocilin olfactomedin domain (myoc-OLF), accelerates rates of aggregation and co-ppts. with myoc-OLF.  These results indicate that aberrant myocilin quaternary structure drives Grp94 recognition, rather than peptide motifs exposed by unfolded protein.  Inhibition of Grp94 ameliorates the effects of Grp94-accelerated myoc-OLF aggregation, and Grp94 remains in soln.  In cells, when wild-type myocilin is driven to misfold and aggregate, it becomes a client of Grp94 and sensitive to Grp94 inhibition.  Taken together, the interaction of Grp94 with myocilin aggregates can be manipulated by cellular environment and genetics; this process can be exploited with Grp94 inhibitors to promote the clearance of toxic forms of myocilin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeQYeK777kKLVg90H21EOLACvtfcHk0lip8tQam5s46g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitl2ntb8%253D&md5=cbabbce383403838a4cbc3ffe24bdce8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddu367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddu367%26sid%3Dliteratum%253Aachs%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DSuntharalingam%26aufirst%3DA.%26aulast%3DHuard%26aufirst%3DD.%2BJ.%26aulast%3DFontaine%26aufirst%3DS.%2BN.%26aulast%3DCrowley%26aufirst%3DV.%2BM.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DExploiting%2520the%2520interaction%2520between%2520Grp94%2520and%2520aggregated%2520myocilin%2520to%2520treat%2520glaucoma%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2014%26volume%3D23%26spage%3D6470%26epage%3D6480%26doi%3D10.1093%2Fhmg%2Fddu367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Soldano, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jivan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structure of the N-terminal domain of GRP94. Basis for ligand specificity and regulation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">48330</span><span class="NLM_x">–</span> <span class="NLM_lpage">48338</span><span class="refDoi"> DOI: 10.1074/jbc.M308661200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M308661200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=12970348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Gjt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=48330-48338&author=K.+L.+Soldanoauthor=A.+Jivanauthor=C.+V.+Nicchittaauthor=D.+T.+Gewirth&title=Structure+of+the+N-terminal+domain+of+GRP94.+Basis+for+ligand+specificity+and+regulation&doi=10.1074%2Fjbc.M308661200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the N-terminal Domain of GRP94: Basis for Ligand Specificity and Regulation</span></div><div class="casAuthors">Soldano, Karen L.; Jivan, Arif; Nicchitta, Christopher V.; Gewirth, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">48330-48338</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">GRP94, the endoplasmic reticulum (ER) paralog of the chaperone Hsp90, plays an essential role in the structural maturation or secretion of a subset of proteins destined for transport to the cell surface, such as the Toll-like receptors 2 and 4, and IgG, resp.  GRP94 differs from cytoplasmic Hsp90 by exhibiting very weak ATP binding and hydrolysis activity.  GRP94 also binds selectively to a series of substituted adenosine analogs.  The high resoln. crystal structures at 1.75-2.1 Å of the N-terminal and adjacent charged domains of GRP94 in complex with N-ethylcarboxamidoadenosine (NECA), radicicol, and 2-chlorodideoxyadenosine reveals a structural mechanism for ligand discrimination among hsp90 family members.  The structures also identify a putative subdomain that may act as a ligand-responsive switch.  The residues of the charged region fold into a disordered loop whose termini are ordered and continue the twisted beta sheet that forms the structural core of the N-domain.  This continuation of the beta sheet past the charged domain suggests a structural basis for the assocn. of the N-terminal and middle domains of the full-length chaperone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1SkIPU21-TLVg90H21EOLACvtfcHk0liHDgAbt6a3tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Gjt78%253D&md5=0d83c7ac820dbdab6faf940dd1052ad0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M308661200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M308661200%26sid%3Dliteratum%253Aachs%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DJivan%26aufirst%3DA.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructure%2520of%2520the%2520N-terminal%2520domain%2520of%2520GRP94.%2520Basis%2520for%2520ligand%2520specificity%2520and%2520regulation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D48330%26epage%3D48338%26doi%3D10.1074%2Fjbc.M308661200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Marzec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span> </span><span class="NLM_article-title">GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1823</span><span class="NLM_x">, </span> <span class="NLM_fpage">774</span><span class="NLM_x">–</span> <span class="NLM_lpage">787</span><span class="refDoi"> DOI: 10.1016/j.bbamcr.2011.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.bbamcr.2011.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22079671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1823&publication_year=2012&pages=774-787&author=M.+Marzecauthor=D.+Elettoauthor=Y.+Argon&title=GRP94%3A+An+HSP90-like+protein+specialized+for+protein+folding+and+quality+control+in+the+endoplasmic+reticulum&doi=10.1016%2Fj.bbamcr.2011.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum</span></div><div class="casAuthors">Marzec, Michal; Eletto, Davide; Argon, Yair</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1823</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">774-787</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glucose-regulated protein 94 is the HSP90-like protein in the lumen of the endoplasmic reticulum and therefore it chaperones secreted and membrane proteins.  It has essential functions in development and physiol. of multicellular organisms, at least in part because of this unique clientele.  GRP94 shares many biochem. features with other HSP90 proteins, in particular its domain structure and ATPase activity, but also displays distinct activities, such as calcium binding, necessitated by the conditions in the endoplasmic reticulum.  GRP94's mode of action varies from the general HSP90 theme in the conformational changes induced by nucleotide binding, and in its interactions with co-chaperones, which are very different from known cytosolic co-chaperones.  GRP94 is more selective than many of the ER chaperones and the basis for this selectivity remains obscure.  Recent development of mol. tools and functional assays has expanded the spectrum of clients that rely on GRP94 activity, but it is still not clear how the chaperone binds them, or what aspect of folding it impacts.  These mechanistic questions and the regulation of GRP94 activity by other proteins and by post-translational modification differences pose new questions and present future research avenues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnr8jU7cub5LVg90H21EOLACvtfcHk0liHDgAbt6a3tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSgt7g%253D&md5=421b27e4a82e34398366793c11147b99</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2011.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2011.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DMarzec%26aufirst%3DM.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DArgon%26aufirst%3DY.%26atitle%3DGRP94%253A%2520An%2520HSP90-like%2520protein%2520specialized%2520for%2520protein%2520folding%2520and%2520quality%2520control%2520in%2520the%2520endoplasmic%2520reticulum%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2012%26volume%3D1823%26spage%3D774%26epage%3D787%26doi%3D10.1016%2Fj.bbamcr.2011.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Stothert, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontaine, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickey, C. A.</span><span> </span><span class="NLM_article-title">Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma</span> <span class="citation_source-journal">Exp. Eye Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1016/j.exer.2015.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.exer.2015.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=26302411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFSitbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2016&pages=38-45&author=A.+R.+Stothertauthor=S.+N.+Fontaineauthor=J.+J.+Sabbaghauthor=C.+A.+Dickey&title=Targeting+the+ER-autophagy+system+in+the+trabecular+meshwork+to+treat+glaucoma&doi=10.1016%2Fj.exer.2015.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma</span></div><div class="casAuthors">Stothert, Andrew R.; Fontaine, Sarah N.; Sabbagh, Jonathan J.; Dickey, Chad A.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Eye Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38-45</span>CODEN:
                <span class="NLM_cas:coden">EXERA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A major drainage network involved in aq. humor dynamics is the conventional outflow pathway, which is gated by the trabecular meshwork (TM).  The TM acts as a mol. sieve, providing resistance to aq. outflow, which is responsible for regulating intraocular pressure (IOP).  If the TM is damaged, aq. outflow is impaired, IOP increases and glaucoma can manifest.  Mutations in the MYOC gene cause hereditary primary open-angle glaucoma (POAG) by promoting the abnormal amyloidosis of the myocilin protein in the endoplasmic reticulum (ER), leading to ER stress-induced TM cell death.  Myocilin accumulation is obsd. in approx. 70-80% of all glaucoma cases suggesting that environmental or other genetic factors may also promote myocilin toxicity.  For example, simply preventing myocilin glycosylation is sufficient to promote its abnormal accretion.  These myocilin amyloids are unique as there are no other known pathogenic proteins that accumulate within the ER of TM cells and cause toxicity.  Moreover, this pathogenic accumulation only kills TM cells, despite expression of this protein in other cell types, suggesting that another modifier exclusive to the TM participates in the proteotoxicity of myocilin.  ER autophagy (reticulophagy) is one of the pathways essential for myocilin clearance that can be impacted dramatically by aging and other environmental factors such as nutrition.  This review will discuss the link between myocilin and autophagy, evaluating the role of this degrdn. pathway in glaucoma as well as its potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ_Ml3J4Yt5LVg90H21EOLACvtfcHk0liHDgAbt6a3tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFSitbbO&md5=c51dc569be7d4b06624daf5f8abe8b30</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.exer.2015.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exer.2015.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DStothert%26aufirst%3DA.%2BR.%26aulast%3DFontaine%26aufirst%3DS.%2BN.%26aulast%3DSabbagh%26aufirst%3DJ.%2BJ.%26aulast%3DDickey%26aufirst%3DC.%2BA.%26atitle%3DTargeting%2520the%2520ER-autophagy%2520system%2520in%2520the%2520trabecular%2520meshwork%2520to%2520treat%2520glaucoma%26jtitle%3DExp.%2520Eye%2520Res.%26date%3D2016%26volume%3D144%26spage%3D38%26epage%3D45%26doi%3D10.1016%2Fj.exer.2015.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Weekes, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antrobus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simecek, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehner, P. J.</span><span> </span><span class="NLM_article-title">Proteomic plasma membrane profiling reveals an essential role for gp96 in the cell surface expression of LDLR family members, including the LDL receptor and LRP6</span> <span class="citation_source-journal">J. Proteome Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">–</span> <span class="NLM_lpage">1484</span><span class="refDoi"> DOI: 10.1021/pr201135e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr201135e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1475-1484&author=M.+P.+Weekesauthor=R.+Antrobusauthor=S.+Talbotauthor=S.+Horauthor=N.+Simecekauthor=D.+L.+Smithauthor=S.+Bloorauthor=F.+Randowauthor=P.+J.+Lehner&title=Proteomic+plasma+membrane+profiling+reveals+an+essential+role+for+gp96+in+the+cell+surface+expression+of+LDLR+family+members%2C+including+the+LDL+receptor+and+LRP6&doi=10.1021%2Fpr201135e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic Plasma Membrane Profiling Reveals an Essential Role for gp96 in the Cell Surface Expression of LDLR Family Members, Including the LDL Receptor and LRP6</span></div><div class="casAuthors">Weekes, Michael P.; Antrobus, Robin; Talbot, Suzanne; Hor, Simon; Simecek, Nikol; Smith, Duncan L.; Bloor, Stuart; Randow, Felix; Lehner, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1475-1484</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The endoplasmic reticulum chaperone gp96 is required for the cell surface expression of a narrow range of proteins, including toll-like receptors (TLRs) and integrins.  To identify a more comprehensive repertoire of proteins whose cell surface expression is dependent on gp96, the authors developed plasma membrane profiling (PMP), a technique that combines SILAC labeling with selective cell surface aminooxy-biotinylation.  This approach allowed the authors to compare the relative abundance of plasma membrane (PM) proteins on gp96-deficient vs. gp96-reconstituted murine pre-B cells.  Anal. of unfractionated tryptic peptides initially identified 113 PM proteins, which extended to 706 PM proteins using peptide prefractionation.  The authors confirmed a requirement for gp96 in the cell surface expression of certain TLRs and integrins and found a marked decrease in cell surface expression of four members of the extended LDL receptor family (LDLR, LRP6, Sorl1 and LRP8) in the absence of gp96.  Other novel gp96 client proteins included CD180/Ly86, important in the B-cell response to lipopolysaccharide.  The authors highlight common structural motifs in these client proteins that may be recognized by gp96, including the beta-propeller and leucine-rich repeat.  This study therefore identifies the extended LDL receptor family as an important new family of proteins whose cell surface expression is regulated by gp96.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyQkiMCW-Z07Vg90H21EOLACvtfcHk0lhtELbrJjVYsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGls7Y%253D&md5=8aa4227b76be5b35db6a0b73a9f16bf7</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fpr201135e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr201135e%26sid%3Dliteratum%253Aachs%26aulast%3DWeekes%26aufirst%3DM.%2BP.%26aulast%3DAntrobus%26aufirst%3DR.%26aulast%3DTalbot%26aufirst%3DS.%26aulast%3DHor%26aufirst%3DS.%26aulast%3DSimecek%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DBloor%26aufirst%3DS.%26aulast%3DRandow%26aufirst%3DF.%26aulast%3DLehner%26aufirst%3DP.%2BJ.%26atitle%3DProteomic%2520plasma%2520membrane%2520profiling%2520reveals%2520an%2520essential%2520role%2520for%2520gp96%2520in%2520the%2520cell%2520surface%2520expression%2520of%2520LDLR%2520family%2520members%252C%2520including%2520the%2520LDL%2520receptor%2520and%2520LRP6%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2012%26volume%3D11%26spage%3D1475%26epage%3D1484%26doi%3D10.1021%2Fpr201135e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidler, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Que, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephani, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">684</span><span class="refDoi"> DOI: 10.1038/nchembio.1335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1038%2Fnchembio.1335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=23995768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=677-684&author=P.+D.+Patelauthor=P.+Yanauthor=P.+M.+Seidlerauthor=H.+J.+Patelauthor=W.+Sunauthor=C.+Yangauthor=N.+S.+Queauthor=T.+Taldoneauthor=P.+Finottiauthor=R.+A.+Stephaniauthor=D.+T.+Gewirthauthor=G.+Chiosis&title=Paralog-selective+Hsp90+inhibitors+define+tumor-specific+regulation+of+HER2&doi=10.1038%2Fnchembio.1335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2</span></div><div class="casAuthors">Patel, Pallav D.; Yan, Pengrong; Seidler, Paul M.; Patel, Hardik J.; Sun, Weilin; Yang, Chenghua; Que, Nanette S.; Taldone, Tony; Finotti, Paola; Stephani, Ralph A.; Gewirth, Daniel T.; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">677-684</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although the Hsp90 chaperone family, comprised in humans of four paralogs, Hsp90α, Hsp90β, Grp94 and Trap-1, has important roles in malignancy, the contribution of each paralog to the cancer phenotype is poorly understood.  This is in large part because reagents to study paralog-specific functions in cancer cells have been unavailable.  Here the authors combine compd. library screening with structural and computational analyses to identify purine-based chem. tools that are specific for Hsp90 paralogs.  The authors show that Grp94 selectivity is due to the insertion of these compds. into a new allosteric pocket.  The authors use these tools to demonstrate that cancer cells use individual Hsp90 paralogs to regulate a client protein in a tumor-specific manner and in response to proteome alterations.  Finally, the authors provide new mechanistic evidence explaining why selective Grp94 inhibition is particularly efficacious in certain breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAIwIoA9btZLVg90H21EOLACvtfcHk0lhtELbrJjVYsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGltb7J&md5=8bdfb2c60b4171bbdd6046e455e413bb</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1335%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSeidler%26aufirst%3DP.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DQue%26aufirst%3DN.%2BS.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DStephani%26aufirst%3DR.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DParalog-selective%2520Hsp90%2520inhibitors%2520define%2520tumor-specific%2520regulation%2520of%2520HER2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D677%26epage%3D684%26doi%3D10.1038%2Fnchembio.1335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Patel, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiana, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tramentozzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolaender, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shrestha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finotti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3922</span><span class="NLM_x">–</span> <span class="NLM_lpage">3943</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3922-3943&author=H.+J.+Patelauthor=P.+D.+Patelauthor=S.+O.+Ochianaauthor=P.+Yanauthor=W.+Sunauthor=M.+R.+Patelauthor=S.+K.+Shahauthor=E.+Tramentozziauthor=J.+Brooksauthor=A.+Bolaenderauthor=L.+Shresthaauthor=R.+Stephaniauthor=P.+Finottiauthor=C.+Leiferauthor=Z.+Liauthor=D.+T.+Gewirthauthor=T.+Taldoneauthor=G.+Chiosis&title=Structure-activity+relationship+in+a+purine-scaffold+compound+series+with+selectivity+for+the+endoplasmic+reticulum+Hsp90+paralog+Grp94&doi=10.1021%2Facs.jmedchem.5b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship in a Purine-Scaffold Compound Series with Selectivity for the Endoplasmic Reticulum Hsp90 Paralog Grp94</span></div><div class="casAuthors">Patel, Hardik J.; Patel, Pallav D.; Ochiana, Stefan O.; Yan, Pengrong; Sun, Weilin; Patel, Maulik R.; Shah, Smit K.; Tramentozzi, Elisa; Brooks, James; Bolaender, Alexander; Shrestha, Liza; Stephani, Ralph; Finotti, Paola; Leifer, Cynthia; Li, Zihai; Gewirth, Daniel T.; Taldone, Tony; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3922-3943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Grp94 is involved in the regulation of a restricted no. of proteins and represents a potential target in a host of diseases, including cancer, septic shock, autoimmune diseases, chronic inflammatory conditions, diabetes, coronary thrombosis, and stroke.  The authors have recently identified a novel allosteric pocket located in the Grp94 N-terminal binding site that can be used to design ligands with a 2-log selectivity over the other Hsp90 paralogs.  Here the authors perform extensive SAR investigations in this ligand series and rationalize the affinity and paralog selectivity of choice derivs. by mol. modeling.  The authors then use this to design I, a deriv. with good potency for Grp94 (IC50 = 0.22 μM) and selectivity over other paralogs (>100- and 33-fold for Hsp90α/β and Trap-1, resp.).  The paralog selectivity and target-mediated activity of I was confirmed in cells through several functional readouts.  Compd. I was also inert when tested against a large panel of kinases.  The authors show that I has biol. activity in several cellular models of inflammation and cancer and also present here for the first time the in vivo profile of a Grp94 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-3SSMDJ2Ti7Vg90H21EOLACvtfcHk0ljw_Ss6RV14Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWnsbg%253D&md5=4c341cedaf3aa4d08afa43cbca301717</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00197%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DH.%2BJ.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DOchiana%26aufirst%3DS.%2BO.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DPatel%26aufirst%3DM.%2BR.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DTramentozzi%26aufirst%3DE.%26aulast%3DBrooks%26aufirst%3DJ.%26aulast%3DBolaender%26aufirst%3DA.%26aulast%3DShrestha%26aufirst%3DL.%26aulast%3DStephani%26aufirst%3DR.%26aulast%3DFinotti%26aufirst%3DP.%26aulast%3DLeifer%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DStructure-activity%2520relationship%2520in%2520a%2520purine-scaffold%2520compound%2520series%2520with%2520selectivity%2520for%2520the%2520endoplasmic%2520reticulum%2520Hsp90%2520paralog%2520Grp94%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3922%26epage%3D3943%26doi%3D10.1021%2Facs.jmedchem.5b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Duerfeldt, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maynard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eletto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrovsky, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinogle, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Development of a Grp94 inhibitor</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">9796</span><span class="NLM_x">–</span> <span class="NLM_lpage">9804</span><span class="refDoi"> DOI: 10.1021/ja303477g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303477g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=9796-9804&author=A.+S.+Duerfeldtauthor=L.+B.+Petersonauthor=J.+C.+Maynardauthor=C.+L.+Ngauthor=D.+Elettoauthor=O.+Ostrovskyauthor=H.+E.+Shinogleauthor=D.+S.+Mooreauthor=Y.+Argonauthor=C.+V.+Nicchittaauthor=B.+S.+Blagg&title=Development+of+a+Grp94+inhibitor&doi=10.1021%2Fja303477g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Grp94 inhibitor</span></div><div class="casAuthors">Duerfeldt, Adam S.; Peterson, Laura B.; Maynard, Jason C.; Ng, Chun Leung; Eletto, Davide; Ostrovsky, Olga; Shinogle, Heather E.; Moore, David S.; Argon, Yair; Nicchitta, Christopher V.; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9796-9804</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) represents a promising therapeutic target for the treatment of cancer and other diseases.  Unfortunately, results from clin. trials have been disappointing as off-target effects and toxicities have been obsd.  These detriments may be a consequence of pan-Hsp90 inhibition, as all clin. evaluated Hsp90 inhibitors simultaneously disrupt all four human Hsp90 isoforms.  Using a structure-based approach, we designed an inhibitor of Grp94, the ER-resident Hsp90.  The effect manifested by compd. (I) on several Grp94 and Hsp90α/β (cytosolic isoforms) clients were investigated.  Compd. I prevented intracellular trafficking of the Toll receptor, inhibited the secretion of IGF-II, affected the conformation of Grp94, and suppressed Drosophila larval growth, all Grp94-dependent processes.  In contrast, compd. I had no effect on cell viability or cytosolic Hsp90α/β client proteins at similar concns.  The design, synthesis, and evaluation of I are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoayCAvZU_mzrVg90H21EOLACvtfcHk0ljw_Ss6RV14Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslGqsLw%253D&md5=00c0b3f15f2cfd04658225c8a6fb708d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja303477g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303477g%26sid%3Dliteratum%253Aachs%26aulast%3DDuerfeldt%26aufirst%3DA.%2BS.%26aulast%3DPeterson%26aufirst%3DL.%2BB.%26aulast%3DMaynard%26aufirst%3DJ.%2BC.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DEletto%26aufirst%3DD.%26aulast%3DOstrovsky%26aufirst%3DO.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DMoore%26aufirst%3DD.%2BS.%26aulast%3DArgon%26aufirst%3DY.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520Grp94%2520inhibitor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D9796%26epage%3D9804%26doi%3D10.1021%2Fja303477g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Muth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khandelwal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Development of radamide analogs as Grp94 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4083</span><span class="NLM_x">–</span> <span class="NLM_lpage">4098</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.05.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.bmc.2014.05.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=25027801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFGru7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4083-4098&author=A.+Muthauthor=V.+Crowleyauthor=A.+Khandelwalauthor=S.+Mishraauthor=J.+Zhaoauthor=J.+Hallauthor=B.+S.+Blagg&title=Development+of+radamide+analogs+as+Grp94+inhibitors&doi=10.1016%2Fj.bmc.2014.05.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Development of radamide analogs as Grp94 inhibitors</span></div><div class="casAuthors">Muth, Aaron; Crowley, Vincent; Khandelwal, Anuj; Mishra, Sanket; Zhao, Jinbo; Hall, Jessica; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4083-4098</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hsp90 isoform-selective inhibition is highly desired as it can potentially avoid the toxic side-effects of pan-inhibition.  The current study developed selective inhibitors of one such isoform, Grp94, predicated on the chimeric and pan-Hsp90 inhibitor, radamide (RDA).  Replacement of the quinone moiety of RDA with a Ph ring (2) was found to be better suited for Grp94 inhibition as it can fully interact with a unique hydrophobic pocket present in Grp94.  An extensive SAR for this scaffold showed that substitutions at the 2- and 4-positions (8 and 27, resp.) manifested excellent Grp94 affinity and selectivity.  Introduction of heteroatoms into the ring also proved beneficial, with a 2-pyridine deriv. (38) exhibiting the highest Grp94 affinity (Kd = 820 nM).  Subsequent cell-based assays showed that these Grp94 inhibitors inhibit migration of the metastatic breast cancer cell line, MDA-MB-231, as well as exhibit an anti-proliferative affect against the multiple myeloma cell line, RPMI 8226.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxdbHibsHh3rVg90H21EOLACvtfcHk0ljw_Ss6RV14Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFGru7bK&md5=6025c533f1c107eb5c54a559c679c8d2</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.05.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.05.075%26sid%3Dliteratum%253Aachs%26aulast%3DMuth%26aufirst%3DA.%26aulast%3DCrowley%26aufirst%3DV.%26aulast%3DKhandelwal%26aufirst%3DA.%26aulast%3DMishra%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDevelopment%2520of%2520radamide%2520analogs%2520as%2520Grp94%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4083%26epage%3D4098%26doi%3D10.1016%2Fj.bmc.2014.05.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Rosser, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span> </span><span class="NLM_article-title">Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. I. Evidence for allosteric regulation of ligand binding</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">22798</span><span class="NLM_x">–</span> <span class="NLM_lpage">22805</span><span class="refDoi"> DOI: 10.1074/jbc.M001477200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M001477200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22798-22805&author=M.+F.+Rosserauthor=C.+V.+Nicchitta&title=Ligand+interactions+in+the+adenosine+nucleotide-binding+domain+of+the+Hsp90+chaperone%2C+GRP94.+I.+Evidence+for+allosteric+regulation+of+ligand+binding&doi=10.1074%2Fjbc.M001477200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001477200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001477200%26sid%3Dliteratum%253Aachs%26aulast%3DRosser%26aufirst%3DM.%2BF.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26atitle%3DLigand%2520interactions%2520in%2520the%2520adenosine%2520nucleotide-binding%2520domain%2520of%2520the%2520Hsp90%2520chaperone%252C%2520GRP94.%2520I.%2520Evidence%2520for%2520allosteric%2520regulation%2520of%2520ligand%2520binding%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22798%26epage%3D22805%26doi%3D10.1074%2Fjbc.M001477200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soldano, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Ligand-induced conformational shift in the N-terminal domain of GRP94, an Hsp90 chaperone</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">46162</span><span class="NLM_x">–</span> <span class="NLM_lpage">46171</span><span class="refDoi"> DOI: 10.1074/jbc.M405253200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M405253200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=46162-46171&author=R.+M.+Immorminoauthor=D.+E.+Dollinsauthor=P.+L.+Shafferauthor=K.+L.+Soldanoauthor=M.+A.+Walkerauthor=D.+T.+Gewirth&title=Ligand-induced+conformational+shift+in+the+N-terminal+domain+of+GRP94%2C+an+Hsp90+chaperone&doi=10.1074%2Fjbc.M405253200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M405253200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M405253200%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DP.%2BL.%26aulast%3DSoldano%26aufirst%3DK.%2BL.%26aulast%3DWalker%26aufirst%3DM.%2BA.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DLigand-induced%2520conformational%2520shift%2520in%2520the%2520N-terminal%2520domain%2520of%2520GRP94%252C%2520an%2520Hsp90%2520chaperone%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D46162%26epage%3D46171%26doi%3D10.1074%2Fjbc.M405253200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wassenberg, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicchitta, C. V.</span><span> </span><span class="NLM_article-title">Ligand interactions in the adenosine nucleotide-binding domain of the Hsp90 chaperone, GRP94. II. Ligand-mediated activation of GRP94 molecular chaperone and peptide binding activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">22806</span><span class="NLM_x">–</span> <span class="NLM_lpage">22814</span><span class="refDoi"> DOI: 10.1074/jbc.M001476200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M001476200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22806-22814&author=J.+J.+Wassenbergauthor=R.+C.+Reedauthor=C.+V.+Nicchitta&title=Ligand+interactions+in+the+adenosine+nucleotide-binding+domain+of+the+Hsp90+chaperone%2C+GRP94.+II.+Ligand-mediated+activation+of+GRP94+molecular+chaperone+and+peptide+binding+activity&doi=10.1074%2Fjbc.M001476200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001476200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001476200%26sid%3Dliteratum%253Aachs%26aulast%3DWassenberg%26aufirst%3DJ.%2BJ.%26aulast%3DReed%26aufirst%3DR.%2BC.%26aulast%3DNicchitta%26aufirst%3DC.%2BV.%26atitle%3DLigand%2520interactions%2520in%2520the%2520adenosine%2520nucleotide-binding%2520domain%2520of%2520the%2520Hsp90%2520chaperone%252C%2520GRP94.%2520II.%2520Ligand-mediated%2520activation%2520of%2520GRP94%2520molecular%2520chaperone%2520and%2520peptide%2520binding%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22806%26epage%3D22814%26doi%3D10.1074%2Fjbc.M001476200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, L. E.,  IV</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1042</span><span class="refDoi"> DOI: 10.1016/j.jmb.2009.03.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.jmb.2009.03.071" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2009&pages=1033-1042&author=R.+M.+Immorminoauthor=L.+E.+Metzgerauthor=P.+N.+Reardonauthor=D.+E.+Dollinsauthor=B.+S.+Blaggauthor=D.+T.+Gewirth&title=Different+poses+for+ligand+and+chaperone+in+inhibitor-bound+Hsp90+and+GRP94%3A+implications+for+paralog-specific+drug+design&doi=10.1016%2Fj.jmb.2009.03.071"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.03.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.03.071%26sid%3Dliteratum%253Aachs%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DMetzger%26aufirst%3DL.%2BE.%26aulast%3DReardon%26aufirst%3DP.%2BN.%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DDifferent%2520poses%2520for%2520ligand%2520and%2520chaperone%2520in%2520inhibitor-bound%2520Hsp90%2520and%2520GRP94%253A%2520implications%2520for%2520paralog-specific%2520drug%2520design%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D388%26spage%3D1033%26epage%3D1042%26doi%3D10.1016%2Fj.jmb.2009.03.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Park, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morieux, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salome, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotten, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reamtong, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stables, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, H.</span><span> </span><span class="NLM_article-title">Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6897</span><span class="NLM_x">–</span> <span class="NLM_lpage">6911</span><span class="refDoi"> DOI: 10.1021/jm9012054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9012054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6897-6911&author=K.+D.+Parkauthor=P.+Morieuxauthor=C.+Salomeauthor=S.+W.+Cottenauthor=O.+Reamtongauthor=C.+Eyersauthor=S.+J.+Gaskellauthor=J.+P.+Stablesauthor=R.+Liuauthor=H.+Kohn&title=Lacosamide+isothiocyanate-based+agents%3A+novel+agents+to+target+and+identify+lacosamide+receptors&doi=10.1021%2Fjm9012054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm9012054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9012054%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BD.%26aulast%3DMorieux%26aufirst%3DP.%26aulast%3DSalome%26aufirst%3DC.%26aulast%3DCotten%26aufirst%3DS.%2BW.%26aulast%3DReamtong%26aufirst%3DO.%26aulast%3DEyers%26aufirst%3DC.%26aulast%3DGaskell%26aufirst%3DS.%2BJ.%26aulast%3DStables%26aufirst%3DJ.%2BP.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DKohn%26aufirst%3DH.%26atitle%3DLacosamide%2520isothiocyanate-based%2520agents%253A%2520novel%2520agents%2520to%2520target%2520and%2520identify%2520lacosamide%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6897%26epage%3D6911%26doi%3D10.1021%2Fjm9012054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Clevenger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of a radicicol and geldanamycin chimera, radamide</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4459</span><span class="NLM_x">–</span> <span class="NLM_lpage">4462</span><span class="refDoi"> DOI: 10.1021/ol048266o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol048266o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4459-4462&author=R.+C.+Clevengerauthor=B.+S.+Blagg&title=Design%2C+synthesis%2C+and+evaluation+of+a+radicicol+and+geldanamycin+chimera%2C+radamide&doi=10.1021%2Fol048266o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fol048266o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol048266o%26sid%3Dliteratum%253Aachs%26aulast%3DClevenger%26aufirst%3DR.%2BC.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520a%2520radicicol%2520and%2520geldanamycin%2520chimera%252C%2520radamide%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4459%26epage%3D4462%26doi%3D10.1021%2Fol048266o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hadden, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">4697</span><span class="NLM_x">–</span> <span class="NLM_lpage">4704</span><span class="refDoi"> DOI: 10.1021/jo900278g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo900278g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=4697-4704&author=M.+K.+Haddenauthor=B.+S.+Blagg&title=Synthesis+and+evaluation+of+radamide+analogues%2C+a+chimera+of+radicicol+and+geldanamycin&doi=10.1021%2Fjo900278g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of radamide analogues, a chimera of radicicol and geldanamycin</span></div><div class="casAuthors">Hadden, M. Kyle; Blagg, Brian S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4697-4704</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Previously, we reported the Hsp90 inhibitory activity of radamide, an open chain amide chimera of geldanamycin and radicicol.  Attempts to further expand upon structure-activity relationships for this class of Hsp90 inhibitors led to the prepn. of a series of radamide analogs focused on differing tether lengths and quinone mimics.  In addn., the cup-shaped conformation adopted by the two natural products when bound to the Hsp90 N-terminal ATP binding pocket suggests that conformationally biased compds. may demonstrate improved binding and inhibition.  The prepn. and evaluation of radamide analogs with cis/trans α,β-unsatd. amides yielded compds. that exhibit improved antiproliferative activity.  In addn., several analogs demonstrated the ability to induce degrdn. of Hsp90-dependent oncogenic signaling proteins in vitro, a hallmark of Hsp90 N-terminal inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolUb0gnS13ebVg90H21EOLACvtfcHk0lgkPyYzHELJKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtLo%253D&md5=ab0a5d5a5822af962943b761fa2c14ab</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo900278g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900278g%26sid%3Dliteratum%253Aachs%26aulast%3DHadden%26aufirst%3DM.%2BK.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520radamide%2520analogues%252C%2520a%2520chimera%2520of%2520radicicol%2520and%2520geldanamycin%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D4697%26epage%3D4704%26doi%3D10.1021%2Fjo900278g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Luo, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carman, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Structural basis of integrin regulation and signaling</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span><span class="refDoi"> DOI: 10.1146/annurev.immunol.25.022106.141618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1146%2Fannurev.immunol.25.022106.141618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=17201681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlansrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=619-647&author=B.+H.+Luoauthor=C.+V.+Carmanauthor=T.+A.+Springer&title=Structural+basis+of+integrin+regulation+and+signaling&doi=10.1146%2Fannurev.immunol.25.022106.141618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of integrin regulation and signaling</span></div><div class="casAuthors">Luo, Bing-Hao; Carman, Christopher V.; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">619-647</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Integrins are cell adhesion mols. that mediate cell-cell, cell-extracellular matrix, and cell-pathogen interactions.  They play crit. roles for the immune system in leukocyte trafficking and migration, immunol. synapse formation, costimulation, and phagocytosis.  Integrin adhesiveness can be dynamically regulated through a process termed inside-out signaling.  In addn., ligand binding transduces signals from the extracellular domain to the cytoplasm in the classical outside-in direction.  Recent structural, biochem., and biophys. studies have greatly advanced our understanding of the mechanisms of integrin bidirectional signaling across the plasma membrane.  Large-scale reorientations of the ectodomain of up to 200 Å couple to conformational change in ligand-binding sites and are linked to changes in α and β subunit transmembrane domain assocn.  In this review, we focus on integrin structure as it relates to affinity modulation, ligand binding, outside-in signaling, and cell surface distribution dynamics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZNENOA_pMEbVg90H21EOLACvtfcHk0lgkPyYzHELJKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlansrc%253D&md5=f6e4ae57d35b2826223e6aeb28e42b6d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.25.022106.141618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.25.022106.141618%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DB.%2BH.%26aulast%3DCarman%26aufirst%3DC.%2BV.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DStructural%2520basis%2520of%2520integrin%2520regulation%2520and%2520signaling%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D25%26spage%3D619%26epage%3D647%26doi%3D10.1146%2Fannurev.immunol.25.022106.141618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Naci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoudjit, F.</span><span> </span><span class="NLM_article-title">α2β1 integrin in cancer development and chemoresistance</span> <span class="citation_source-journal">Semin. Cancer Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span><span class="refDoi"> DOI: 10.1016/j.semcancer.2015.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.semcancer.2015.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=26297892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyjtLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=145-153&author=D.+Naciauthor=K.+Vuoriauthor=F.+Aoudjit&title=%CE%B12%CE%B21+integrin+in+cancer+development+and+chemoresistance&doi=10.1016%2Fj.semcancer.2015.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">α2β1 integrin in cancer development and chemoresistance</span></div><div class="casAuthors">Naci, Dalila; Vuori, Kristiina; Aoudjit, Fawzi</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-153</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Extracellular matrix, via its receptors the integrins, has emerged as a crucial factor in cancer development.  The α2β1 integrin is a major collagen receptor that is widely expressed and known to promote cell migration and control tissue homeostasis.  Growing evidence suggests that it can be a key pathway in cancer.  Recent studies have shown that α2β1 integrin is a regulator of cancer metastasis either by promoting or inhibiting the dissemination process of cancer cells.  The α2β1 integrin signaling can also enhance tumor angiogenesis.  Emerging evidence supports a role for α2β1 integrin in cancer chemoresistance esp. in hematol. malignancies originating from the T cell lineage.  In addn., α2β1 integrin has been assocd. with cancer stem cells.  In this review, we will discuss the complex role of α2β1 integrin in these processes.  Collagen is a major matrix protein of the tumor microenvironment and thus, understanding how α2β1 integrin regulates cancer pathogenesis is likely to lead to new therapeutic approaches and agents for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfc4wrw4MlKLVg90H21EOLACvtfcHk0lgkPyYzHELJKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyjtLrO&md5=fc9e5a82ccdf89141e62d8fa562b35a2</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2015.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2015.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DNaci%26aufirst%3DD.%26aulast%3DVuori%26aufirst%3DK.%26aulast%3DAoudjit%26aufirst%3DF.%26atitle%3D%25CE%25B12%25CE%25B21%2520integrin%2520in%2520cancer%2520development%2520and%2520chemoresistance%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2015%26volume%3D35%26spage%3D145%26epage%3D153%26doi%3D10.1016%2Fj.semcancer.2015.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span> </span><span class="NLM_article-title">The molecular chaperone gp96/GRP94 interacts with Toll-like receptors and integrins via its C-terminal hydrophobic domain</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">6735</span><span class="NLM_x">–</span> <span class="NLM_lpage">6742</span><span class="refDoi"> DOI: 10.1074/jbc.M111.309526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M111.309526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22223641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38Xisl2ksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=6735-6742&author=S.+Wuauthor=F.+Hongauthor=D.+Gewirthauthor=B.+Guoauthor=B.+Liuauthor=Z.+Li&title=The+molecular+chaperone+gp96%2FGRP94+interacts+with+Toll-like+receptors+and+integrins+via+its+C-terminal+hydrophobic+domain&doi=10.1074%2Fjbc.M111.309526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Molecular Chaperone gp96/GRP94 Interacts with Toll-like Receptors and Integrins via Its C-terminal Hydrophobic Domain</span></div><div class="casAuthors">Wu, Shuang; Hong, Feng; Gewirth, Daniel; Guo, Beichu; Liu, Bei; Li, Zihai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6735-6742</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The structural basis for mol. chaperones to discern misfolded proteins has long been an enigma.  As the endoplasmic reticulum paralogue of the cytosolic HSP90, gp96 (GRP94, HSP90b1) is an essential mol. chaperone for Toll-like receptors (TLRs) and integrins.  However, little is known about its client-binding domain (CBD).  Herein, we provide genetic and biochem. evidence to definitively demonstrate that a C-terminal loop structure, formed by residues 652-678, is the crit. region of CBD for both TLRs and integrins.  Deletion of this region affects neither the intrinsic ATPase activity nor the overall conformation of gp96.  However, without it, the chaperoning function of gp96 collapses.  We also find a crit. Met pair (Met658-Met662) for the folding of integrins but not TLRs.  Moreover, we find that the TLR binding to gp96 is also dependent on the C-terminal dimerization domain but not the N-terminal ATP-binding pocket of gp96.  Our study has unveiled surprisingly the exquisite specificity of gp96 in substrate binding and suggests a manipulation of its CBD as an alternative strategy for targeted therapy of a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbUZKYPoen27Vg90H21EOLACvtfcHk0lgkPyYzHELJKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xisl2ksr0%253D&md5=1e09f7597b9d41e87eeac61da356d690</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.309526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.309526%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DHong%26aufirst%3DF.%26aulast%3DGewirth%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DThe%2520molecular%2520chaperone%2520gp96%252FGRP94%2520interacts%2520with%2520Toll-like%2520receptors%2520and%2520integrins%2520via%2520its%2520C-terminal%2520hydrophobic%2520domain%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D6735%26epage%3D6742%26doi%3D10.1074%2Fjbc.M111.309526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Haidari, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caivano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganjehei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortazavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodside, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willerson, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. A.</span><span> </span><span class="NLM_article-title">Integrin α2β1 mediates tyrosine phosphorylation of vascular endothelial cadherin induced by invasive breast cancer cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">32981</span><span class="NLM_x">–</span> <span class="NLM_lpage">32992</span><span class="refDoi"> DOI: 10.1074/jbc.M112.395905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M112.395905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=32981-32992&author=M.+Haidariauthor=W.+Zhangauthor=A.+Caivanoauthor=Z.+Chenauthor=L.+Ganjeheiauthor=A.+Mortazaviauthor=C.+Stroudauthor=D.+G.+Woodsideauthor=J.+T.+Willersonauthor=R.+A.+Dixon&title=Integrin+%CE%B12%CE%B21+mediates+tyrosine+phosphorylation+of+vascular+endothelial+cadherin+induced+by+invasive+breast+cancer+cells&doi=10.1074%2Fjbc.M112.395905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.395905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.395905%26sid%3Dliteratum%253Aachs%26aulast%3DHaidari%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DCaivano%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGanjehei%26aufirst%3DL.%26aulast%3DMortazavi%26aufirst%3DA.%26aulast%3DStroud%26aufirst%3DC.%26aulast%3DWoodside%26aufirst%3DD.%2BG.%26aulast%3DWillerson%26aufirst%3DJ.%2BT.%26aulast%3DDixon%26aufirst%3DR.%2BA.%26atitle%3DIntegrin%2520%25CE%25B12%25CE%25B21%2520mediates%2520tyrosine%2520phosphorylation%2520of%2520vascular%2520endothelial%2520cadherin%2520induced%2520by%2520invasive%2520breast%2520cancer%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D32981%26epage%3D32992%26doi%3D10.1074%2Fjbc.M112.395905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Dejeans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glorieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sid, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rousseau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisig, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delvenne, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buc Calderon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrax, J.</span><span> </span><span class="NLM_article-title">Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1002</span><span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2011.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.freeradbiomed.2011.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=22245095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFSitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=993-1002&author=N.+Dejeansauthor=C.+Glorieuxauthor=S.+Gueninauthor=R.+Beckauthor=B.+Sidauthor=R.+Rousseauauthor=B.+Bisigauthor=P.+Delvenneauthor=P.+Buc+Calderonauthor=J.+Verrax&title=Overexpression+of+GRP94+in+breast+cancer+cells+resistant+to+oxidative+stress+promotes+high+levels+of+cancer+cell+proliferation+and+migration%3A+implications+for+tumor+recurrence&doi=10.1016%2Fj.freeradbiomed.2011.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: Implications for tumor recurrence</span></div><div class="casAuthors">Dejeans, Nicolas; Glorieux, Christophe; Guenin, Samuel; Beck, Raphael; Sid, Brice; Rousseau, Rejane; Bisig, Bettina; Delvenne, Philippe; Buc Calderon, Pedro; Verrax, Julien</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-1002</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting the altered redox status of cancer cells is emerging as an interesting approach to potentiate chemotherapy.  However, to maximize the effectiveness of this strategy and define the correct chemotherapeutic assocns., it is important to understand the biol. consequences of chronically exposing cancer cells to reactive oxygen species (ROS).  Using an H2O2-generating system, we selected a ROS-resistant MCF-7 breast cancer cell line, namely Resox cells.  By exploring different survival pathways that are usually induced during oxidative stress, we identified a constitutive overexpression of the endoplasmic reticulum chaperone, GRP94, in these cells, whereas levels of its cytoplasmic homolog HSP90, or GRP78, were not modified.  This overexpression was not mediated by constitutive unfolded protein response (UPR) activation.  The increase in GRP94 is tightly linked to an increase in cell proliferation and migration capacities, as shown by GRP94-silencing expts.  Interestingly, we also obsd. that GRP94 silencing inhibits migration and proliferation of the highly aggressive MDA-MB-231 cells.  By immunohistochem., we showed that GRP94 expression was higher in recurrent human breast cancers than in their paired primary neoplasias.  Similar to the situation in the Resox cells, this increase was not assocd. with an increase in UPR activation in recurrent tumors.  In conclusion, this study suggests that GRP94 overexpression may be a hallmark of aggressiveness and recurrence in breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvjqFOXM39gbVg90H21EOLACvtfcHk0lh_jvRu609yVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFSitbs%253D&md5=7125eef26433c15ec7b357151ecc5d20</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2011.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2011.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DDejeans%26aufirst%3DN.%26aulast%3DGlorieux%26aufirst%3DC.%26aulast%3DGuenin%26aufirst%3DS.%26aulast%3DBeck%26aufirst%3DR.%26aulast%3DSid%26aufirst%3DB.%26aulast%3DRousseau%26aufirst%3DR.%26aulast%3DBisig%26aufirst%3DB.%26aulast%3DDelvenne%26aufirst%3DP.%26aulast%3DBuc%2BCalderon%26aufirst%3DP.%26aulast%3DVerrax%26aufirst%3DJ.%26atitle%3DOverexpression%2520of%2520GRP94%2520in%2520breast%2520cancer%2520cells%2520resistant%2520to%2520oxidative%2520stress%2520promotes%2520high%2520levels%2520of%2520cancer%2520cell%2520proliferation%2520and%2520migration%253A%2520implications%2520for%2520tumor%2520recurrence%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2012%26volume%3D52%26spage%3D993%26epage%3D1002%26doi%3D10.1016%2Fj.freeradbiomed.2011.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinogle, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galeva, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrowsky, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, B. S.</span><span> </span><span class="NLM_article-title">Endoplasmic reticulum resident heat shock protein 90 (Hsp90) isoform glucose-regulated protein 94 (Grp94) regulates cell polarity and cancer cell migration by affecting intracellular transport</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1074/jbc.M115.688374</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1074%2Fjbc.M115.688374" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Ghoshauthor=H.+E.+Shinogleauthor=N.+A.+Galevaauthor=R.+T.+Dobrowskyauthor=B.+S.+Blagg&title=Endoplasmic+reticulum+resident+heat+shock+protein+90+%28Hsp90%29+isoform+glucose-regulated+protein+94+%28Grp94%29+regulates+cell+polarity+and+cancer+cell+migration+by+affecting+intracellular+transport&doi=10.1074%2Fjbc.M115.688374"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.688374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.688374%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DShinogle%26aufirst%3DH.%2BE.%26aulast%3DGaleva%26aufirst%3DN.%2BA.%26aulast%3DDobrowsky%26aufirst%3DR.%2BT.%26aulast%3DBlagg%26aufirst%3DB.%2BS.%26atitle%3DEndoplasmic%2520reticulum%2520resident%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520isoform%2520glucose-regulated%2520protein%252094%2520%2528Grp94%2529%2520regulates%2520cell%2520polarity%2520and%2520cancer%2520cell%2520migration%2520by%2520affecting%2520intracellular%2520transport%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26doi%3D10.1074%2Fjbc.M115.688374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Tamm, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunger, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchshofer, R.</span><span> </span><span class="NLM_article-title">Intraocular pressure and the mechanisms involved in resistance of the aqueous humor flow in the trabecular meshwork outflow pathways</span> <span class="citation_source-journal">Prog. Mol. Biol. Transl. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1016/bs.pmbts.2015.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fbs.pmbts.2015.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=26310162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A280%3ADC%252BC287ms1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2015&pages=301-314&author=E.+R.+Tammauthor=B.+M.+Braungerauthor=R.+Fuchshofer&title=Intraocular+pressure+and+the+mechanisms+involved+in+resistance+of+the+aqueous+humor+flow+in+the+trabecular+meshwork+outflow+pathways&doi=10.1016%2Fbs.pmbts.2015.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Intraocular Pressure and the Mechanisms Involved in Resistance of the Aqueous Humor Flow in the Trabecular Meshwork Outflow Pathways</span></div><div class="casAuthors">Tamm Ernst R; Braunger Barbara M; Fuchshofer Rudolf</div><div class="citationInfo"><span class="NLM_cas:title">Progress in molecular biology and translational science</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">301-14</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Intraocular pressure (IOP), the critical risk factor for glaucoma, is generated and maintained by the aqueous humor circulation system.  Aqueous humor is secreted from the epithelial layers of the ciliary body and exits the eye through the trabecular meshwork or the uveoscleral outflow pathways.  IOP builds up in response to a resistance to aqueous humor flow in the trabecular outflow pathways.  The trabecular outflow resistance is localized in the inner wall region, which comprises the juxtacanalicular connective tissue (JCT) and the inner wall endothelium of Schlemm's canal (SC).  Outflow resistance in this region is lowered through the relaxation of contractile myofibroblast-like cells in trabecular meshwork and the adjacent scleral spur, or the contraction of the ciliary muscle.  In primary open-angle glaucoma, the most frequent form of glaucoma, outflow resistance of the inner wall region is typically higher than normal.  There is evidence that the increase in resistance is related to characteristic biological changes in the resident cells of the JCT, which more and more acquire the structural and functional characteristics of contractile myofibroblasts.  The changes involve an augmentation of their actin cytoskeleton and of their surrounding fibrillary extracellular matrix, which connects to JCT cells via integrins.  This scenario leads to an overall stiffening of the inner wall region, and is modulated by transforming growth factor-β/connective tissue growth factor signaling.  Essentially comparable changes appear to occur in SC endothelial cells.  Stiffening of JCT and SC cells is very likely a critical causative factor for the increase in trabecular outflow resistance in POAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRIRhOrbxe3cu3MPKNEWB5RfW6udTcc2eb28SQjDWcfJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287ms1ymtQ%253D%253D&md5=a484733a8c3c3164f6c8cd39653c9255</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fbs.pmbts.2015.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.pmbts.2015.06.007%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DE.%2BR.%26aulast%3DBraunger%26aufirst%3DB.%2BM.%26aulast%3DFuchshofer%26aufirst%3DR.%26atitle%3DIntraocular%2520pressure%2520and%2520the%2520mechanisms%2520involved%2520in%2520resistance%2520of%2520the%2520aqueous%2520humor%2520flow%2520in%2520the%2520trabecular%2520meshwork%2520outflow%2520pathways%26jtitle%3DProg.%2520Mol.%2520Biol.%2520Transl.%2520Sci.%26date%3D2015%26volume%3D134%26spage%3D301%26epage%3D314%26doi%3D10.1016%2Fbs.pmbts.2015.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Donegan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span> </span><span class="NLM_article-title">Discovery of molecular therapeutics for glaucoma: challenges, successes, and promising directions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00828</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00828" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=788-809&author=R.+K.+Doneganauthor=R.+L.+Lieberman&title=Discovery+of+molecular+therapeutics+for+glaucoma%3A+challenges%2C+successes%2C+and+promising+directions&doi=10.1021%2Facs.jmedchem.5b00828"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions</span></div><div class="casAuthors">Donegan, Rebecca K.; Lieberman, Raquel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">788-809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glaucoma, a heterogeneous ocular disorder affecting ∼60 million people worldwide, is characterized by painless neurodegeneration of retinal ganglion cells (RGCs), resulting in irreversible vision loss.  Available therapies, which decrease the common causal risk factor of elevated intraocular pressure, delay, but cannot prevent, RGC death and blindness.  Notably, it is changes in the anterior segment of the eye, particularly in the drainage of aq. humor fluid, which are believed to bring about changes in pressure.  Thus, it is primarily this region whose properties are manipulated in current and emerging therapies for glaucoma.  Here, we focus on the challenges assocd. with developing treatments, review the available exptl. methods to evaluate the therapeutic potential of new drugs, describe the development and evaluation of emerging Rho-kinase inhibitors and adenosine receptor ligands that offer the potential to improve aq. humor outflow and protect RGCs simultaneously, and present new targets and approaches on the horizon.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1zW4SfFzeH7Vg90H21EOLACvtfcHk0ljjHwn1l9ZPiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVygs7rE&md5=fb3c7936206db063ba3b99b767f38504</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00828%26sid%3Dliteratum%253Aachs%26aulast%3DDonegan%26aufirst%3DR.%2BK.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520of%2520molecular%2520therapeutics%2520for%2520glaucoma%253A%2520challenges%252C%2520successes%252C%2520and%2520promising%2520directions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D788%26epage%3D809%26doi%3D10.1021%2Facs.jmedchem.5b00828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Hill, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donegan, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberman, R. L.</span><span> </span><span class="NLM_article-title">The glaucoma-associated olfactomedin domain of myocilin forms polymorphic fibrils that are constrained by partial unfolding and peptide sequence</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">921</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span><span class="refDoi"> DOI: 10.1016/j.jmb.2013.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.jmb.2013.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=24333014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVWntb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2014&pages=921-935&author=S.+E.+Hillauthor=R.+K.+Doneganauthor=R.+L.+Lieberman&title=The+glaucoma-associated+olfactomedin+domain+of+myocilin+forms+polymorphic+fibrils+that+are+constrained+by+partial+unfolding+and+peptide+sequence&doi=10.1016%2Fj.jmb.2013.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The Glaucoma-Associated Olfactomedin Domain of Myocilin Forms Polymorphic Fibrils That Are Constrained by Partial Unfolding and Peptide Sequence</span></div><div class="casAuthors">Hill, Shannon E.; Donegan, Rebecca K.; Lieberman, Raquel L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">921-935</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The glaucoma-assocd. olfactomedin domain of myocilin (myoc-OLF) is a recent addn. to the growing list of disease-assocd. amyloidogenic proteins.  Inherited, disease-causing myocilin variants aggregate intracellularly instead of being secreted to the trabecular meshwork (TM), which is a scenario toxic to trabecular meshwork cells and leads to early onset of ocular hypertension, the major risk factor for glaucoma.  Here we systematically structurally and biophys. dissected myoc-OLF to better understand its amyloidogenesis.  Under mildly destabilizing conditions, wild-type myoc-OLF adopts non-native structures that readily fibrillize when incubated at a temp. just below the transition for tertiary unfolding.  With buffers at physiol. pH, two main endpoint fibril morphologies are obsd.: (a) straight fibrils common to many amyloids and (b) unique micron-length, ∼300 nm or larger diam., species that lasso oligomers, which also exhibit classical spectroscopic amyloid signatures.  Three disease-causing variants investigated herein exhibit non-native tertiary structures under physiol. conditions, leading to a variety of growth rates and a fibril morphologies.  In particular, the well-documented D380A variant, which lacks calcium, forms large circular fibrils.  Two amyloid-forming peptide stretches have been identified, one for each of the main fibril morphologies obsd.  Our study places myoc-OLF within the larger landscape of the amylome and provides insight into the diversity of myoc-OLF aggregation that plays a role in glaucoma pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqatLM_cpzTfrVg90H21EOLACvtfcHk0ljjHwn1l9ZPiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVWntb%252FO&md5=046a26d965d57fd7f94759c2678f8c76</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2013.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2013.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DS.%2BE.%26aulast%3DDonegan%26aufirst%3DR.%2BK.%26aulast%3DLieberman%26aufirst%3DR.%2BL.%26atitle%3DThe%2520glaucoma-associated%2520olfactomedin%2520domain%2520of%2520myocilin%2520forms%2520polymorphic%2520fibrils%2520that%2520are%2520constrained%2520by%2520partial%2520unfolding%2520and%2520peptide%2520sequence%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2014%26volume%3D426%26spage%3D921%26epage%3D935%26doi%3D10.1016%2Fj.jmb.2013.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Kamal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sensintaffar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritz, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrows, F. J.</span><span> </span><span class="NLM_article-title">A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span><span class="refDoi"> DOI: 10.1038/nature01913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1038%2Fnature01913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=14508491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=407-410&author=A.+Kamalauthor=L.+Thaoauthor=J.+Sensintaffarauthor=L.+Zhangauthor=M.+F.+Boehmauthor=L.+C.+Fritzauthor=F.+J.+Burrows&title=A+high-affinity+conformation+of+Hsp90+confers+tumour+selectivity+on+Hsp90+inhibitors&doi=10.1038%2Fnature01913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors</span></div><div class="casAuthors">Kamal, Adeela; Thao, Lia; Sensintaffar, John; Zhang, Lin; Boehm, Marcus F.; Fritz, Lawrence C.; Burrows, Francis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6956</span>),
    <span class="NLM_cas:pages">407-410</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone that plays a key role in the conformational maturation of oncogenic signaling proteins, including HER-2/ErbB2, Akt, Raf-1, Bcr-Abl and mutated p53.  Hsp90 inhibitors bind to Hsp90, and induce the proteasomal degrdn. of Hsp90 client proteins.  Although Hsp90 is highly expressed in most cells, Hsp90 inhibitors selectively kill cancer cells compared to normal cells, and the Hsp90 inhibitor 17-allylaminogeldanamycin (17-AAG) is currently in phase I clin. trials.  However, the mol. basis of the tumor selectivity of Hsp90 inhibitors is unknown.  Here we report that Hsp90 derived from tumor cells has a 100-fold higher binding affinity for 17-AAG than does Hsp90 from normal cells.  Tumor Hsp90 is present entirely in multi-chaperone complexes with high ATPase activity, whereas Hsp90 from normal tissues is in a latent, uncomplexed state.  In vitro reconstitution of chaperone complexes with Hsp90 resulted in increased binding affinity to 17-AAG, and increased ATPase activity.  These results suggest that tumor cells contain Hsp90 complexes in an activated, high-affinity conformation that facilitates malignant progression, and that may represent a unique target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ozo1K3wfA7Vg90H21EOLACvtfcHk0ljNyzVLmRa2Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsV2kt7w%253D&md5=7c83fca7aaf685b589c4aef6e5f39b02</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnature01913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01913%26sid%3Dliteratum%253Aachs%26aulast%3DKamal%26aufirst%3DA.%26aulast%3DThao%26aufirst%3DL.%26aulast%3DSensintaffar%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DBoehm%26aufirst%3DM.%2BF.%26aulast%3DFritz%26aufirst%3DL.%2BC.%26aulast%3DBurrows%26aufirst%3DF.%2BJ.%26atitle%3DA%2520high-affinity%2520conformation%2520of%2520Hsp90%2520confers%2520tumour%2520selectivity%2520on%2520Hsp90%2520inhibitors%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D407%26epage%3D410%26doi%3D10.1038%2Fnature01913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Dollins, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Immormino, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gewirth, D. T.</span><span> </span><span class="NLM_article-title">Structures of GRP94-nucleotide complexes reveal mechanistic differences between the Hsp90 chaperones</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1016/j.molcel.2007.08.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1016%2Fj.molcel.2007.08.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=41-56&author=D.+E.+Dollinsauthor=J.+J.+Warrenauthor=R.+M.+Immorminoauthor=D.+T.+Gewirth&title=Structures+of+GRP94-nucleotide+complexes+reveal+mechanistic+differences+between+the+Hsp90+chaperones&doi=10.1016%2Fj.molcel.2007.08.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.08.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.08.024%26sid%3Dliteratum%253Aachs%26aulast%3DDollins%26aufirst%3DD.%2BE.%26aulast%3DWarren%26aufirst%3DJ.%2BJ.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DGewirth%26aufirst%3DD.%2BT.%26atitle%3DStructures%2520of%2520GRP94-nucleotide%2520complexes%2520reveal%2520mechanistic%2520differences%2520between%2520the%2520Hsp90%2520chaperones%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D28%26spage%3D41%26epage%3D56%26doi%3D10.1016%2Fj.molcel.2007.08.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Tropea, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waugh, D. S.</span><span> </span><span class="NLM_article-title">Expression and purification of soluble His(6)-tagged TEV protease</span> <span class="citation_source-journal">Methods Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">498</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1007/978-1-59745-196-3_19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1007%2F978-1-59745-196-3_19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=18988033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=498&publication_year=2009&pages=297-307&author=J.+E.+Tropeaauthor=S.+Cherryauthor=D.+S.+Waugh&title=Expression+and+purification+of+soluble+His%286%29-tagged+TEV+protease&doi=10.1007%2F978-1-59745-196-3_19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and purification of soluble His6-tagged TEV protease</span></div><div class="casAuthors">Tropea, Joseph E.; Cherry, Scott; Waugh, David S.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (Totowa, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">498</span>
        (<span class="NLM_cas:issue">High Throughput Protein Expression and Purification</span>),
    <span class="NLM_cas:pages">297-307</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1064-3745</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">This chapter describes a simple method for overproducing a sol. form of the tobacco etch virus (TEV) protease in Escherichia coli and purifying it to homogeneity so that it may be used as a reagent for removing affinity tags from recombinant proteins by site-specific endoproteolysis.  The protease is initially produced as a fusion on the C-terminus of E.coli maltose binding protein (MBP), which causes it to accumulate in a sol. and active form rather than in inclusion bodies.  The fusion protein subsequently cleaves itself in vivo to remove the MBP moiety, yielding a sol. TEV protease catalytic domain with an N-terminal polyhistidine tag.  The His-tagged TEV protease can be purified in two steps using immobilized metal affinity chromatog. (IMAC) followed by gel filtration.  An S219V mutation in the protease reduces its rate of autolysis by approx. 100-fold and also gives rise to an enzyme with greater catalytic efficiency than the wild-type protease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNe7Jl6qta0LVg90H21EOLACvtfcHk0ljNyzVLmRa2Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFyqsbs%253D&md5=8031a280366500e8c1b20ba4e50d793b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2F978-1-59745-196-3_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-59745-196-3_19%26sid%3Dliteratum%253Aachs%26aulast%3DTropea%26aufirst%3DJ.%2BE.%26aulast%3DCherry%26aufirst%3DS.%26aulast%3DWaugh%26aufirst%3DD.%2BS.%26atitle%3DExpression%2520and%2520purification%2520of%2520soluble%2520His%25286%2529-tagged%2520TEV%2520protease%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2009%26volume%3D498%26spage%3D297%26epage%3D307%26doi%3D10.1007%2F978-1-59745-196-3_19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Xds</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Xds&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljNyzVLmRa2Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXds%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhTKPaZs7h3tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhTKPaZs7h3tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Schuttelkopf, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Aalten, D. M.</span><span> </span><span class="NLM_article-title">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1355</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span><span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;key=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Schuttelkopfauthor=D.+M.+van+Aalten&title=PRODRG%3A+a+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuttelkopf Alexander W; van Aalten Daan M F</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1355-63</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The small-molecule topology generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and molecular topologies suitable for X-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compounds from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the standard libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallographic R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdNRIcoht5aXy-c-E1v-fmfW6udTcc2eafEgov6N-AdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D&md5=1adce6cd2cacdace513a69efa33c4e93</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DPRODRG%253A%2520a%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2GFD','PDB','2GFD'); return false;">PDB: 2GFD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2FXS','PDB','2FXS'); return false;">PDB: 2FXS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3O2F','PDB','3O2F'); return false;">PDB: 3O2F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IN9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IN9','PDB','5IN9'); return false;">PDB: 5IN9</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i113"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00085">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_84346"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00085">10.1021/acs.jmedchem.6b00085</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR spectra for all new compounds and HPLC traces for most active compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00085/suppl_file/jm6b00085_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00085/suppl_file/jm6b00085_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00085/suppl_file/jm6b00085_si_001.pdf">jm6b00085_si_001.pdf (17.5 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00085/suppl_file/jm6b00085_si_002.csv">jm6b00085_si_002.csv (5.61 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00085&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00085%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00085" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b6773aa92308","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
